This is a Validated Antibody Database (VAD) review about human EGFR, based on 428 published articles (read how Labome selects the articles), using EGFR antibody in all methods. It is aimed to help Labome visitors find the most suited EGFR antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
EGFR synonym: ERBB; ERBB1; HER1; NISBD2; PIG61; mENA

Knockout validation
Abcam
domestic rabbit monoclonal (EP38Y)
  • immunohistochemistry knockout validation; mouse; loading ...; fig 9b
Abcam EGFR antibody (Abcam, ab52894) was used in immunohistochemistry knockout validation on mouse samples (fig 9b). Cell Mol Gastroenterol Hepatol (2019) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (D38B1)
  • western blot knockout validation; human; 1:400; loading ...; fig s49
  • immunohistochemistry - paraffin section; human; 1:400; loading ...; fig 5g
Cell Signaling Technology EGFR antibody (Cell Signaling, 4267) was used in western blot knockout validation on human samples at 1:400 (fig s49) and in immunohistochemistry - paraffin section on human samples at 1:400 (fig 5g). Nat Commun (2022) ncbi
Abcam
domestic rabbit monoclonal (EP38Y)
  • western blot; human; loading ...; fig 7c
Abcam EGFR antibody (Abcam, ab52894) was used in western blot on human samples (fig 7c). Front Immunol (2022) ncbi
domestic rabbit monoclonal (Y38)
  • western blot; human; loading ...; fig 7c
Abcam EGFR antibody (Abcam, ab32430) was used in western blot on human samples (fig 7c). Front Immunol (2022) ncbi
domestic rabbit monoclonal (EP38Y)
  • western blot; human; 1:1000; fig 7a
Abcam EGFR antibody (Abcam, ab52894) was used in western blot on human samples at 1:1000 (fig 7a). Int J Mol Sci (2022) ncbi
domestic rabbit monoclonal (EP38Y)
  • western blot; human; 1:100; fig 3c
Abcam EGFR antibody (abcam, ab52894) was used in western blot on human samples at 1:100 (fig 3c). Am J Cancer Res (2022) ncbi
domestic rabbit monoclonal (EP38Y)
  • western blot; human; 1:10,000; fig 4b
Abcam EGFR antibody (Abcam, ab52894) was used in western blot on human samples at 1:10,000 (fig 4b). JCI Insight (2021) ncbi
domestic rabbit monoclonal (EP38Y)
  • immunohistochemistry; mouse; loading ...; fig 7b
Abcam EGFR antibody (Abcam, ab52894) was used in immunohistochemistry on mouse samples (fig 7b). Sci Adv (2021) ncbi
domestic rabbit monoclonal (EP774Y)
  • immunocytochemistry; human; loading ...; fig 6b
Abcam EGFR antibody (Abcam, ab40815) was used in immunocytochemistry on human samples (fig 6b). J Exp Clin Cancer Res (2021) ncbi
domestic rabbit monoclonal
  • immunocytochemistry; human; loading ...; fig 4g
Abcam EGFR antibody (Abcam, ab192982) was used in immunocytochemistry on human samples (fig 4g). Mol Oncol (2021) ncbi
domestic rabbit monoclonal (EP774Y)
  • immunohistochemistry - paraffin section; mouse; 1:1000; loading ...; fig 1b
Abcam EGFR antibody (Abcam, ab40815) was used in immunohistochemistry - paraffin section on mouse samples at 1:1000 (fig 1b). iScience (2021) ncbi
domestic rabbit monoclonal (E235)
  • immunohistochemistry - frozen section; human; 1:100; fig 3c
Abcam EGFR antibody (Abcam, ab32077) was used in immunohistochemistry - frozen section on human samples at 1:100 (fig 3c). bioRxiv (2021) ncbi
domestic rabbit monoclonal (E234)
  • western blot; human; 1:1000; loading ...; fig ev3e
Abcam EGFR antibody (Abcam, E234) was used in western blot on human samples at 1:1000 (fig ev3e). EMBO Mol Med (2020) ncbi
domestic rabbit monoclonal (EP38Y)
  • immunohistochemistry - paraffin section; human; 1:50; loading ...; fig 2
Abcam EGFR antibody (Abcam, ab52894) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 2). BMC Cancer (2020) ncbi
mouse monoclonal (EM-12)
  • western blot; human; 1:1000; loading ...; fig 4d
Abcam EGFR antibody (Abcam, ab81440) was used in western blot on human samples at 1:1000 (fig 4d). Biosci Rep (2020) ncbi
domestic rabbit monoclonal (EP774Y)
  • western blot; human; 1:1000; loading ...; fig 4d
Abcam EGFR antibody (Abcam, ab40815) was used in western blot on human samples at 1:1000 (fig 4d). Biosci Rep (2020) ncbi
domestic rabbit monoclonal (EP38Y)
  • western blot; human; 1:1000; loading ...; fig 4d
Abcam EGFR antibody (Abcam, ab52894) was used in western blot on human samples at 1:1000 (fig 4d). Biosci Rep (2020) ncbi
domestic rabbit monoclonal (E235)
  • immunohistochemistry; rat; loading ...; fig 4h
Abcam EGFR antibody (Abcam, ab32077) was used in immunohistochemistry on rat samples (fig 4h). Cell Commun Signal (2020) ncbi
domestic rabbit monoclonal (EP38Y)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig s2c
  • immunocytochemistry; human; 1:200; loading ...; fig 2d
  • western blot; human; 1:1000; loading ...; fig s3
Abcam EGFR antibody (Abcam, ab52894) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig s2c), in immunocytochemistry on human samples at 1:200 (fig 2d) and in western blot on human samples at 1:1000 (fig s3). Nat Commun (2020) ncbi
domestic rabbit monoclonal (EP38Y)
  • immunocytochemistry; human; 1:100; loading ...; fig 6c
  • western blot; human; 1:500; loading ...; fig 6a
Abcam EGFR antibody (Abcam, ab52894) was used in immunocytochemistry on human samples at 1:100 (fig 6c) and in western blot on human samples at 1:500 (fig 6a). Front Oncol (2019) ncbi
mouse monoclonal (EGFR1)
  • proximity ligation assay; human; loading ...; fig 2a
Abcam EGFR antibody (Abcam, ab30) was used in proximity ligation assay on human samples (fig 2a). Breast Cancer Res (2019) ncbi
domestic rabbit monoclonal (E235)
  • western blot; mouse; 1:2000; loading ...; fig 3d
Abcam EGFR antibody (Abcam, ab32077) was used in western blot on mouse samples at 1:2000 (fig 3d). Breast Cancer Res (2019) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 3d
Abcam EGFR antibody (Abcam, ab5652) was used in western blot on mouse samples at 1:1000 (fig 3d). Breast Cancer Res (2019) ncbi
domestic rabbit monoclonal (EP774Y)
  • western blot; human; loading ...; fig 7a
Abcam EGFR antibody (Abcam, ab40815) was used in western blot on human samples (fig 7a). Theranostics (2019) ncbi
domestic rabbit monoclonal (EP38Y)
  • western blot; human; loading ...; fig 3a
Abcam EGFR antibody (Abcam, ab52894) was used in western blot on human samples (fig 3a). Theranostics (2019) ncbi
domestic rabbit monoclonal (EP38Y)
  • immunohistochemistry knockout validation; mouse; loading ...; fig 9b
Abcam EGFR antibody (Abcam, ab52894) was used in immunohistochemistry knockout validation on mouse samples (fig 9b). Cell Mol Gastroenterol Hepatol (2019) ncbi
domestic rabbit monoclonal (EP38Y)
  • mass cytometry; human; loading ...; fig 3a
Abcam EGFR antibody (Abcam, ab52894) was used in mass cytometry on human samples (fig 3a). Cell (2019) ncbi
domestic rabbit monoclonal (EP38Y)
  • western blot; human; 1:2000; loading ...; fig s5
Abcam EGFR antibody (Abcam, ab52894) was used in western blot on human samples at 1:2000 (fig s5). J Biol Chem (2019) ncbi
domestic rabbit monoclonal (EP38Y)
  • western blot; mouse; fig 7a
Abcam EGFR antibody (Abcam, ab52894) was used in western blot on mouse samples (fig 7a). Int J Biol Sci (2019) ncbi
domestic rabbit monoclonal (EP38Y)
  • western blot; human; loading ...; fig 3g
Abcam EGFR antibody (Abcam, ab52894) was used in western blot on human samples (fig 3g). J Mol Med (Berl) (2019) ncbi
domestic rabbit monoclonal (EP38Y)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1a
  • western blot; human; loading ...; fig 1c
Abcam EGFR antibody (Abcam, ab52894) was used in immunohistochemistry - paraffin section on human samples (fig 1a) and in western blot on human samples (fig 1c). Exp Mol Med (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 2e
Abcam EGFR antibody (Abcam, ab5644) was used in western blot on human samples (fig 2e). Exp Mol Med (2018) ncbi
domestic rabbit monoclonal (EP38Y)
  • western blot; human; 1:1000; loading ...; fig 6a
Abcam EGFR antibody (Abcam, ab52894) was used in western blot on human samples at 1:1000 (fig 6a). Cancer Sci (2019) ncbi
domestic rabbit monoclonal (Y38)
  • western blot; human; 1:2000; loading ...; fig 6a
Abcam EGFR antibody (Abcam, ab32430) was used in western blot on human samples at 1:2000 (fig 6a). Cancer Sci (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 5e
Abcam EGFR antibody (Abcam, ab5644) was used in western blot on human samples (fig 5e). Cell Res (2018) ncbi
domestic rabbit monoclonal (E124)
  • other; human; loading ...; fig 4c
Abcam EGFR antibody (Abcam, ab32578) was used in other on human samples (fig 4c). Cancer Cell (2018) ncbi
domestic rabbit monoclonal (EP38Y)
  • immunocytochemistry; human; loading ...; fig s8
Abcam EGFR antibody (Abcam, ab52894) was used in immunocytochemistry on human samples (fig s8). Nat Commun (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 3a
Abcam EGFR antibody (Abcam, ab5644) was used in western blot on human samples at 1:1000 (fig 3a). Nat Commun (2017) ncbi
domestic rabbit monoclonal (E124)
  • immunocytochemistry; human; 1:200; loading ...; fig 6e
In order to study H2O2-dependent wound repair mechanisms in human keratinocytes, Abcam EGFR antibody (Abcam, ab32578) was used in immunocytochemistry on human samples at 1:200 (fig 6e). J Cell Sci (2017) ncbi
domestic rabbit monoclonal (EP38Y)
  • western blot; human; loading ...; fig 2b
Abcam EGFR antibody (Abcam, 1138-1) was used in western blot on human samples (fig 2b). Autophagy (2017) ncbi
domestic rabbit monoclonal (EP38Y)
  • immunohistochemistry - paraffin section; human; loading ...; fig 4a
  • western blot; human; loading ...; fig 4d
In order to improve the therapeutic efficacy of cetuximab for non-small cell lung cancer by co-administrating the tumor-penetrating internalizing RGD peptide, Abcam EGFR antibody (Abcam, ab52894) was used in immunohistochemistry - paraffin section on human samples (fig 4a) and in western blot on human samples (fig 4d). Oncol Lett (2016) ncbi
mouse monoclonal (EM-12)
  • western blot; hamsters; 1:1000; loading ...; fig s6a
Abcam EGFR antibody (Abcam, ab81440) was used in western blot on hamsters samples at 1:1000 (fig s6a). Nat Commun (2016) ncbi
domestic rabbit monoclonal (EP774Y)
  • western blot; mouse; 1:500; fig 1
Abcam EGFR antibody (Abcam, AB40815) was used in western blot on mouse samples at 1:500 (fig 1). J Cell Sci (2016) ncbi
rat monoclonal (ICR10)
  • flow cytometry; human; 1:40; loading ...; fig 4a
In order to suggest that EGFR promotes survival of prostate tumor-initiating cells and circulating tumor cells that metastasize to bone, whereas HER2 supports the growth of prostate cancer cells once they are established at metastatic sites, Abcam EGFR antibody (Abcam, ICR10) was used in flow cytometry on human samples at 1:40 (fig 4a). Cancer Res (2017) ncbi
domestic rabbit monoclonal (EP774Y)
  • western blot; human; 1:800; loading ...; fig 8
In order to elucidate the relationship between protease prolyl endopeptidase and neural cell adhesion molecule, Abcam EGFR antibody (Abcam, EP774Y) was used in western blot on human samples at 1:800 (fig 8). J Cell Sci (2016) ncbi
domestic rabbit monoclonal (EP38Y)
  • western blot; human; 1:1000; loading ...; fig 8
In order to elucidate the relationship between protease prolyl endopeptidase and neural cell adhesion molecule, Abcam EGFR antibody (Abcam, EP38Y) was used in western blot on human samples at 1:1000 (fig 8). J Cell Sci (2016) ncbi
domestic rabbit monoclonal (EP38Y)
  • immunocytochemistry; mouse; fig s1
  • immunohistochemistry; mouse; fig 1
Abcam EGFR antibody (Abcam, ab52894) was used in immunocytochemistry on mouse samples (fig s1) and in immunohistochemistry on mouse samples (fig 1). Nat Commun (2016) ncbi
domestic rabbit monoclonal (EP38Y)
  • western blot; human; 1:1000; loading ...; fig 7c
Abcam EGFR antibody (Abcam, ab52894) was used in western blot on human samples at 1:1000 (fig 7c). Oncotarget (2016) ncbi
domestic rabbit monoclonal (Y38)
  • western blot; human; fig 4
Abcam EGFR antibody (abcam, ab32430) was used in western blot on human samples (fig 4). Oncotarget (2016) ncbi
domestic rabbit monoclonal (EP774Y)
  • western blot; human; loading ...; fig 4c
Abcam EGFR antibody (Abcam, ab40815) was used in western blot on human samples (fig 4c). Oncotarget (2016) ncbi
domestic rabbit monoclonal (EP38Y)
  • western blot; human; loading ...; fig 5a
Abcam EGFR antibody (Abcam, ab52894) was used in western blot on human samples (fig 5a). Oncotarget (2016) ncbi
domestic rabbit monoclonal (EP774Y)
  • western blot; human; loading ...; fig 5a
Abcam EGFR antibody (Abcam, ab40815) was used in western blot on human samples (fig 5a). Oncotarget (2016) ncbi
domestic rabbit monoclonal (EP38Y)
  • immunohistochemistry - paraffin section; human; loading ...; fig 3a
In order to present the role of nfatc4 in sox9 gene expression in acinar cell plasticity and pancreatic cancer initiation, Abcam EGFR antibody (Abcam, ab52894) was used in immunohistochemistry - paraffin section on human samples (fig 3a). Stem Cells Int (2016) ncbi
domestic rabbit monoclonal (E235)
  • western blot; human; fig 5
In order to describe functionally enriched ES cell transgenics, Abcam EGFR antibody (Abcam, ab32077) was used in western blot on human samples (fig 5). Sci Rep (2015) ncbi
rat monoclonal (ICR10)
  • flow cytometry; human; tbl 1
Abcam EGFR antibody (Abcam, ab231) was used in flow cytometry on human samples (tbl 1). PLoS ONE (2015) ncbi
rat monoclonal (ICR10)
  • other; mouse; 1:100; loading ...; fig 2h
Abcam EGFR antibody (Abcam, ab231) was used in other on mouse samples at 1:100 (fig 2h). Cell Death Dis (2015) ncbi
domestic rabbit monoclonal (EP38Y)
  • western blot; human; fig 3
Abcam EGFR antibody (Abcam, ab52894) was used in western blot on human samples (fig 3). Oncotarget (2015) ncbi
domestic rabbit monoclonal (EP774Y)
  • western blot; mouse; 1:1000; fig 5
Abcam EGFR antibody (abcam, ab40815) was used in western blot on mouse samples at 1:1000 (fig 5). Mol Cancer (2015) ncbi
domestic rabbit monoclonal (EP38Y)
  • western blot; mouse; fig s8
In order to study induction of sarcomatoid phenotype solely due to ductal activation of oncogenic KRAS, Abcam EGFR antibody (Abcam, ab52894) was used in western blot on mouse samples (fig s8). Sci Rep (2015) ncbi
domestic rabbit monoclonal (EP774Y)
  • western blot; mouse; fig s8
In order to study induction of sarcomatoid phenotype solely due to ductal activation of oncogenic KRAS, Abcam EGFR antibody (Abcam, ab40815) was used in western blot on mouse samples (fig s8). Sci Rep (2015) ncbi
domestic rabbit monoclonal (EP38Y)
  • immunocytochemistry; mouse; 1:100
  • western blot; mouse; 1:1000
Abcam EGFR antibody (Abcam, ab52894) was used in immunocytochemistry on mouse samples at 1:100 and in western blot on mouse samples at 1:1000. Neuroscience (2015) ncbi
domestic rabbit monoclonal (EP774Y)
  • immunohistochemistry - paraffin section; mouse; fig 6
  • western blot; mouse; fig s7
Abcam EGFR antibody (Abcam, ab40815) was used in immunohistochemistry - paraffin section on mouse samples (fig 6) and in western blot on mouse samples (fig s7). Nat Commun (2015) ncbi
domestic rabbit monoclonal (EP774Y)
  • western blot; human; fig 2
Abcam EGFR antibody (Abcam, ab40815) was used in western blot on human samples (fig 2). Oncotarget (2015) ncbi
domestic rabbit monoclonal (EP38Y)
  • western blot; mouse
Abcam EGFR antibody (AbCam, EP38Y) was used in western blot on mouse samples . Oncogene (2016) ncbi
domestic rabbit monoclonal (Y38)
  • western blot; pigs ; loading ...; fig 6a
Abcam EGFR antibody (Epitomics, ab32430) was used in western blot on pigs samples (fig 6a). PLoS ONE (2015) ncbi
domestic rabbit monoclonal (EP774Y)
  • western blot; human; fig  3
Abcam EGFR antibody (Abcam, ab40815) was used in western blot on human samples (fig  3). J Biol Chem (2015) ncbi
domestic rabbit monoclonal (Y38)
  • western blot; human
In order to study the role of EGFR in regulating the Keap1/Nrf2 cascade, Abcam EGFR antibody (Abcam, ab32430) was used in western blot on human samples . Am J Transl Res (2014) ncbi
mouse monoclonal (EGFR1)
  • other; mouse; loading ...; fig 2,3a,4,5a,5b,6a
Abcam EGFR antibody (Abcam, Ab30) was used in other on mouse samples (fig 2,3a,4,5a,5b,6a). Lasers Surg Med (2015) ncbi
mouse monoclonal (EGFR1)
  • immunocytochemistry; human; 1:100
Abcam EGFR antibody (Abcam, ab24293) was used in immunocytochemistry on human samples at 1:100. Neuro Oncol (2013) ncbi
domestic rabbit monoclonal (EP38Y)
  • immunohistochemistry; human
Abcam EGFR antibody (Abcam, ab52894) was used in immunohistochemistry on human samples . EMBO J (2011) ncbi
Invitrogen
domestic rabbit polyclonal
  • immunocytochemistry; human; loading ...; fig 2b
Invitrogen EGFR antibody (Thermofisher Scientific, 36?C9700) was used in immunocytochemistry on human samples (fig 2b). iScience (2022) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; mouse; 1:1000; fig 6c
Invitrogen EGFR antibody (Thermo Fisher Scientific, PA1-1110) was used in immunocytochemistry on mouse samples at 1:1000 (fig 6c). BMC Biol (2021) ncbi
mouse monoclonal (111.6)
  • immunohistochemistry; dogs; fig 2f
Invitrogen EGFR antibody (NeoMarkers, 111.6) was used in immunohistochemistry on dogs samples (fig 2f). Animals (Basel) (2021) ncbi
mouse monoclonal (111.6)
  • immunocytochemistry; human; loading ...; fig 7a
Invitrogen EGFR antibody (Thermo, MA5-13269) was used in immunocytochemistry on human samples (fig 7a). elife (2020) ncbi
mouse monoclonal (S.684.2)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig s2b
  • immunocytochemistry; human; 1:200; loading ...; fig 2e
Invitrogen EGFR antibody (ThermoFisher, S.684.2) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig s2b) and in immunocytochemistry on human samples at 1:200 (fig 2e). Nat Commun (2020) ncbi
mouse monoclonal (199.12)
  • immunocytochemistry; human; 1:100; loading ...; fig 6s1a
Invitrogen EGFR antibody (Thermo Fisher, MA5-13319) was used in immunocytochemistry on human samples at 1:100 (fig 6s1a). elife (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig e11-7b
Invitrogen EGFR antibody (Thermo Fisher Scientific, 44-788) was used in western blot on human samples (fig e11-7b). Nature (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; 1 ug/ml; loading ...; fig 1c
Invitrogen EGFR antibody (Thermo Fisher, PA1-1110) was used in western blot on human samples at 1 ug/ml (fig 1c). Proc Natl Acad Sci U S A (2019) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; 1:250; loading ...; fig s4i
Invitrogen EGFR antibody (ThermoFischer Scientific, 36-9700) was used in immunocytochemistry on human samples at 1:250 (fig s4i). Science (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig s2a
Invitrogen EGFR antibody (Thermo Fisher, 36-9700) was used in western blot on human samples at 1:1000 (fig s2a). Nat Med (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 5a
In order to discover regions of rare genetic variation that contribute to emphysema with severe airflow obstruction, Invitrogen EGFR antibody (Invitrogen, 44-784G) was used in western blot on human samples (fig 5a). Am J Respir Crit Care Med (2017) ncbi
mouse monoclonal (H9B4)
  • immunocytochemistry; human; 1:1000; loading ...; fig 4b
  • western blot; human; 1:1000; loading ...; fig 4a
In order to test if Dub3 contributes to Snail1 stability in cancer cells, Invitrogen EGFR antibody (Neomarkers, Ab-15) was used in immunocytochemistry on human samples at 1:1000 (fig 4b) and in western blot on human samples at 1:1000 (fig 4a). Nat Commun (2017) ncbi
mouse monoclonal (225)
  • immunocytochemistry; human; 1:200; loading ...; fig 6e
In order to study H2O2-dependent wound repair mechanisms in human keratinocytes, Invitrogen EGFR antibody (ThermoFisher, MA5-12880) was used in immunocytochemistry on human samples at 1:200 (fig 6e). J Cell Sci (2017) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; loading ...; fig 1c
In order to show the Nogo-B receptor promotes accumulation of prenylated Ras at the plasma membrane, Invitrogen EGFR antibody (Invitrogen, PA1-1110) was used in immunocytochemistry on human samples (fig 1c). Oncogene (2017) ncbi
mouse monoclonal (199.12)
  • immunocytochemistry; human; fig s5a
In order to elucidate how adaptor protein 2 complexes regulate clathrin-coated pit assembly, Invitrogen EGFR antibody (NeoMarkers, 199.12) was used in immunocytochemistry on human samples (fig s5a). J Cell Biol (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:2000; loading ...; fig 3
In order to assess the contribution of amphiregulin, epidermal growth factor, heparin-binding epidermal growth factor, and transforming growth factor alpha in the responsiveness of gastric cancer cell lines to cetuximab and trastuzumab, Invitrogen EGFR antibody (Invitrogen, 44788G) was used in western blot on human samples at 1:2000 (fig 3). J Cancer Res Clin Oncol (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; loading ...; fig 4a
  • western blot; human; loading ...; fig 4d
In order to improve the therapeutic efficacy of cetuximab for non-small cell lung cancer by co-administrating the tumor-penetrating internalizing RGD peptide, Invitrogen EGFR antibody (Thermo Fisher, 36-9700) was used in immunohistochemistry - paraffin section on human samples (fig 4a) and in western blot on human samples (fig 4d). Oncol Lett (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 4g
In order to investigate the molecular mechanisms by which human esophageal cancer endothelial cells contribute to esophageal carcinoma progression, Invitrogen EGFR antibody (Invitrogen, 44796G) was used in western blot on human samples at 1:1000 (fig 4g). Am J Cancer Res (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 4g
In order to investigate the molecular mechanisms by which human esophageal cancer endothelial cells contribute to esophageal carcinoma progression, Invitrogen EGFR antibody (Invitrogen, 44790G) was used in western blot on human samples at 1:1000 (fig 4g). Am J Cancer Res (2016) ncbi
mouse monoclonal (H9B4)
  • western blot; human; loading ...; fig 1b
In order to suggest that EGFR promotes survival of prostate tumor-initiating cells and circulating tumor cells that metastasize to bone, whereas HER2 supports the growth of prostate cancer cells once they are established at metastatic sites, Invitrogen EGFR antibody (NeoMarkers, H9B4) was used in western blot on human samples (fig 1b). Cancer Res (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 5b
In order to elucidate how JNJ-61186372 attenuates therapeutic resistance in patients with epidermal growth factor receptor mutations, Invitrogen EGFR antibody (Invitrogen, 44-794G) was used in western blot on human samples (fig 5b). MAbs (2017) ncbi
mouse monoclonal (111.6)
  • immunohistochemistry; human; fig 3a
In order to perform Raman-encoded molecular imaging with five nanoparticle flavors, Invitrogen EGFR antibody (Thermo Scientific, MS-378-PABX) was used in immunohistochemistry on human samples (fig 3a). PLoS ONE (2016) ncbi
mouse monoclonal (199.12)
  • immunocytochemistry; human; 1:1000; fig s6
In order to develop and characterize a three-dimensional model to study tumor-stroma interactions, Invitrogen EGFR antibody (Thermo Scientific, MA5-13319) was used in immunocytochemistry on human samples at 1:1000 (fig s6). Sci Rep (2016) ncbi
mouse monoclonal (199.12)
  • blocking or activating experiments; human; loading ...; fig 1c
In order to propose that ikarugamycin is a useful reagent to study routes of endocytic trafficking, Invitrogen EGFR antibody (Thermo Scientific, MS-396-P) was used in blocking or activating experiments on human samples (fig 1c). Traffic (2016) ncbi
domestic rabbit recombinant (30H45L48)
  • western blot; human; loading ...; fig 5a
In order to characterize novel EGF receptor inhibitors, Invitrogen EGFR antibody (Thermo Fisher Scientific, ABfinity) was used in western blot on human samples (fig 5a). Bioorg Med Chem (2016) ncbi
mouse monoclonal (H11)
  • immunohistochemistry; human; 1:200; fig 6a
  • western blot; human; loading ...; fig 1b
In order to determine that MUC1 stimulates epidermal growth factor receptor expression and function in endometrial cancer, Invitrogen EGFR antibody (Thermo Scientific, H11) was used in immunohistochemistry on human samples at 1:200 (fig 6a) and in western blot on human samples (fig 1b). Oncotarget (2016) ncbi
mouse monoclonal (H9B4)
  • immunohistochemistry; human; 1:200; fig 6a
  • western blot; human; loading ...; fig 1b
In order to determine that MUC1 stimulates epidermal growth factor receptor expression and function in endometrial cancer, Invitrogen EGFR antibody (Thermo Scientific, H9B4) was used in immunohistochemistry on human samples at 1:200 (fig 6a) and in western blot on human samples (fig 1b). Oncotarget (2016) ncbi
mouse monoclonal (528)
  • flow cytometry; human; fig 2
  • western blot; human; 1:10,000; fig 1
In order to characterize the epidermal growth factor receptor in triple-negative breast cancer for a cancer-specific epitope target, Invitrogen EGFR antibody (Pierce, MA5-12875) was used in flow cytometry on human samples (fig 2) and in western blot on human samples at 1:10,000 (fig 1). J Natl Cancer Inst (2016) ncbi
domestic rabbit recombinant (30H45L48)
  • immunocytochemistry; human; loading ...; fig 5a
In order to describe a multiplex analysis method to examine anti-EGFR functions in heterogeneous cells, Invitrogen EGFR antibody (Thermo Fisher Scientific, ABfinity) was used in immunocytochemistry on human samples (fig 5a). Anal Chem (2016) ncbi
domestic rabbit polyclonal
  • flow cytometry; human; 1:100; fig 8
In order to study the molecular basis for activation of the epidermal growth factor receptor by multimerization, Invitrogen EGFR antibody (Thermo Fisher Scientific, 44-786G) was used in flow cytometry on human samples at 1:100 (fig 8). elife (2016) ncbi
mouse monoclonal (225)
  • immunocytochemistry; human; fig 2
In order to study the interaction between EGFR and delta catenin, which leads to delta catenin phosphorylation and EGFR signaling enhancement, Invitrogen EGFR antibody (ThermoFisher Scientific, MA5-12880) was used in immunocytochemistry on human samples (fig 2). Sci Rep (2016) ncbi
mouse monoclonal (111.6)
  • flow cytometry; human; fig 5
In order to learn about intraoperative guidance of breast cancer lumpectomy by quantitative molecular phenotyping with topically applied SERS nanoparticles, Invitrogen EGFR antibody (Thermo Scientific, MS-378-PABX) was used in flow cytometry on human samples (fig 5). Sci Rep (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 1
In order to study how ZEB1 drives the epithelial-mesenchymal transition-related resistance to EGFR-tyrosine kinases inhibitors in non-small cell lung cancer, Invitrogen EGFR antibody (Invitrogen, 44-788G) was used in western blot on human samples (fig 1). PLoS ONE (2016) ncbi
domestic rabbit recombinant (30H45L48)
  • immunocytochemistry; human; 5 ug/ml; loading ...; fig 2a
In order to examine the role of epidermal growth factor in medulloblastoma chemotactic migration, Invitrogen EGFR antibody (Life Technologies, 700308) was used in immunocytochemistry on human samples at 5 ug/ml (fig 2a). Cell Mol Bioeng (2015) ncbi
domestic rabbit polyclonal
In order to investigate changes to AURKA signaling after treatment with erlotinib/alisertib combination therapy, Invitrogen EGFR antibody (Invitrogen, 44794G) was used . Front Oncol (2015) ncbi
domestic rabbit polyclonal
In order to study a non-small-cell lung cancer and relevant EGFR mutants in an in vitro model to determine mutation specificity of EGFR tyrosine kinase inhibitors, Invitrogen EGFR antibody (Invitrogen, 44788G) was used . Oncotarget (2015) ncbi
mouse monoclonal (111.6)
  • immunohistochemistry - paraffin section; human; 1:400; fig 1
In order to characterize hepatocellular carcinoma tissues and missense mutations in exons 18-24 of EGFR, Invitrogen EGFR antibody (Lab Vision, 111.6) was used in immunohistochemistry - paraffin section on human samples at 1:400 (fig 1). Biomed Res Int (2015) ncbi
domestic rabbit polyclonal
In order to elucidate the mechanism of intracellular activation of EGFR by fatty acid synthase dependent palmitoylation, Invitrogen EGFR antibody (Invitrogen, 44794G) was used . Oncotarget (2015) ncbi
mouse monoclonal (EGFR.1)
  • immunocytochemistry; human; fig s9
In order to use nonlinear and multiplexed illumination to get high-resolution and deep three-dimensional tracking of single particles, Invitrogen EGFR antibody (Thermo Scientific, MS-311-B) was used in immunocytochemistry on human samples (fig s9). Nat Commun (2015) ncbi
mouse monoclonal (199.12)
  • immunocytochemistry; human; 1:1000
In order to discuss detection of colorectal cancer using conventional wide-field endoscopy, Invitrogen EGFR antibody (Thermo Scientific, MS-396) was used in immunocytochemistry on human samples at 1:1000. Clin Transl Gastroenterol (2015) ncbi
mouse monoclonal (H11)
  • immunocytochemistry; human; 1:200
In order to use a high-throughput 3D hyaluronic acid hydrogel coculture of cancer cells with stromal cells to evaluate chemotherapeutics, Invitrogen EGFR antibody (NeoMarkers, H11) was used in immunocytochemistry on human samples at 1:200. Adv Healthc Mater (2015) ncbi
domestic rabbit polyclonal
In order to characterize two new cell lines with the potential to be used to study portal (myo)fibroblasts, Invitrogen EGFR antibody (Thermo Scientific, PA1-1110) was used . PLoS ONE (2015) ncbi
mouse monoclonal (111.6)
  • ELISA; human; fig 2
In order to use of dual-probe modeling of SERS nanoparticles to quantify binding potential of cell-surface receptors in fresh excised specimens, Invitrogen EGFR antibody (Thermo Scientific, MS-378-PABX) was used in ELISA on human samples (fig 2). Sci Rep (2015) ncbi
mouse monoclonal (111.6)
  • western blot; human
In order to elucidate the relationship between LRRK2 and Rab5b, Invitrogen EGFR antibody (Thermo Scientific Pierce, MA5-13269) was used in western blot on human samples . J Biochem (2015) ncbi
domestic rabbit polyclonal
In order to show that a new alkyne amino acid can be site-selectively incorporated into mammalian proteins, Invitrogen EGFR antibody (Pierce, PA1-1110) was used . ACS Chem Biol (2015) ncbi
mouse monoclonal (H9B4)
  • immunoprecipitation; human
  • western blot; human
In order to examine the effects of kinase inhibtors that target the epidermal growth factor receptor in lung cancer, Invitrogen EGFR antibody (Neomarker, Ab15) was used in immunoprecipitation on human samples and in western blot on human samples . Cancer Res (2014) ncbi
mouse monoclonal (H9B4)
  • western blot; human; fig 1
In order to study the efficacy and tolerability of the irreversible tyrosine kinase inhibitor dacomitinib in human bladder cancer models, Invitrogen EGFR antibody (Neo-markers, clone Ab-15 H9B4) was used in western blot on human samples (fig 1). Mol Med (2013) ncbi
mouse monoclonal (EGFR.1)
  • immunohistochemistry; human
In order to describe histological features of a tumor from a patient with pleuropulmonary blastoma, Invitrogen EGFR antibody (Lab Vision, EGFR.113) was used in immunohistochemistry on human samples . Fetal Pediatr Pathol (2014) ncbi
mouse monoclonal (EGFR.1)
  • immunocytochemistry; human; fig s1
In order to use gold nanoparticles and ultrashort pulses to kill cancer cells, Invitrogen EGFR antibody (Lab Vision, EGFR.1) was used in immunocytochemistry on human samples (fig s1). Sci Rep (2013) ncbi
mouse monoclonal (H9B4)
  • immunoprecipitation; mouse; 1:1000
In order to study targeting sEcad for treatment of breast cancer, Invitrogen EGFR antibody (Thermo Fisher Scientific, Ab-15) was used in immunoprecipitation on mouse samples at 1:1000. Mol Carcinog (2014) ncbi
mouse monoclonal (H9B4)
  • western blot; human; 1:1000; fig 3
In order to examine the role that EGFR activation plays in modulating MUC1 levels, Invitrogen EGFR antibody (Invitrogen, H9B4) was used in western blot on human samples at 1:1000 (fig 3). J Cell Biochem (2013) ncbi
mouse monoclonal (H9B4)
  • western blot; human; 1:5000; fig 1
In order to assess EGFR and MUC1 as targets for nanoparticle intracellular accumulation and clustering, Invitrogen EGFR antibody (Invitrogen, clone H9B4) was used in western blot on human samples at 1:5000 (fig 1). Theranostics (2012) ncbi
mouse monoclonal (528)
  • immunohistochemistry; human; fig 3
In order to study the expression pattern of stem cells in the bulbar conjunctival epithelium, Invitrogen EGFR antibody (Lab Vision, 528) was used in immunohistochemistry on human samples (fig 3). J Cell Physiol (2010) ncbi
mouse monoclonal (199.12)
  • immunoprecipitation; human; fig 6
  • immunocytochemistry; human; fig 2
  • western blot; human; fig 6
In order to investigate the effect of EGFR ligands on receptor internalization and endocytic sorting, Invitrogen EGFR antibody (Thermo Fisher, 199.12) was used in immunoprecipitation on human samples (fig 6), in immunocytochemistry on human samples (fig 2) and in western blot on human samples (fig 6). Traffic (2009) ncbi
mouse monoclonal (EGFR.1)
  • immunohistochemistry; human; 1:25; tbl 3
In order to investigate the sub-classification invasive breast carcinoma patients and its prognostic significance, Invitrogen EGFR antibody (Lab Vision/Neomarkers, EGFR.113) was used in immunohistochemistry on human samples at 1:25 (tbl 3). Cancer (2007) ncbi
mouse monoclonal (H9B4)
  • immunocytochemistry; mouse; 1:50; loading ...; fig 5
  • western blot; mouse; loading ...; fig 3a
In order to study EGF-independent activation of mutant cell-surface EGF receptors in gefitinib-sensitive lung cancer, Invitrogen EGFR antibody (LabVision, Ab15) was used in immunocytochemistry on mouse samples at 1:50 (fig 5) and in western blot on mouse samples (fig 3a). Oncogene (2007) ncbi
mouse monoclonal (H9B4)
  • western blot; human; 1:1000; fig 6
In order to study the antiproliferative capacity of hTERT antisense oligonucleotides, Invitrogen EGFR antibody (Biosource, H9B4) was used in western blot on human samples at 1:1000 (fig 6). Int J Cancer (2006) ncbi
mouse monoclonal (F4)
  • western blot; human
In order to test if sulindac metabolites block activation or expression of the epidermal growth factor receptor, Invitrogen EGFR antibody (Biosource, F4) was used in western blot on human samples . J Carcinog (2005) ncbi
mouse monoclonal (111.6)
  • western blot; human
In order to test if sulindac metabolites block activation or expression of the epidermal growth factor receptor, Invitrogen EGFR antibody (Biosource, 111.6) was used in western blot on human samples . J Carcinog (2005) ncbi
mouse monoclonal (199.12)
  • western blot; human
In order to test if sulindac metabolites block activation or expression of the epidermal growth factor receptor, Invitrogen EGFR antibody (Biosource, 199.12) was used in western blot on human samples . J Carcinog (2005) ncbi
mouse monoclonal (H9B4)
  • western blot; fruit fly ; fig 4b
In order to study the role of ligand-induced dimer interface conformational changes in the dimerization and activation of EGFR, Invitrogen EGFR antibody (NeoMarkers, Ab-15) was used in western blot on fruit fly samples (fig 4b). Mol Cell Biol (2005) ncbi
mouse monoclonal (199.12)
  • western blot; human; fig 7
In order to investigate factors that protect malignant cells from detachment-induced death, Invitrogen EGFR antibody (NeoMarkers, Ab-11) was used in western blot on human samples (fig 7). Am J Pathol (2004) ncbi
mouse monoclonal (H11)
  • ELISA; human; tbl 2
In order to suggest that AEE788 is an anticancer agent that deregulates tumor cell proliferation and angiogenic parameters, Invitrogen EGFR antibody (NeoMarkers, MS316-P1ABX) was used in ELISA on human samples (tbl 2). Cancer Res (2004) ncbi
mouse monoclonal (H11)
  • ELISA; human; 50 ng/well; tbl 1
In order to study the in vivo antitumor activity of a potent and selective IGF-1 receptor kinase inhibitor, Invitrogen EGFR antibody (Neomarkers, MS-316-P) was used in ELISA on human samples at 50 ng/well (tbl 1). Cancer Cell (2004) ncbi
mouse monoclonal (H11)
  • western blot; human; fig 2
In order to study the role of a constitutively active variant of the EGFR in increasing mouse fibroblast motility, Invitrogen EGFR antibody (NeoMarkers, H-11) was used in western blot on human samples (fig 2). Int J Cancer (2004) ncbi
Santa Cruz Biotechnology
mouse monoclonal (A-10)
  • immunocytochemistry; human; loading ...; fig 4b
Santa Cruz Biotechnology EGFR antibody (Santa Cruz Biotechnology, sc-373746) was used in immunocytochemistry on human samples (fig 4b). iScience (2022) ncbi
mouse monoclonal (528)
  • proximity ligation assay; human; loading ...; fig 1e
  • western blot; human; loading ...; fig 5l
Santa Cruz Biotechnology EGFR antibody (Santa Cruz, sc-120) was used in proximity ligation assay on human samples (fig 1e) and in western blot on human samples (fig 5l). Cell Death Dis (2022) ncbi
mouse monoclonal (A-10)
  • western blot; human; loading ...; fig 6a, 8i
Santa Cruz Biotechnology EGFR antibody (Santa Cruz, sc-373746) was used in western blot on human samples (fig 6a, 8i). J Exp Clin Cancer Res (2021) ncbi
mouse monoclonal (A-10)
  • western blot; human; loading ...; fig 2c, 2d
Santa Cruz Biotechnology EGFR antibody (Santa Cruz Biotechnology, sc-373746) was used in western blot on human samples (fig 2c, 2d). Neoplasia (2021) ncbi
mouse monoclonal (528)
  • western blot; human; 1:2000; loading ...; fig 2a
Santa Cruz Biotechnology EGFR antibody (Santa Cruz Biotechnology, sc-120) was used in western blot on human samples at 1:2000 (fig 2a). Nat Commun (2021) ncbi
mouse monoclonal (A-10)
  • western blot; mouse; 1:1000; loading ...; fig 3c
Santa Cruz Biotechnology EGFR antibody (Santa Cruz, sc-373746) was used in western blot on mouse samples at 1:1000 (fig 3c). J Cancer (2020) ncbi
mouse monoclonal (528)
  • immunohistochemistry; human; loading ...; fig s8f
Santa Cruz Biotechnology EGFR antibody (Santa Cruz Biotechnology, sc-120) was used in immunohistochemistry on human samples (fig s8f). Cell (2020) ncbi
mouse monoclonal (A-10)
  • western blot; human; loading ...; fig 10a
Santa Cruz Biotechnology EGFR antibody (Santa Cruz Biotechnology, sc-373746) was used in western blot on human samples (fig 10a). J Virol (2019) ncbi
mouse monoclonal
  • western blot; human; 1:1000; loading ...; fig 5g
Santa Cruz Biotechnology EGFR antibody (Santa Cruz Biotechnology, A-10) was used in western blot on human samples at 1:1000 (fig 5g). Cell Mol Life Sci (2019) ncbi
mouse monoclonal (A-10)
  • western blot; human; 1:1000; loading ...; fig 5g
Santa Cruz Biotechnology EGFR antibody (Santa Cruz Biotechnology, A-10) was used in western blot on human samples at 1:1000 (fig 5g). Cell Mol Life Sci (2019) ncbi
mouse monoclonal (A-10)
  • immunocytochemistry; human; 1:150; loading ...; fig s4i
Santa Cruz Biotechnology EGFR antibody (Santa Cruz Biotechnology, sc-373746) was used in immunocytochemistry on human samples at 1:150 (fig s4i). Science (2018) ncbi
mouse monoclonal
  • western blot; human; 1:660; loading ...; fig 3a
Santa Cruz Biotechnology EGFR antibody (Santa Cruz, A-10) was used in western blot on human samples at 1:660 (fig 3a). J Med Chem (2017) ncbi
mouse monoclonal (A-10)
  • western blot; human; 1:660; loading ...; fig 3a
Santa Cruz Biotechnology EGFR antibody (Santa Cruz, A-10) was used in western blot on human samples at 1:660 (fig 3a). J Med Chem (2017) ncbi
mouse monoclonal (R-1)
  • flow cytometry; human; loading ...; fig s4b
  • western blot; human; loading ...; fig 5a
Santa Cruz Biotechnology EGFR antibody (Santa Cruz, sc-101) was used in flow cytometry on human samples (fig s4b) and in western blot on human samples (fig 5a). MBio (2017) ncbi
mouse monoclonal (A-10)
  • western blot; rat; loading ...; fig 13a
Santa Cruz Biotechnology EGFR antibody (Santa Cruz Biotechnology, sc-373746) was used in western blot on rat samples (fig 13a). Am J Pathol (2017) ncbi
mouse monoclonal (E-8)
  • western blot; human; 1:1000; loading ...; fig 5d
Santa Cruz Biotechnology EGFR antibody (Santa Cruz, sc-374607) was used in western blot on human samples at 1:1000 (fig 5d). Sci Rep (2017) ncbi
mouse monoclonal (A-10)
  • western blot; rat; 1:200; loading ...; fig 5
Santa Cruz Biotechnology EGFR antibody (Santa Cruz Biotechnology, sc-373746) was used in western blot on rat samples at 1:200 (fig 5). J Immunol Res (2016) ncbi
mouse monoclonal (C-2)
  • western blot; human; loading ...; fig 7c
Santa Cruz Biotechnology EGFR antibody (Santa Cruz, sc-377229) was used in western blot on human samples (fig 7c). EMBO J (2017) ncbi
mouse monoclonal (R-1)
  • immunocytochemistry; human; 1:250; loading ...; fig 1a
In order to research the role of the endosomal transcriptional regulator RNF11 in EGFR degradation and transportation, Santa Cruz Biotechnology EGFR antibody (Santa Cruz, sc-101) was used in immunocytochemistry on human samples at 1:250 (fig 1a). J Cell Biol (2016) ncbi
mouse monoclonal (C-2)
  • western blot; human; 1:2000; loading ...; fig s6a
Santa Cruz Biotechnology EGFR antibody (Santa Cruz, sc-377229) was used in western blot on human samples at 1:2000 (fig s6a). Nat Cell Biol (2016) ncbi
mouse monoclonal (A-10)
  • western blot; human; 1:1000; loading ...; fig 4g
In order to demonstrate the bipartite role of Hsp90 in chaperoning CRAF kinase, Santa Cruz Biotechnology EGFR antibody (Santa Cruz, SC373746) was used in western blot on human samples at 1:1000 (fig 4g). J Biol Chem (2016) ncbi
mouse monoclonal (528)
  • flow cytometry; Chinese hamsters; fig 1
Santa Cruz Biotechnology EGFR antibody (Santa Cruz, Sc-120) was used in flow cytometry on Chinese hamsters samples (fig 1). Sci Rep (2016) ncbi
mouse monoclonal (528)
  • flow cytometry; hamsters; loading ...; fig 1d
Santa Cruz Biotechnology EGFR antibody (Santa Cruz, Sc-120) was used in flow cytometry on hamsters samples (fig 1d). Cell Commun Signal (2016) ncbi
mouse monoclonal (528)
In order to determine control of clathrin coat recruitment to early endosomes for fast endocytic recycling by NECAP2, Santa Cruz Biotechnology EGFR antibody (Santa Cruz Biotechnology, sc-120) was used . J Cell Sci (2016) ncbi
mouse monoclonal (528)
  • immunocytochemistry; human; 1:100; loading ...; fig 7b
Santa Cruz Biotechnology EGFR antibody (Santa Cruz Biotechnology, sc-120) was used in immunocytochemistry on human samples at 1:100 (fig 7b). Oncotarget (2016) ncbi
mouse monoclonal (R-1)
In order to characterize the interaction with the fusion protein of respiratory syncytial virus strain 2-20 and mediation of infection and mucin expression by EGFR, Santa Cruz Biotechnology EGFR antibody (santa Cruz, sc-101) was used . PLoS Pathog (2016) ncbi
mouse monoclonal (A-10)
  • western blot; human; fig 4
Santa Cruz Biotechnology EGFR antibody (santa Cruz, sc-373746) was used in western blot on human samples (fig 4). PLoS ONE (2016) ncbi
mouse monoclonal (R-1)
  • immunocytochemistry; human; 1:100
In order to study the conversion of phosphatidylinositol 3-phosphate to phosphatidylinositol 4-phosphate at endosomes en route to the plasma membrane, Santa Cruz Biotechnology EGFR antibody (Santa Cruz, R-1) was used in immunocytochemistry on human samples at 1:100. Nature (2016) ncbi
mouse monoclonal (R-1)
  • western blot; human; fig 1
Santa Cruz Biotechnology EGFR antibody (Santa Cruz, sc-101) was used in western blot on human samples (fig 1). BMC Cell Biol (2015) ncbi
mouse monoclonal (A-10)
  • western blot; human; fig 6
In order to study the fusion between lysosomes and amphisomes/MVBs regulated by mahogunin via ubiquitination of TSG101, Santa Cruz Biotechnology EGFR antibody (Santa Cruz, sc-373746) was used in western blot on human samples (fig 6). Cell Death Dis (2015) ncbi
mouse monoclonal (528)
  • flow cytometry; human; 1:100; fig 3d
In order to characterize enhancement of tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b by H19 non coding RNA-derived miR-675, Santa Cruz Biotechnology EGFR antibody (Santa Cruz, sc-120) was used in flow cytometry on human samples at 1:100 (fig 3d). Oncotarget (2015) ncbi
mouse monoclonal (R-1)
  • immunocytochemistry; human; fig 3
Santa Cruz Biotechnology EGFR antibody (Santa Cruz, sc-101) was used in immunocytochemistry on human samples (fig 3). Mol Biol Cell (2015) ncbi
mouse monoclonal (528)
  • flow cytometry; mouse; fig 5
Santa Cruz Biotechnology EGFR antibody (Santa Cruz Biotechnology, SC-120) was used in flow cytometry on mouse samples (fig 5). Analyst (2015) ncbi
mouse monoclonal (A-10)
  • western blot; human; fig 1
Santa Cruz Biotechnology EGFR antibody (Santa cruz, sc-373746) was used in western blot on human samples (fig 1). PLoS ONE (2015) ncbi
mouse monoclonal (528)
  • blocking or activating experiments; human; 1:200
In order to study signaling events downstream to the G-protein-coupled estrogen receptor activated by dehydroepiandrosterone, Santa Cruz Biotechnology EGFR antibody (Santa Cruz Biotechnology, sc-120) was used in blocking or activating experiments on human samples at 1:200. J Biol Chem (2015) ncbi
mouse monoclonal (R-1)
  • immunoprecipitation; human; fig 5
  • immunocytochemistry; human; fig s3
Santa Cruz Biotechnology EGFR antibody (Santa Cruz, sc-101) was used in immunoprecipitation on human samples (fig 5) and in immunocytochemistry on human samples (fig s3). J Cell Sci (2015) ncbi
mouse monoclonal (A-10)
  • immunoprecipitation; human
  • western blot; human
In order to identify LRRK1 as a target for FIH-1 during epithelial migration, Santa Cruz Biotechnology EGFR antibody (Santa Cruz, sc-373746) was used in immunoprecipitation on human samples and in western blot on human samples . Am J Pathol (2014) ncbi
mouse monoclonal (528)
  • immunoprecipitation; human
Santa Cruz Biotechnology EGFR antibody (Santa Cruz, 528) was used in immunoprecipitation on human samples . Am J Reprod Immunol (2015) ncbi
mouse monoclonal (528)
  • western blot; human
Santa Cruz Biotechnology EGFR antibody (Santa Cruz, sc-120) was used in western blot on human samples . Mol Oncol (2015) ncbi
mouse monoclonal (R-1)
  • immunohistochemistry; rat; 1:200
Santa Cruz Biotechnology EGFR antibody (Stemcells Inc, SC101) was used in immunohistochemistry on rat samples at 1:200. Neuroreport (2014) ncbi
BioLegend
mouse monoclonal (AY13)
  • flow cytometry; human
BioLegend EGFR antibody (BioLegend, 352911) was used in flow cytometry on human samples . Front Immunol (2022) ncbi
mouse monoclonal (AY13)
  • other; human; fig 1d
BioLegend EGFR antibody (Biolegend, 352923) was used in other on human samples (fig 1d). Sci Rep (2021) ncbi
mouse monoclonal (AY13)
  • flow cytometry; human; loading ...; fig 1d
BioLegend EGFR antibody (BioLegend, 352903) was used in flow cytometry on human samples (fig 1d). Sci Adv (2021) ncbi
mouse monoclonal (AY13)
  • other; human; 1:100; loading ...
BioLegend EGFR antibody (Biolegend, AY13) was used in other on human samples at 1:100. elife (2020) ncbi
mouse monoclonal (AY13)
  • flow cytometry; human; loading ...; fig 2c
BioLegend EGFR antibody (Biolegend, 352907) was used in flow cytometry on human samples (fig 2c). Nat Commun (2020) ncbi
mouse monoclonal (AY13)
  • flow cytometry; human; loading ...; fig 1c
BioLegend EGFR antibody (BioLegend, AY13) was used in flow cytometry on human samples (fig 1c). Oncoimmunology (2020) ncbi
mouse monoclonal (AY13)
  • flow cytometry; human; loading ...; fig 2a
BioLegend EGFR antibody (Biolegend, AY13) was used in flow cytometry on human samples (fig 2a). Bone Rep (2020) ncbi
mouse monoclonal (AY13)
  • flow cytometry; human; fig 4A
BioLegend EGFR antibody (BioLegend, 352903) was used in flow cytometry on human samples (fig 4A). PLoS ONE (2016) ncbi
mouse monoclonal (AY13)
  • flow cytometry; human
In order to use a multi-omics strategy to elucidate the cellular programs altered by Staphylococcus aureus alpha-toxin, BioLegend EGFR antibody (BioLegend, 352904) was used in flow cytometry on human samples . PLoS ONE (2015) ncbi
Miltenyi Biotec
human monoclonal (REA688)
  • immunohistochemistry - frozen section; human; loading ...; fig 4a, 5
Miltenyi Biotec EGFR antibody (Miltenyi Biotec, 130-110-586) was used in immunohistochemistry - frozen section on human samples (fig 4a, 5). Sci Rep (2022) ncbi
Cell Signaling Technology
domestic rabbit polyclonal
  • western blot; human; 1:2000; loading ...; fig 4g
Cell Signaling Technology EGFR antibody (Cell Signaling, 2232) was used in western blot on human samples at 1:2000 (fig 4g). iScience (2022) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; 1:2000; loading ...; fig 4g
Cell Signaling Technology EGFR antibody (Cell Signaling, 3777) was used in western blot on human samples at 1:2000 (fig 4g). iScience (2022) ncbi
domestic rabbit monoclonal (D38B1)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 7a
Cell Signaling Technology EGFR antibody (Cell Signaling, 5616) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 7a). Nat Commun (2022) ncbi
domestic rabbit monoclonal (D38B1)
  • immunohistochemistry; mouse; loading ...; fig 2f
Cell Signaling Technology EGFR antibody (Cell Signaling, 4267S) was used in immunohistochemistry on mouse samples (fig 2f). Cancers (Basel) (2022) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; 1:300; loading ...; fig 4h
Cell Signaling Technology EGFR antibody (Cell Signaling, 2232) was used in immunocytochemistry on human samples at 1:300 (fig 4h). Cancers (Basel) (2022) ncbi
domestic rabbit monoclonal (53A5)
  • western blot; human; loading ...; fig s3a, s3b
Cell Signaling Technology EGFR antibody (CST, 4407) was used in western blot on human samples (fig s3a, s3b). Cell Oncol (Dordr) (2022) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; loading ...; fig s3a, s3b
Cell Signaling Technology EGFR antibody (CST, 4267) was used in western blot on human samples (fig s3a, s3b). Cell Oncol (Dordr) (2022) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig s3g
Cell Signaling Technology EGFR antibody (CST, 2234) was used in western blot on human samples (fig s3g). J Immunother Cancer (2022) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig s3g
Cell Signaling Technology EGFR antibody (CST, 2232) was used in western blot on human samples (fig s3g). J Immunother Cancer (2022) ncbi
domestic rabbit monoclonal (6B6)
  • western blot; human; loading ...; fig 3a
Cell Signaling Technology EGFR antibody (Cell Signaling, 2085T) was used in western blot on human samples (fig 3a). Thorac Cancer (2022) ncbi
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig 1a
  • western blot; human; loading ...; fig 2b
Cell Signaling Technology EGFR antibody (Cell Signaling, 2234) was used in western blot on mouse samples (fig 1a) and in western blot on human samples (fig 2b). Oncoimmunology (2022) ncbi
domestic rabbit monoclonal (43B2)
  • western blot; human; loading ...; fig 2b
  • western blot; mouse; loading ...; fig 1a
Cell Signaling Technology EGFR antibody (Cell Signaling, 3197) was used in western blot on human samples (fig 2b) and in western blot on mouse samples (fig 1a). Oncoimmunology (2022) ncbi
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig 1a
  • western blot; human; loading ...; fig 2b
Cell Signaling Technology EGFR antibody (Cell Signaling, 2232) was used in western blot on mouse samples (fig 1a) and in western blot on human samples (fig 2b). Oncoimmunology (2022) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 4
Cell Signaling Technology EGFR antibody (CST, 2232) was used in western blot on human samples (fig 4). Cancers (Basel) (2022) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1a, 1b, 1c
Cell Signaling Technology EGFR antibody (Cell Signaling, 2232) was used in western blot on human samples (fig 1a, 1b, 1c). Cancers (Basel) (2022) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1a, 1b, 1c
Cell Signaling Technology EGFR antibody (Cell Signaling, 2234) was used in western blot on human samples (fig 1a, 1b, 1c). Cancers (Basel) (2022) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; rat; 1:100; loading ...; fig s1
  • western blot; rat; loading ...; fig s2
Cell Signaling Technology EGFR antibody (Cell Signaling, 2232) was used in immunohistochemistry - paraffin section on rat samples at 1:100 (fig s1) and in western blot on rat samples (fig s2). Front Med (Lausanne) (2022) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; rat; 1:200; loading ...; fig 4c
  • western blot; rat; loading ...; fig 6a
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 1a
Cell Signaling Technology EGFR antibody (Cell Signaling, 2234) was used in immunohistochemistry - paraffin section on rat samples at 1:200 (fig 4c), in western blot on rat samples (fig 6a) and in immunohistochemistry - paraffin section on human samples at 1:200 (fig 1a). Front Med (Lausanne) (2022) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; loading ...; fig s4b
Cell Signaling Technology EGFR antibody (Cell Signaling, 3777) was used in western blot on human samples (fig s4b). Oncoimmunology (2022) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot knockout validation; human; 1:400; loading ...; fig s49
  • immunohistochemistry - paraffin section; human; 1:400; loading ...; fig 5g
Cell Signaling Technology EGFR antibody (Cell Signaling, 4267) was used in western blot knockout validation on human samples at 1:400 (fig s49) and in immunohistochemistry - paraffin section on human samples at 1:400 (fig 5g). Nat Commun (2022) ncbi
domestic rabbit monoclonal (D7A5)
  • immunohistochemistry - paraffin section; human; 1:400; loading ...; fig 5g
  • western blot; human; 1:400; loading ...; fig 5f, s41a, s52b, s52c
Cell Signaling Technology EGFR antibody (Cell Signaling, 3777) was used in immunohistochemistry - paraffin section on human samples at 1:400 (fig 5g) and in western blot on human samples at 1:400 (fig 5f, s41a, s52b, s52c). Nat Commun (2022) ncbi
domestic rabbit monoclonal (6B6)
  • proximity ligation assay; human; loading ...; fig 1e
  • western blot; human; loading ...; fig 5l
Cell Signaling Technology EGFR antibody (Cell Signaling, 2085) was used in proximity ligation assay on human samples (fig 1e) and in western blot on human samples (fig 5l). Cell Death Dis (2022) ncbi
mouse monoclonal (1H12)
  • proximity ligation assay; human; loading ...; fig 1g
  • immunoprecipitation; human; loading ...; fig 1h
  • western blot; human; loading ...; fig 1h
Cell Signaling Technology EGFR antibody (Cell Signaling, 2236) was used in proximity ligation assay on human samples (fig 1g), in immunoprecipitation on human samples (fig 1h) and in western blot on human samples (fig 1h). Cell Death Dis (2022) ncbi
domestic rabbit monoclonal (D7A5)
  • immunohistochemistry - paraffin section; human; 1:100; fig 8d
  • western blot; human; 1:1000; loading ...; fig 5a
Cell Signaling Technology EGFR antibody (Cell Signaling, 3777) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 8d) and in western blot on human samples at 1:1000 (fig 5a). Cancer Cell Int (2022) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; mouse; 1:500; loading ...; fig 9a
Cell Signaling Technology EGFR antibody (Cell Signaling, 3777S) was used in western blot on mouse samples at 1:500 (fig 9a). J Clin Invest (2022) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; mouse; 1:1000; loading ...; fig 9a
Cell Signaling Technology EGFR antibody (Cell Signaling, 4267) was used in western blot on mouse samples at 1:1000 (fig 9a). J Clin Invest (2022) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; rat; fig 6a
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 4267) was used in western blot on rat samples (fig 6a). Front Pharmacol (2021) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; rat; fig 6a
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 3777) was used in western blot on rat samples (fig 6a). Front Pharmacol (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig s7
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 2220) was used in western blot on human samples at 1:1000 (fig s7). Oncogenesis (2021) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; 1:1000; loading ...; fig s7
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 4267) was used in western blot on human samples at 1:1000 (fig s7). Oncogenesis (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig s7
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 4404) was used in western blot on human samples at 1:1000 (fig s7). Oncogenesis (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig s7
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 2235) was used in western blot on human samples at 1:1000 (fig s7). Oncogenesis (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig s7
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 2237) was used in western blot on human samples at 1:1000 (fig s7). Oncogenesis (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig s7
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 2231) was used in western blot on human samples at 1:1000 (fig s7). Oncogenesis (2021) ncbi
domestic rabbit monoclonal (53A5)
  • western blot; human; 1:1000; loading ...; fig s7
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 4407) was used in western blot on human samples at 1:1000 (fig s7). Oncogenesis (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 4d
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 2231) was used in western blot on human samples (fig 4d). BMC Cancer (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 4d
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 2232) was used in western blot on human samples (fig 4d). BMC Cancer (2021) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; loading ...; fig 5d
Cell Signaling Technology EGFR antibody (Cell Signaling, 3777) was used in western blot on human samples (fig 5d). Front Pharmacol (2021) ncbi
mouse monoclonal (1F4)
  • western blot; human; 1:500; loading ...; fig s2a
Cell Signaling Technology EGFR antibody (Cell Signaling, 2239) was used in western blot on human samples at 1:500 (fig s2a). Nat Commun (2021) ncbi
domestic rabbit monoclonal (6B6)
  • western blot; human; 1:1000; loading ...; fig 8a
Cell Signaling Technology EGFR antibody (Cell Signaling Technologies, 2085) was used in western blot on human samples at 1:1000 (fig 8a). Nat Commun (2021) ncbi
domestic rabbit monoclonal (43B2)
  • western blot; human; 1:1000; loading ...; fig 8a
Cell Signaling Technology EGFR antibody (Cell Signaling Technologies, 3197) was used in western blot on human samples at 1:1000 (fig 8a). Nat Commun (2021) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 4c
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 2234) was used in western blot on mouse samples at 1:1000 (fig 4c). Commun Biol (2021) ncbi
domestic rabbit monoclonal (C74B9)
  • western blot; mouse; 1:1000; loading ...; fig 4c
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 2646) was used in western blot on mouse samples at 1:1000 (fig 4c). Commun Biol (2021) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; loading ...; fig 1c
Cell Signaling Technology EGFR antibody (Cell Signalin, 3777) was used in western blot on human samples (fig 1c). Cancers (Basel) (2021) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; loading ...; fig 1c
Cell Signaling Technology EGFR antibody (Cell Signalin, 4267) was used in western blot on human samples (fig 1c). Cancers (Basel) (2021) ncbi
domestic rabbit monoclonal (D38B1)
  • immunohistochemistry; human; 1:50; loading ...
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 4267S) was used in immunohistochemistry on human samples at 1:50. BMC Cancer (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:100; loading ...; fig s6b
Cell Signaling Technology EGFR antibody (Cell Signaling, 2237) was used in western blot on human samples at 1:100 (fig s6b). Nucleic Acids Res (2021) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; loading ...; fig 6a, 8d
Cell Signaling Technology EGFR antibody (Cell Signaling, 3777) was used in western blot on human samples (fig 6a, 8d). J Exp Clin Cancer Res (2021) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; mouse; 1:1000; fig ev5b
Cell Signaling Technology EGFR antibody (Cell Signaling, 3777) was used in western blot on mouse samples at 1:1000 (fig ev5b). EMBO Mol Med (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 1l
Cell Signaling Technology EGFR antibody (Cell signalling, 2232L) was used in western blot on human samples at 1:1000 (fig 1l). Cell Death Dis (2021) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; mouse; 1:1000; loading ...; fig 2e
Cell Signaling Technology EGFR antibody (Cell Signaling, 3777) was used in western blot on mouse samples at 1:1000 (fig 2e). Cancers (Basel) (2021) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; mouse; 1:1000; loading ...; fig 2e
Cell Signaling Technology EGFR antibody (Cell Signaling, 4267) was used in western blot on mouse samples at 1:1000 (fig 2e). Cancers (Basel) (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:2000; loading ...; fig 2a
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 2234) was used in western blot on human samples at 1:2000 (fig 2a). Nat Commun (2021) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; mouse; 1:1000; fig s6a
Cell Signaling Technology EGFR antibody (Cell Signaling, 3777) was used in western blot on mouse samples at 1:1000 (fig s6a). Nat Commun (2021) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; mouse; loading ...; fig s1a
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 3777) was used in western blot on mouse samples (fig s1a). Cell (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 6b
Cell Signaling Technology EGFR antibody (CST, 2234) was used in western blot on human samples at 1:1000 (fig 6b). Front Cell Dev Biol (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 6b
Cell Signaling Technology EGFR antibody (CST, 2232) was used in western blot on human samples at 1:1000 (fig 6b). Front Cell Dev Biol (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 6b
Cell Signaling Technology EGFR antibody (CST, 2220) was used in western blot on human samples at 1:1000 (fig 6b). Front Cell Dev Biol (2021) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; mouse; 1:1000; loading ...; fig 3a
Cell Signaling Technology EGFR antibody (Cell Signaling, 3777) was used in western blot on mouse samples at 1:1000 (fig 3a). Mol Oncol (2021) ncbi
domestic rabbit monoclonal (D38B1)
  • immunocytochemistry; human; 1:100; loading ...; fig 4c
  • western blot; human; 1:1000; loading ...; fig 4b
Cell Signaling Technology EGFR antibody (CST, 4267S) was used in immunocytochemistry on human samples at 1:100 (fig 4c) and in western blot on human samples at 1:1000 (fig 4b). Cell Death Dis (2021) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; loading ...; fig 3i
Cell Signaling Technology EGFR antibody (Cell Signaling, 3777) was used in western blot on human samples (fig 3i). Sci Adv (2021) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; 1:1000; loading ...; fig 6d, s10d
Cell Signaling Technology EGFR antibody (CST, 3777) was used in western blot on human samples at 1:1000 (fig 6d, s10d). Clin Transl Med (2021) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; 1:1000; loading ...; fig 6d, s10d
Cell Signaling Technology EGFR antibody (CST, 4267) was used in western blot on human samples at 1:1000 (fig 6d, s10d). Clin Transl Med (2021) ncbi
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig 2b
Cell Signaling Technology EGFR antibody (Cell Signaling, 2232) was used in western blot on mouse samples (fig 2b). Sci Rep (2021) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 4a
Cell Signaling Technology EGFR antibody (Cell Signaling, 2234) was used in western blot on mouse samples at 1:1000 (fig 4a). Cancer Sci (2021) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; mouse; 1:1000; loading ...; fig 4a
Cell Signaling Technology EGFR antibody (Cell Signaling, 4267) was used in western blot on mouse samples at 1:1000 (fig 4a). Cancer Sci (2021) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 4a
Cell Signaling Technology EGFR antibody (Cell Signaling, 2231) was used in western blot on mouse samples at 1:1000 (fig 4a). Cancer Sci (2021) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 4a
Cell Signaling Technology EGFR antibody (Cell Signaling, 2235) was used in western blot on mouse samples at 1:1000 (fig 4a). Cancer Sci (2021) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; mouse; 1:1000; loading ...; fig 4a
Cell Signaling Technology EGFR antibody (Cell Signaling, 4267) was used in western blot on mouse samples at 1:1000 (fig 4a). Commun Biol (2021) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; mouse; 1:1000; loading ...; fig 4a
Cell Signaling Technology EGFR antibody (Cell Signaling, 3777) was used in western blot on mouse samples at 1:1000 (fig 4a). Commun Biol (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1a
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 2232) was used in western blot on human samples (fig 1a). Signal Transduct Target Ther (2021) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; loading ...; fig 1a
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 3777) was used in western blot on human samples (fig 1a). Signal Transduct Target Ther (2021) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; 1:1000; loading ...; fig 3a
Cell Signaling Technology EGFR antibody (Cell Signaling, 3777S) was used in western blot on human samples at 1:1000 (fig 3a). Commun Biol (2021) ncbi
domestic rabbit monoclonal (D38B1)
  • immunohistochemistry - paraffin section; human; 1:500; fig 3e, 3f
  • western blot; human; 1:1000; loading ...; fig 3a
Cell Signaling Technology EGFR antibody (Cell Signaling, 4267) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 3e, 3f) and in western blot on human samples at 1:1000 (fig 3a). Commun Biol (2021) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; 1:1000; fig 5j
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 4267S) was used in western blot on human samples at 1:1000 (fig 5j). Theranostics (2021) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; 1:1000; fig 5j
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 3777S) was used in western blot on human samples at 1:1000 (fig 5j). Theranostics (2021) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; 1:1000; loading ...
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 4267S) was used in western blot on human samples at 1:1000. Nature (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 1
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 2232) was used in western blot on human samples at 1:1000 (fig 1). Biotechnol Rep (Amst) (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 2d, 2e, 2f
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 2234) was used in western blot on human samples at 1:1000 (fig 2d, 2e, 2f). Biotechnol Rep (Amst) (2020) ncbi
domestic rabbit monoclonal (D7A5)
  • immunocytochemistry; mouse; loading ...; fig 5h
  • western blot; mouse; loading ...; fig 5d
Cell Signaling Technology EGFR antibody (Cell Signaling technology, 3777) was used in immunocytochemistry on mouse samples (fig 5h) and in western blot on mouse samples (fig 5d). Cell Res (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 4i
Cell Signaling Technology EGFR antibody (Cell Signaling Technologies, 2234) was used in western blot on human samples at 1:1000 (fig 4i). Nature (2020) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; 1:1000; loading ...; fig 4b
Cell Signaling Technology EGFR antibody (Cell Signaling Technologies, 4267) was used in western blot on human samples at 1:1000 (fig 4b). Nature (2020) ncbi
mouse monoclonal (1H12)
  • immunohistochemistry; human; 1:100; loading ...; fig 2j
Cell Signaling Technology EGFR antibody (CST, 1H12) was used in immunohistochemistry on human samples at 1:100 (fig 2j). Dev Cell (2020) ncbi
mouse monoclonal (1H12)
  • immunohistochemistry; mouse; loading ...; fig 4f
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 2236) was used in immunohistochemistry on mouse samples (fig 4f). Mol Cancer Ther (2020) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; 1:1000; loading ...; fig 2a: 4c
Cell Signaling Technology EGFR antibody (CST, 4267) was used in western blot on human samples at 1:1000 (fig 2a: 4c). Nat Commun (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 4c
Cell Signaling Technology EGFR antibody (CST, 2234) was used in western blot on human samples at 1:1000 (fig 4c). Nat Commun (2020) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; loading ...; fig 1f
Cell Signaling Technology EGFR antibody (CST, 4267) was used in western blot on human samples (fig 1f). FASEB Bioadv (2020) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; loading ...; fig 1f
Cell Signaling Technology EGFR antibody (CST, 3777) was used in western blot on human samples (fig 1f). FASEB Bioadv (2020) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; loading ...; fig 8a, 8b
Cell Signaling Technology EGFR antibody (Cell Signaling, 4267) was used in western blot on human samples (fig 8a, 8b). Cancers (Basel) (2020) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; 1:1000; loading ...; fig 3f
Cell Signaling Technology EGFR antibody (Cell Signaling, 4267) was used in western blot on human samples at 1:1000 (fig 3f). Theranostics (2020) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; 1:1000; loading ...; fig s5b
Cell Signaling Technology EGFR antibody (Cell Signaling, 3777) was used in western blot on human samples at 1:1000 (fig s5b). Theranostics (2020) ncbi
domestic rabbit monoclonal (D7A5)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig s2c
  • western blot; human; 1:1000; loading ...; fig 3a
Cell Signaling Technology EGFR antibody (Cell signaling, 3777) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig s2c) and in western blot on human samples at 1:1000 (fig 3a). Nat Commun (2020) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; 1:1000; loading ...; fig 1s3
Cell Signaling Technology EGFR antibody (Cell Signaling, 3777) was used in western blot on human samples at 1:1000 (fig 1s3). elife (2020) ncbi
domestic rabbit monoclonal (D38B1)
  • immunocytochemistry; human; 1:1000; loading ...; fig 1c
  • western blot; human; 1:1000; loading ...; fig 5e
Cell Signaling Technology EGFR antibody (Cell Signaling, 4267) was used in immunocytochemistry on human samples at 1:1000 (fig 1c) and in western blot on human samples at 1:1000 (fig 5e). Cancers (Basel) (2020) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; 1:1000; fig 2d
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 4267) was used in western blot on human samples at 1:1000 (fig 2d). Nature (2020) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; 1:1000; fig 2d
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 3777) was used in western blot on human samples at 1:1000 (fig 2d). Nature (2020) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; loading ...; fig 2c
Cell Signaling Technology EGFR antibody (Cell Signaling, 4267) was used in western blot on human samples (fig 2c). J Cancer Res Clin Oncol (2020) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; loading ...; fig 4a
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, D38B1) was used in western blot on human samples (fig 4a). Breast Cancer Res (2019) ncbi
domestic rabbit monoclonal (D38B1)
  • immunohistochemistry - frozen section; human; loading ...; fig 5a
Cell Signaling Technology EGFR antibody (Cell Signaling Technologies, 4267) was used in immunohistochemistry - frozen section on human samples (fig 5a). Acta Neuropathol Commun (2019) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; 1:1000; loading ...; fig 2a, 3f, 3k
Cell Signaling Technology EGFR antibody (Cell Signaling, 3777) was used in western blot on human samples at 1:1000 (fig 2a, 3f, 3k). elife (2019) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; 1:20,000; loading ...; fig 2a, 3f, 3k
Cell Signaling Technology EGFR antibody (Cell Signaling, 4267) was used in western blot on human samples at 1:20,000 (fig 2a, 3f, 3k). elife (2019) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; 1:1000; loading ...; fig e2b
Cell Signaling Technology EGFR antibody (Cell Signaling, 4267) was used in western blot on human samples at 1:1000 (fig e2b). Nature (2019) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; 1:1000; loading ...; fig e2b
Cell Signaling Technology EGFR antibody (Cell Signaling, 3777) was used in western blot on human samples at 1:1000 (fig e2b). Nature (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig s1e
Cell Signaling Technology EGFR antibody (Cell Signaling, 2235) was used in western blot on human samples (fig s1e). Cell (2019) ncbi
domestic rabbit polyclonal
  • western blot; rat; loading ...; fig 1b
Cell Signaling Technology EGFR antibody (Cell Signaling, 2234) was used in western blot on rat samples (fig 1b). Cell (2019) ncbi
domestic rabbit monoclonal (53A5)
  • immunohistochemistry - paraffin section; human; 1:50; loading ...; fig 9a
  • western blot; human; 1:1000; loading ...; fig 1b, 8a, s14a
Cell Signaling Technology EGFR antibody (Cell Signaling, 4407) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 9a) and in western blot on human samples at 1:1000 (fig 1b, 8a, s14a). Nat Commun (2019) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; 1:1000; loading ...; fig 1b, 8a, s14a
Cell Signaling Technology EGFR antibody (Cell Signaling, 4267) was used in western blot on human samples at 1:1000 (fig 1b, 8a, s14a). Nat Commun (2019) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; 1:2000; loading ...; fig 2a
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 3777) was used in western blot on human samples at 1:2000 (fig 2a). Mol Med Rep (2019) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; loading ...; fig 1a
Cell Signaling Technology EGFR antibody (CST, 4267) was used in western blot on human samples (fig 1a). Cell Commun Signal (2019) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; loading ...; fig 2d
Cell Signaling Technology EGFR antibody (Cell Signaling, 4267) was used in western blot on human samples (fig 2d). Cell (2019) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; loading ...; fig 3b
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 4267) was used in western blot on human samples (fig 3b). Breast Cancer Res (2019) ncbi
domestic rabbit monoclonal (D7A5)
  • immunohistochemistry - paraffin section; human; 1:800; fig 4d
  • western blot; human; 1:1000; loading ...; fig 2a, 2c, 2i
Cell Signaling Technology EGFR antibody (Cell Signaling, 3777) was used in immunohistochemistry - paraffin section on human samples at 1:800 (fig 4d) and in western blot on human samples at 1:1000 (fig 2a, 2c, 2i). Cell Metab (2019) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; loading ...; fig 2b
  • western blot; mouse; loading ...; fig 2e
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 4267) was used in western blot on human samples (fig 2b) and in western blot on mouse samples (fig 2e). Science (2019) ncbi
mouse monoclonal (1H12)
  • western blot; human; 1:1000; loading ...; fig 1c
Cell Signaling Technology EGFR antibody (Cell Signaling, 2236) was used in western blot on human samples at 1:1000 (fig 1c). elife (2019) ncbi
domestic rabbit monoclonal (53A5)
  • western blot; human; 1:1000; loading ...; fig 3c
Cell Signaling Technology EGFR antibody (CST, 4407S) was used in western blot on human samples at 1:1000 (fig 3c). Science (2019) ncbi
domestic rabbit monoclonal (D38B1)
  • immunoprecipitation; human; 1:1000; loading ...; fig 7a
Cell Signaling Technology EGFR antibody (Cell Signaling, 4267) was used in immunoprecipitation on human samples at 1:1000 (fig 7a). Nat Commun (2019) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; 1:1000; loading ...; fig 5c
Cell Signaling Technology EGFR antibody (Cell Signaling, 3777) was used in western blot on human samples at 1:1000 (fig 5c). Int J Oncol (2019) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; 1:1000; loading ...; fig 2f
Cell Signaling Technology EGFR antibody (Cell Signaling, 4267S) was used in western blot on human samples at 1:1000 (fig 2f). elife (2019) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; 1:1000; loading ...; fig 2f
Cell Signaling Technology EGFR antibody (Cell Signaling, 3777S) was used in western blot on human samples at 1:1000 (fig 2f). elife (2019) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; loading ...; fig 3b
Cell Signaling Technology EGFR antibody (cell signaling, 4267) was used in western blot on human samples (fig 3b). Sci Rep (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig s2
Cell Signaling Technology EGFR antibody (Cell Signaling, 2232) was used in western blot on human samples (fig s2). Breast Cancer Res (2019) ncbi
domestic rabbit monoclonal (43B2)
  • western blot; human; loading ...; fig 4b
Cell Signaling Technology EGFR antibody (Cell Signaling, 3197) was used in western blot on human samples (fig 4b). J Exp Med (2019) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; loading ...; fig 4b
Cell Signaling Technology EGFR antibody (Cell Signaling, 4267) was used in western blot on human samples (fig 4b). J Exp Med (2019) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; loading ...; fig 1b
Cell Signaling Technology EGFR antibody (Cell Signaling, 3777S) was used in western blot on human samples (fig 1b). BMC Med Genomics (2019) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; loading ...; fig 1b
Cell Signaling Technology EGFR antibody (Cell Signaling, 4267S) was used in western blot on human samples (fig 1b). BMC Med Genomics (2019) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; loading ...; fig s6f
Cell Signaling Technology EGFR antibody (Cell Signaling, 4267) was used in western blot on human samples (fig s6f). Proc Natl Acad Sci U S A (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig s6f
Cell Signaling Technology EGFR antibody (Cell Signaling, 2234) was used in western blot on human samples (fig s6f). Proc Natl Acad Sci U S A (2019) ncbi
domestic rabbit monoclonal (43B2)
  • western blot; mouse; loading ...; fig 6d
Cell Signaling Technology EGFR antibody (Cell Signaling, 3197) was used in western blot on mouse samples (fig 6d). Cell Discov (2019) ncbi
mouse monoclonal (1H12)
  • western blot; mouse; loading ...; fig 3c
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 2236) was used in western blot on mouse samples (fig 3c). J Exp Clin Cancer Res (2019) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; rat; 1:500; loading ...; fig 5g
  • western blot; human; 1:500; loading ...; fig 5g
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, D7A5) was used in western blot on rat samples at 1:500 (fig 5g) and in western blot on human samples at 1:500 (fig 5g). Cell Mol Life Sci (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1c
Cell Signaling Technology EGFR antibody (Cell Signaling, 2232) was used in western blot on human samples (fig 1c). elife (2018) ncbi
domestic rabbit monoclonal (D38B1)
  • immunocytochemistry; human; loading ...; fig 2e
Cell Signaling Technology EGFR antibody (Cell Signaling, 4267S) was used in immunocytochemistry on human samples (fig 2e). J Biol Chem (2019) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; mouse; loading ...; fig 3g
Cell Signaling Technology EGFR antibody (Cell Signaling, 4267) was used in western blot on mouse samples (fig 3g). Cell (2018) ncbi
domestic rabbit monoclonal (6B6)
  • western blot; human; fig 1b
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 2085) was used in western blot on human samples (fig 1b). Proc Natl Acad Sci U S A (2018) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; loading ...; fig 1b
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 3777) was used in western blot on human samples (fig 1b). Proc Natl Acad Sci U S A (2018) ncbi
domestic rabbit monoclonal (53A5)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig s5a
Cell Signaling Technology EGFR antibody (Cell Signaling, 4407) was used in immunohistochemistry - paraffin section on mouse samples (fig s5a). Mol Cancer Res (2018) ncbi
domestic rabbit polyclonal
  • other; human; loading ...; fig 4c
Cell Signaling Technology EGFR antibody (Cell Signaling, 2232) was used in other on human samples (fig 4c). Cancer Cell (2018) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; 1:1000; loading ...; fig 1e
Cell Signaling Technology EGFR antibody (Cell Signaling, 3777) was used in western blot on human samples at 1:1000 (fig 1e). Science (2018) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; mouse; 1:600; loading ...; fig 2c
Cell Signaling Technology EGFR antibody (Cell Signaling, 4267) was used in western blot on mouse samples at 1:600 (fig 2c). Nat Neurosci (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 1a
Cell Signaling Technology EGFR antibody (Cell Signaling, 2232) was used in western blot on human samples at 1:1000 (fig 1a). Mol Med Rep (2018) ncbi
domestic rabbit monoclonal (6B6)
  • western blot; mouse; 1:1000-1:5000; loading ...; fig 5c
  • western blot; human; 1:1000-1:5000; loading ...; fig 1c
Cell Signaling Technology EGFR antibody (Cell Signaling, 2085) was used in western blot on mouse samples at 1:1000-1:5000 (fig 5c) and in western blot on human samples at 1:1000-1:5000 (fig 1c). Nat Commun (2017) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; 1:1000; loading ...; fig 2e
Cell Signaling Technology EGFR antibody (Cell Signaling, 3777) was used in western blot on human samples at 1:1000 (fig 2e). Nat Commun (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 2b
Cell Signaling Technology EGFR antibody (Cell Signaling, 2232) was used in western blot on human samples (fig 2b). Cancer Res (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 8c
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 2232) was used in western blot on human samples at 1:1000 (fig 8c). Sci Transl Med (2017) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; 1:1000; loading ...; fig 8c
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 3777T) was used in western blot on human samples at 1:1000 (fig 8c). Sci Transl Med (2017) ncbi
domestic rabbit monoclonal (C74B9)
  • western blot; human; loading ...; fig 7f
In order to investigate the mechanism of the inductive effect of MLKL in necroptosis, Cell Signaling Technology EGFR antibody (cell signalling, 2646) was used in western blot on human samples (fig 7f). Proc Natl Acad Sci U S A (2017) ncbi
domestic rabbit monoclonal (53A5)
  • western blot; human; loading ...; fig 1a
Cell Signaling Technology EGFR antibody (Cell Signaling, 4407) was used in western blot on human samples (fig 1a). Mol Oncol (2017) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; loading ...; fig 1b
Cell Signaling Technology EGFR antibody (Cell Signaling, 4267) was used in western blot on human samples (fig 1b). Mol Cell Biol (2017) ncbi
domestic rabbit monoclonal (53A5)
  • western blot; human; loading ...; fig 1b
Cell Signaling Technology EGFR antibody (Cell Signaling, 53A5) was used in western blot on human samples (fig 1b). Cancer Res (2017) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; loading ...; fig 1b
Cell Signaling Technology EGFR antibody (Cell Signaling, D7A5) was used in western blot on human samples (fig 1b). Cancer Res (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1b
Cell Signaling Technology EGFR antibody (Cell Signaling, 2232L) was used in western blot on human samples (fig 1b). Cancer Res (2017) ncbi
domestic rabbit monoclonal (53A5)
  • western blot; human; loading ...; fig 2
Cell Signaling Technology EGFR antibody (cell signalling, 4407) was used in western blot on human samples (fig 2). Neoplasia (2017) ncbi
domestic rabbit monoclonal (C74B9)
  • western blot; mouse; loading ...; fig 1f
In order to report that the Myomixer-Myomaker interaction regulates myofiber formation during muscle development, Cell Signaling Technology EGFR antibody (Cell Signaling, 2646) was used in western blot on mouse samples (fig 1f). Science (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 4g
Cell Signaling Technology EGFR antibody (Cell Signaling, 2231) was used in western blot on human samples at 1:1000 (fig 4g). Physiol Rep (2017) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; mouse; loading ...; fig 5a
Cell Signaling Technology EGFR antibody (Cell Signaling, 3777) was used in western blot on mouse samples (fig 5a). Sci Rep (2017) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; loading ...; fig s3a
Cell Signaling Technology EGFR antibody (Cell Signaling, 4267) was used in western blot on human samples (fig s3a). Mol Cell (2017) ncbi
domestic rabbit polyclonal
  • reverse phase protein lysate microarray; human; loading ...; fig st6
In order to characterize the molecular identity of uterine carcinosarcomas., Cell Signaling Technology EGFR antibody (CST, 2232) was used in reverse phase protein lysate microarray on human samples (fig st6). Cancer Cell (2017) ncbi
domestic rabbit polyclonal
  • reverse phase protein lysate microarray; human; loading ...; fig st6
In order to characterize the molecular identity of uterine carcinosarcomas., Cell Signaling Technology EGFR antibody (CST, 2234) was used in reverse phase protein lysate microarray on human samples (fig st6). Cancer Cell (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 2a
  • western blot; mouse; loading ...; fig 2b
Cell Signaling Technology EGFR antibody (Cell Signaling, 2232S) was used in western blot on human samples (fig 2a) and in western blot on mouse samples (fig 2b). Mol Cell Biol (2017) ncbi
domestic rabbit monoclonal (53A5)
  • western blot; human; loading ...; fig 2a
  • western blot; mouse; loading ...; fig 2b
Cell Signaling Technology EGFR antibody (Cell Signaling, 4407S) was used in western blot on human samples (fig 2a) and in western blot on mouse samples (fig 2b). Mol Cell Biol (2017) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; loading ...; fig 1f
Cell Signaling Technology EGFR antibody (Cell signalling, 3777) was used in western blot on human samples (fig 1f). Cancer Lett (2017) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; loading ...; fig 1f
Cell Signaling Technology EGFR antibody (Cell signalling, 4267) was used in western blot on human samples (fig 1f). Cancer Lett (2017) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; mouse; 1:1000; loading ...; fig 4a
Cell Signaling Technology EGFR antibody (Cell Signaling, 3777) was used in western blot on mouse samples at 1:1000 (fig 4a). Theranostics (2017) ncbi
domestic rabbit monoclonal (D38B1)
  • immunocytochemistry; human; 1:100; loading ...; tbl 1
Cell Signaling Technology EGFR antibody (cell signalling, mAb4267) was used in immunocytochemistry on human samples at 1:100 (tbl 1). PLoS ONE (2017) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; mouse; 1:1000; loading ...; fig 1g
In order to observe a novel role for ErbB4 in macrophage apoptosis, Cell Signaling Technology EGFR antibody (Cell Signaling, 4267) was used in western blot on mouse samples at 1:1000 (fig 1g). Cell Death Dis (2017) ncbi
mouse monoclonal (1F4)
  • western blot; human; 1:1000; loading ...; fig 2a
Cell Signaling Technology EGFR antibody (Cell signaling, 1F4) was used in western blot on human samples at 1:1000 (fig 2a). Nat Commun (2017) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; loading ...; fig 5a
In order to discover regions of rare genetic variation that contribute to emphysema with severe airflow obstruction, Cell Signaling Technology EGFR antibody (Cell Signaling, 4267) was used in western blot on human samples (fig 5a). Am J Respir Crit Care Med (2017) ncbi
domestic rabbit monoclonal (D38B1)
  • immunohistochemistry - paraffin section; human; 1:100
  • immunohistochemistry; human; fig 100
In order to outline the protocols for antibodies used for immunohistochemical studies, Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 4267) was used in immunohistochemistry - paraffin section on human samples at 1:100 and in immunohistochemistry on human samples (fig 100). J Toxicol Pathol (2017) ncbi
domestic rabbit monoclonal (6B6)
  • western blot; human; 1:1000; loading ...; fig 6a
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 2085) was used in western blot on human samples at 1:1000 (fig 6a). Oncotarget (2017) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; 1:1000; loading ...; fig 6a
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 3777) was used in western blot on human samples at 1:1000 (fig 6a). Oncotarget (2017) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; 1:1000-1:2000; loading ...; fig 2a
Cell Signaling Technology EGFR antibody (Cell signaling, 4267) was used in western blot on human samples at 1:1000-1:2000 (fig 2a). BMC Genomics (2017) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; loading ...; fig 6a
In order to demonstrate that ADAM12 supports the cancer stem cell phenotype in claudin-low breast cancer cells via modulation of the epidermal growth factor receptor pathway, Cell Signaling Technology EGFR antibody (Cell Signaling, D7A5) was used in western blot on human samples (fig 6a). Mol Cancer (2017) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; loading ...; fig 6a
In order to demonstrate that ADAM12 supports the cancer stem cell phenotype in claudin-low breast cancer cells via modulation of the epidermal growth factor receptor pathway, Cell Signaling Technology EGFR antibody (Cell Signaling, D38B1) was used in western blot on human samples (fig 6a). Mol Cancer (2017) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; loading ...; fig 4a
Cell Signaling Technology EGFR antibody (Cell Signaling, 3777) was used in western blot on human samples (fig 4a). Biomed Pharmacother (2017) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; loading ...; fig 4a
Cell Signaling Technology EGFR antibody (Cell Signaling, 4267) was used in western blot on human samples (fig 4a). Biomed Pharmacother (2017) ncbi
domestic rabbit monoclonal (53A5)
  • western blot; human; loading ...
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 4407) was used in western blot on human samples . FEBS Open Bio (2017) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; 1:1000; loading ...; fig 1b
In order to demonstrate a crosstalk between stromal fibroblasts and epithelial cells under starvation, Cell Signaling Technology EGFR antibody (Cell Signaling, 4267) was used in western blot on human samples at 1:1000 (fig 1b). Nat Commun (2017) ncbi
mouse monoclonal (1H12)
  • western blot; human; loading ...; fig 2f
Cell Signaling Technology EGFR antibody (Cell signaling, 2236) was used in western blot on human samples (fig 2f). Oncotarget (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; loading ...; fig 1
Cell Signaling Technology EGFR antibody (New England Biolabs, 2234) was used in immunohistochemistry - paraffin section on human samples (fig 1). Oncotarget (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...
In order to analyze the context specificity of signaling networks within a causal conceptual framework using reverse-phase protein array time-course assays and network analysis approaches, Cell Signaling Technology EGFR antibody (Santa Cruz / Cell Signaling Technology, SC-03 / 2232) was used in western blot on human samples . Cell Syst (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...
In order to analyze the context specificity of signaling networks within a causal conceptual framework using reverse-phase protein array time-course assays and network analysis approaches, Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 2234) was used in western blot on human samples . Cell Syst (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...
In order to analyze the context specificity of signaling networks within a causal conceptual framework using reverse-phase protein array time-course assays and network analysis approaches, Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 2235) was used in western blot on human samples . Cell Syst (2017) ncbi
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig 1c
Cell Signaling Technology EGFR antibody (Cell Signaling, 2231) was used in western blot on mouse samples (fig 1c). Exp Clin Endocrinol Diabetes (2017) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; fig 1c
In order to assess the effects of LY3009120, a panRAF and RAF dimer inhibitor, in human models of colorectal cancer, Cell Signaling Technology EGFR antibody (Cell Signaling, 3777) was used in western blot on human samples (fig 1c). Oncotarget (2017) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; fig 1c
In order to assess the effects of LY3009120, a panRAF and RAF dimer inhibitor, in human models of colorectal cancer, Cell Signaling Technology EGFR antibody (Cell Signaling, 4267) was used in western blot on human samples (fig 1c). Oncotarget (2017) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; loading ...; fig 6a
In order to examine the role of Breast Cancer Associated gene 2 in EGFR endocytosis and down-regulation and to determine its links with breast cancer outcome, Cell Signaling Technology EGFR antibody (Cell signaling, 3777) was used in western blot on human samples (fig 6a). J Cancer (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 3
In order to assess the contribution of amphiregulin, epidermal growth factor, heparin-binding epidermal growth factor, and transforming growth factor alpha in the responsiveness of gastric cancer cell lines to cetuximab and trastuzumab, Cell Signaling Technology EGFR antibody (Cell Signaling, 2232) was used in western blot on human samples at 1:1000 (fig 3). J Cancer Res Clin Oncol (2017) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; mouse; loading ...; fig 3
In order to propose that casitas B-cell lymphoma family proteins protect mammary epithelial cells from proteotoxic stress-induced cell death by promoting turnover of active c-Src, Cell Signaling Technology EGFR antibody (Cell Signaling, 3777) was used in western blot on mouse samples (fig 3). Proc Natl Acad Sci U S A (2016) ncbi
domestic rabbit monoclonal (53A5)
  • western blot; mouse; loading ...; fig 8b
Cell Signaling Technology EGFR antibody (Cell Signaling, 53A5) was used in western blot on mouse samples (fig 8b). J Biol Chem (2017) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; mouse; loading ...; fig 8b
Cell Signaling Technology EGFR antibody (Cell Signaling, D38B1) was used in western blot on mouse samples (fig 8b). J Biol Chem (2017) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; mouse; loading ...; fig 8b
Cell Signaling Technology EGFR antibody (Cell Signaling, D7A5) was used in western blot on mouse samples (fig 8b). J Biol Chem (2017) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; loading ...; fig s3
In order to report the effects of NVP-CGM097 on the p53wildtype GOT1 cells, Cell Signaling Technology EGFR antibody (Cell Signaling, 3777) was used in western blot on human samples (fig s3). Neuroendocrinology (2018) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; loading ...; fig s3
In order to report the effects of NVP-CGM097 on the p53wildtype GOT1 cells, Cell Signaling Technology EGFR antibody (Cell Signaling, 4267) was used in western blot on human samples (fig s3). Neuroendocrinology (2018) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; fig 4a
Cell Signaling Technology EGFR antibody (Cell Signaling, 4267) was used in western blot on human samples (fig 4a). Biochem Biophys Res Commun (2017) ncbi
domestic rabbit monoclonal (D63B4)
  • western blot; human; fig 3a
Cell Signaling Technology EGFR antibody (Cell Signaling, D63B4) was used in western blot on human samples (fig 3a). Oncotarget (2016) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; fig 3a
Cell Signaling Technology EGFR antibody (Cell Signaling, 3777) was used in western blot on human samples (fig 3a). Oncotarget (2016) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; fig 1a
Cell Signaling Technology EGFR antibody (Cell Signaling, 4267) was used in western blot on human samples (fig 1a). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 3b
In order to demonstrate that entinostat targets SALL4-positive lung cancer, Cell Signaling Technology EGFR antibody (Cell Signaling, 2234) was used in western blot on human samples (fig 3b). Oncotarget (2016) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; fig 2
In order to elucidate the compartmentalization of p110alpha and p110beta, Cell Signaling Technology EGFR antibody (Cell Signaling, 4267) was used in western blot on human samples (fig 2). elife (2016) ncbi
domestic rabbit monoclonal (D7A5)
  • immunocytochemistry; human; 1:100; fig s6
In order to develop and characterize a three-dimensional model to study tumor-stroma interactions, Cell Signaling Technology EGFR antibody (Cell signaling, 3777S) was used in immunocytochemistry on human samples at 1:100 (fig s6). Sci Rep (2016) ncbi
mouse monoclonal (1F4)
  • western blot; human; 1:1000; loading ...; fig 3c
Cell Signaling Technology EGFR antibody (Cell Signaling, 2239) was used in western blot on human samples at 1:1000 (fig 3c). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:100; fig st1
In order to identify and characterize alterations in signal transduction that occur during the development Lapatinib resistance, Cell Signaling Technology EGFR antibody (Cell Signaling, 2235) was used in western blot on human samples at 1:100 (fig st1). Nat Commun (2016) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; loading ...; fig 7b
Cell Signaling Technology EGFR antibody (Cell Signaling, 4267) was used in western blot on human samples (fig 7b). Cancer Res (2016) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; loading ...; fig 7b
Cell Signaling Technology EGFR antibody (Cell Signaling, 3777) was used in western blot on human samples (fig 7b). Cancer Res (2016) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; Chinese hamsters; fig 2
Cell Signaling Technology EGFR antibody (Cell Signaling, 3777) was used in western blot on Chinese hamsters samples (fig 2). Sci Rep (2016) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; 1:1000; fig 2
Cell Signaling Technology EGFR antibody (Cell Signaling, 4267) was used in western blot on human samples at 1:1000 (fig 2). Sci Rep (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 3C
Cell Signaling Technology EGFR antibody (Cell Signaling, 2234) was used in western blot on human samples at 1:1000 (fig 3C). PLoS ONE (2016) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; loading ...; fig 4a
Cell Signaling Technology EGFR antibody (Cell Signaling, 3777) was used in western blot on human samples (fig 4a). J Exp Clin Cancer Res (2016) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; loading ...; fig 4c
Cell Signaling Technology EGFR antibody (Cell Signaling, 4267) was used in western blot on human samples (fig 4c). J Exp Clin Cancer Res (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; tbl s6
Cell Signaling Technology EGFR antibody (Cell Signaling, 2232) was used in western blot on human samples at 1:1000 (tbl s6). PLoS Genet (2016) ncbi
domestic rabbit monoclonal (C74B9)
  • western blot; human; 1:1000; loading ...; fig 3f
In order to determine if the extracellular matrix components of human skin fibroblasts change under non-stretch, static stretch, or cyclic stretch conditions, Cell Signaling Technology EGFR antibody (Cell Signaling, 2646) was used in western blot on human samples at 1:1000 (fig 3f). Exp Ther Med (2016) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; 1:1000; loading ...; fig 4a
Cell Signaling Technology EGFR antibody (Cell Signaling, 4267) was used in western blot on human samples at 1:1000 (fig 4a). Nat Commun (2016) ncbi
domestic rabbit monoclonal (D7A5)
  • immunohistochemistry; human; 1:200; loading ...; fig s8c
Cell Signaling Technology EGFR antibody (Cell Signaling, 3777) was used in immunohistochemistry on human samples at 1:200 (fig s8c). Nat Commun (2016) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; loading ...; fig 1a
Cell Signaling Technology EGFR antibody (Cell Signaling, 3777) was used in western blot on human samples (fig 1a). J Biol Chem (2016) ncbi
domestic rabbit monoclonal (D38B1)
  • immunocytochemistry; human; loading ...
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, D38B1) was used in immunocytochemistry on human samples . Nature (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 3d
In order to study how CUB domain-containing protein1 contributes to metastasis and drug resistance, Cell Signaling Technology EGFR antibody (Cell Signaling, 2235) was used in western blot on human samples (fig 3d). Breast Cancer Res (2016) ncbi
domestic rabbit monoclonal (D63B4)
  • western blot; human; loading ...; fig 2a
In order to study how CUB domain-containing protein1 contributes to metastasis and drug resistance, Cell Signaling Technology EGFR antibody (Cell Signaling, 6963) was used in western blot on human samples (fig 2a). Breast Cancer Res (2016) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; loading ...; fig 1d
In order to study how CUB domain-containing protein1 contributes to metastasis and drug resistance, Cell Signaling Technology EGFR antibody (Cell Signaling, 4267) was used in western blot on human samples (fig 1d). Breast Cancer Res (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 2f
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 2232) was used in western blot on human samples (fig 2f). Biochim Biophys Acta (2016) ncbi
mouse monoclonal (1H12)
  • western blot; human; loading ...; fig 2f
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 2236) was used in western blot on human samples (fig 2f). Biochim Biophys Acta (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 6a
Cell Signaling Technology EGFR antibody (Cell Signaling, 2232) was used in western blot on human samples at 1:1000 (fig 6a). Oncotarget (2016) ncbi
domestic rabbit monoclonal (53A5)
  • western blot; human; 1:1000; loading ...; fig 6a
Cell Signaling Technology EGFR antibody (Cell Signaling, 4407) was used in western blot on human samples at 1:1000 (fig 6a). Oncotarget (2016) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; 1:1000; fig 5e
In order to discuss the role of myeloid cells in pancreatic cancer pathogenesis, Cell Signaling Technology EGFR antibody (cell signalling, 4267) was used in western blot on human samples at 1:1000 (fig 5e). Gut (2017) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; 1:1000; fig 5e
In order to discuss the role of myeloid cells in pancreatic cancer pathogenesis, Cell Signaling Technology EGFR antibody (cell signalling, 3777) was used in western blot on human samples at 1:1000 (fig 5e). Gut (2017) ncbi
domestic rabbit monoclonal (53A5)
  • western blot; human; 1:1000; fig s2
Cell Signaling Technology EGFR antibody (Cell Signaling, 4407) was used in western blot on human samples at 1:1000 (fig s2). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig s2
Cell Signaling Technology EGFR antibody (Cell Signaling, 2232) was used in western blot on human samples at 1:1000 (fig s2). Nat Commun (2016) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; loading ...; fig 1a
In order to identify signaling pathways that mediate the EGF-induced epithelial to mesenchymal transition, Cell Signaling Technology EGFR antibody (Cell Signaling, 3777) was used in western blot on human samples (fig 1a). J Proteomics (2017) ncbi
domestic rabbit monoclonal (C74B9)
  • western blot; human; loading ...; fig 1a
In order to identify signaling pathways that mediate the EGF-induced epithelial to mesenchymal transition, Cell Signaling Technology EGFR antibody (Cell Signaling, 2646) was used in western blot on human samples (fig 1a). J Proteomics (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 6
In order to characterize attenuation of endosomal EGFR signaling by cathepsin S as a mechanical rationale for the combination of EGFR tyrosine kinase and cathepsin S inhibitors, Cell Signaling Technology EGFR antibody (Cell Signaling, 2234) was used in western blot on human samples (fig 6). Sci Rep (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 6
In order to characterize attenuation of endosomal EGFR signaling by cathepsin S as a mechanical rationale for the combination of EGFR tyrosine kinase and cathepsin S inhibitors, Cell Signaling Technology EGFR antibody (Cell Signaling, 2235) was used in western blot on human samples (fig 6). Sci Rep (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 6
In order to characterize attenuation of endosomal EGFR signaling by cathepsin S as a mechanical rationale for the combination of EGFR tyrosine kinase and cathepsin S inhibitors, Cell Signaling Technology EGFR antibody (Cell Signaling, 2237) was used in western blot on human samples (fig 6). Sci Rep (2016) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; fig 6
In order to characterize 3D-cultured prostate cancer cells' drug response and expression of drug-action associated proteins and the influence of matrices, Cell Signaling Technology EGFR antibody (Cell Signaling, 4267) was used in western blot on human samples (fig 6). PLoS ONE (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 5d
Cell Signaling Technology EGFR antibody (cell signalling, 2231) was used in western blot on human samples at 1:1000 (fig 5d). Oncotarget (2016) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; 1:1000; loading ...; fig 5d
Cell Signaling Technology EGFR antibody (cell signalling, 4267) was used in western blot on human samples at 1:1000 (fig 5d). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:500; fig s1
  • western blot; human; 1:500; fig s4
Cell Signaling Technology EGFR antibody (Cell Signaling, 2234) was used in western blot on mouse samples at 1:500 (fig s1) and in western blot on human samples at 1:500 (fig s4). Nat Commun (2016) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; fig 7e
Cell Signaling Technology EGFR antibody (Cell signalling, D7A5) was used in western blot on human samples (fig 7e). J Biol Chem (2016) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; fig 7e
Cell Signaling Technology EGFR antibody (Cell signalling, D38B1) was used in western blot on human samples (fig 7e). J Biol Chem (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 5
Cell Signaling Technology EGFR antibody (Cell Signalling, 2234) was used in western blot on human samples (fig 5). Traffic (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 4f
Cell Signaling Technology EGFR antibody (Cell Signaling, 2232) was used in western blot on human samples (fig 4f). Mol Cell (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:500; fig 3
Cell Signaling Technology EGFR antibody (Cell signaling, 2234) was used in western blot on human samples at 1:500 (fig 3). Nat Neurosci (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:500; fig 3
Cell Signaling Technology EGFR antibody (Cell signaling, 2232) was used in western blot on human samples at 1:500 (fig 3). Nat Neurosci (2016) ncbi
mouse monoclonal (1F4)
  • western blot; mouse; fig 1B
Cell Signaling Technology EGFR antibody (CST, 2239) was used in western blot on mouse samples (fig 1B). PLoS ONE (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:200; fig 2
In order to analyze the induction of the phosphorylation of EGFR and downregulation of cdc25C and MEK phosphorylation by CD147-targeted siRNA in A375 malignant melanoma cells, Cell Signaling Technology EGFR antibody (Cell signaling, 2234) was used in western blot on human samples at 1:200 (fig 2). Oncol Lett (2016) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human
In order to analyze Src homology 2 (SH2) domain binding in signaling by receptor tyrosine kinases by time-resolved multimodal analysis, Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 3777P) was used in western blot on human samples . elife (2016) ncbi
domestic rabbit polyclonal
  • western blot; human
In order to analyze Src homology 2 (SH2) domain binding in signaling by receptor tyrosine kinases by time-resolved multimodal analysis, Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 2235P) was used in western blot on human samples . elife (2016) ncbi
domestic rabbit monoclonal (53A5)
  • western blot; human
In order to analyze Src homology 2 (SH2) domain binding in signaling by receptor tyrosine kinases by time-resolved multimodal analysis, Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 4407S) was used in western blot on human samples . elife (2016) ncbi
domestic rabbit polyclonal
  • western blot; human
In order to analyze Src homology 2 (SH2) domain binding in signaling by receptor tyrosine kinases by time-resolved multimodal analysis, Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 2237P) was used in western blot on human samples . elife (2016) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; fig 2
In order to analyze Src homology 2 (SH2) domain binding in signaling by receptor tyrosine kinases by time-resolved multimodal analysis, Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 4267) was used in western blot on human samples (fig 2). elife (2016) ncbi
domestic rabbit polyclonal
  • western blot; human
In order to analyze Src homology 2 (SH2) domain binding in signaling by receptor tyrosine kinases by time-resolved multimodal analysis, Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 2220S) was used in western blot on human samples . elife (2016) ncbi
domestic rabbit monoclonal (C24A5)
  • western blot; human
In order to analyze Src homology 2 (SH2) domain binding in signaling by receptor tyrosine kinases by time-resolved multimodal analysis, Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 2641S) was used in western blot on human samples . elife (2016) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; fig 4
Cell Signaling Technology EGFR antibody (CST, 4267) was used in western blot on human samples (fig 4). Oncotarget (2016) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; fig 4
Cell Signaling Technology EGFR antibody (Cell Signaling Tech, 3777) was used in western blot on human samples (fig 4). PLoS ONE (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 4b
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 2232) was used in western blot on human samples at 1:1000 (fig 4b). J Clin Invest (2016) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; 1:1000; loading ...; fig 4b
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 3777) was used in western blot on human samples at 1:1000 (fig 4b). J Clin Invest (2016) ncbi
domestic rabbit monoclonal (D38B1)
  • immunohistochemistry - paraffin section; human; loading ...; fig s1n
Cell Signaling Technology EGFR antibody (Cell Signaling, D38B1) was used in immunohistochemistry - paraffin section on human samples (fig s1n). Proc Natl Acad Sci U S A (2016) ncbi
domestic rabbit monoclonal (D38B1)
  • immunohistochemistry - paraffin section; mouse; fig 6
Cell Signaling Technology EGFR antibody (Cell Signaling, 4267) was used in immunohistochemistry - paraffin section on mouse samples (fig 6). Oncotarget (2016) ncbi
domestic rabbit monoclonal (D7A5)
  • immunohistochemistry - paraffin section; mouse; fig 6
Cell Signaling Technology EGFR antibody (Cell Signaling, 3777) was used in immunohistochemistry - paraffin section on mouse samples (fig 6). Oncotarget (2016) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; fig 1
Cell Signaling Technology EGFR antibody (CST, 3777s) was used in western blot on human samples (fig 1). Oncotarget (2016) ncbi
mouse monoclonal (1H12)
  • western blot; human; fig 1
Cell Signaling Technology EGFR antibody (Cell Signaling, 2236) was used in western blot on human samples (fig 1). Oncogenesis (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 4
Cell Signaling Technology EGFR antibody (Cell Signaling Tech, 2220) was used in western blot on human samples (fig 4). Cancer Sci (2016) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; fig 7
Cell Signaling Technology EGFR antibody (Cell Signaling, 4267) was used in western blot on human samples (fig 7). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 4
In order to determine facilitation of chemoresistance and cancer proliferation by Haem-dependent dimerization of PGRMC1/Sigma-2 receptor, Cell Signaling Technology EGFR antibody (Cell signaling, 2234S) was used in western blot on human samples (fig 4). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 4
In order to determine facilitation of chemoresistance and cancer proliferation by Haem-dependent dimerization of PGRMC1/Sigma-2 receptor, Cell Signaling Technology EGFR antibody (Cell signaling, 2232S) was used in western blot on human samples (fig 4). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 3d
Cell Signaling Technology EGFR antibody (Cell Signaling, 3056) was used in western blot on human samples (fig 3d). Oncotarget (2016) ncbi
domestic rabbit monoclonal (D38B1)
  • immunocytochemistry; human; loading ...; fig 1b
  • western blot; human; loading ...; fig 1a
In order to research the role of ezrin in EGFR signaling and Erlotinib sensitivity in non-small cell lung cancer cells, Cell Signaling Technology EGFR antibody (Cell Signaling, 4267) was used in immunocytochemistry on human samples (fig 1b) and in western blot on human samples (fig 1a). Neoplasia (2016) ncbi
mouse monoclonal (1H12)
  • western blot; human; loading ...; fig 2a
In order to research the role of ezrin in EGFR signaling and Erlotinib sensitivity in non-small cell lung cancer cells, Cell Signaling Technology EGFR antibody (Cell Signaling, 2236) was used in western blot on human samples (fig 2a). Neoplasia (2016) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human
In order to discuss the findings of The Reproducibility Project: Cancer Biology, Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 3777) was used in western blot on human samples . elife (2016) ncbi
mouse monoclonal (1F4)
  • western blot; human
In order to discuss the findings of The Reproducibility Project: Cancer Biology, Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 2239) was used in western blot on human samples . elife (2016) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; fig 8
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 3777) was used in western blot on human samples (fig 8). Oncogene (2016) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; fig 8
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 4267) was used in western blot on human samples (fig 8). Oncogene (2016) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; fig 1
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 4267) was used in western blot on human samples (fig 1). Cell Commun Signal (2016) ncbi
mouse monoclonal (1H12)
  • western blot; human; fig 1
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 2236) was used in western blot on human samples (fig 1). Cell Commun Signal (2016) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; mouse; 1:1000; fig 3h
In order to analyze the suppression of soft tissue sarcoma growth due to epigenetic re-expression of HIF-2 alpha, Cell Signaling Technology EGFR antibody (Cell Signaling, 4267) was used in western blot on mouse samples at 1:1000 (fig 3h). Nat Commun (2016) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; mouse; 1:1000; fig 3h
In order to analyze the suppression of soft tissue sarcoma growth due to epigenetic re-expression of HIF-2 alpha, Cell Signaling Technology EGFR antibody (Cell Signaling, 3777) was used in western blot on mouse samples at 1:1000 (fig 3h). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 4
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 2234) was used in western blot on human samples (fig 4). J Cell Sci (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 4
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 2232) was used in western blot on human samples (fig 4). J Cell Sci (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:2000; fig 5
In order to determine the role of Kindlin-2 tp activate integrins by cooperating with talin and induction of cell spreading by directly binding paxillin, Cell Signaling Technology EGFR antibody (Cell Signaling, 2235) was used in western blot on mouse samples at 1:2000 (fig 5). elife (2016) ncbi
domestic rabbit polyclonal
  • flow cytometry; human; 2 ug/ml; fig 1
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 2232) was used in flow cytometry on human samples at 2 ug/ml (fig 1). Cell Death Dis (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 1
In order to study how ZEB1 drives the epithelial-mesenchymal transition-related resistance to EGFR-tyrosine kinases inhibitors in non-small cell lung cancer, Cell Signaling Technology EGFR antibody (Cell Signaling, 2232) was used in western blot on human samples (fig 1). PLoS ONE (2016) ncbi
domestic rabbit monoclonal (D38B1)
  • immunohistochemistry - paraffin section; human; 1:100; fig s4
  • western blot; human; 1:1000
In order to characterize colorectal cancer and nuclear localization of YBX1 and uncoupling of EGFR-RAS signaling, Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 4267) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig s4) and in western blot on human samples at 1:1000. Oncogenesis (2016) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; 1:1000; fig 3a
In order to generate and characterize extracellular vesicles decorated with ligands decorated with polyethylene glycol, Cell Signaling Technology EGFR antibody (Cell Signaling, D38B1) was used in western blot on human samples at 1:1000 (fig 3a). J Control Release (2016) ncbi
domestic rabbit monoclonal (D63B4)
  • western blot; human; 1:1000; loading ...; fig s3j
In order to discuss the contribution of LINK-A to cancer, Cell Signaling Technology EGFR antibody (Cell Signaling, 6963) was used in western blot on human samples at 1:1000 (fig s3j). Nat Cell Biol (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig s3j
In order to discuss the contribution of LINK-A to cancer, Cell Signaling Technology EGFR antibody (Cell Signaling, 4404) was used in western blot on human samples at 1:1000 (fig s3j). Nat Cell Biol (2016) ncbi
domestic rabbit monoclonal (D38B1)
  • immunocytochemistry; human; 1:200; loading ...; fig 3a
In order to discuss the contribution of LINK-A to cancer, Cell Signaling Technology EGFR antibody (Cell Signaling, 5108) was used in immunocytochemistry on human samples at 1:200 (fig 3a). Nat Cell Biol (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig s3j
In order to discuss the contribution of LINK-A to cancer, Cell Signaling Technology EGFR antibody (Cell Signaling, 2237) was used in western blot on human samples at 1:1000 (fig s3j). Nat Cell Biol (2016) ncbi
domestic rabbit monoclonal (53A5)
  • western blot; human; 1:1000; loading ...; fig s3j
In order to discuss the contribution of LINK-A to cancer, Cell Signaling Technology EGFR antibody (Cell Signaling, 4407) was used in western blot on human samples at 1:1000 (fig s3j). Nat Cell Biol (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig s3j
In order to discuss the contribution of LINK-A to cancer, Cell Signaling Technology EGFR antibody (Cell Signaling, 2235) was used in western blot on human samples at 1:1000 (fig s3j). Nat Cell Biol (2016) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; 1:1000; loading ...; fig 4c
In order to discuss the contribution of LINK-A to cancer, Cell Signaling Technology EGFR antibody (Cell Signaling, 3777) was used in western blot on human samples at 1:1000 (fig 4c). Nat Cell Biol (2016) ncbi
domestic rabbit monoclonal (43B2)
  • immunohistochemistry; mouse; fig 4
In order to report the role for EPHA2 in the cell survival of tyrosine kinase inhibitors-resistant, EGFR-mutant lung cancers, Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 3197S) was used in immunohistochemistry on mouse samples (fig 4). Cancer Res (2016) ncbi
domestic rabbit monoclonal (D38B1)
  • immunocytochemistry; human; fig 3
  • western blot; human; fig 1
In order to study the interactions between PMCA2 and HER2 in breast cancer cells, Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 4267) was used in immunocytochemistry on human samples (fig 3) and in western blot on human samples (fig 1). Proc Natl Acad Sci U S A (2016) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; fig 1
Cell Signaling Technology EGFR antibody (Cell Signaling, 2232) was used in immunocytochemistry on human samples (fig 1). Oncotarget (2016) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; 1:1000; loading ...; fig st12
Cell Signaling Technology EGFR antibody (Cell Signalling, 3777) was used in western blot on human samples at 1:1000 (fig st12). Nat Cell Biol (2016) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; 1:1000; loading ...; fig st12
Cell Signaling Technology EGFR antibody (Cell Signalling, 4267) was used in western blot on human samples at 1:1000 (fig st12). Nat Cell Biol (2016) ncbi
domestic rabbit monoclonal (D38B1)
  • immunocytochemistry; human; loading ...; fig 1-s1a
Cell Signaling Technology EGFR antibody (Cell signaling, 4267) was used in immunocytochemistry on human samples (fig 1-s1a). elife (2015) ncbi
domestic rabbit monoclonal (D7A5)
  • immunocytochemistry; human; loading ...; fig 1-s1c
  • western blot; human; loading ...; fig 1-s2c
Cell Signaling Technology EGFR antibody (Cell signaling, 3777) was used in immunocytochemistry on human samples (fig 1-s1c) and in western blot on human samples (fig 1-s2c). elife (2015) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 3a
Cell Signaling Technology EGFR antibody (Cell signaling, 2220) was used in western blot on human samples (fig 3a). Oncotarget (2016) ncbi
mouse monoclonal (1H12)
  • western blot; human; loading ...; fig 3a
Cell Signaling Technology EGFR antibody (Cell signaling, 2236) was used in western blot on human samples (fig 3a). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 3a
Cell Signaling Technology EGFR antibody (Cell signaling, 2235) was used in western blot on human samples (fig 3a). Oncotarget (2016) ncbi
mouse monoclonal (1H12)
  • western blot; human; fig 2
Cell Signaling Technology EGFR antibody (Cell Signaling, 1H12) was used in western blot on human samples (fig 2). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; fig 2
Cell Signaling Technology EGFR antibody (Cell Signaling Tech, 2234) was used in western blot on mouse samples (fig 2). Oncogene (2016) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; fig 6
Cell Signaling Technology EGFR antibody (Cell Signaling, 3777) was used in western blot on human samples (fig 6). PLoS ONE (2015) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; rat; 1:1000; fig 3
Cell Signaling Technology EGFR antibody (Cell Signaling, 3777p) was used in western blot on rat samples at 1:1000 (fig 3). Evid Based Complement Alternat Med (2015) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; mouse; fig 4
In order to investigate changes to AURKA signaling after treatment with erlotinib/alisertib combination therapy, Cell Signaling Technology EGFR antibody (Cell Signaling, 3777) was used in western blot on mouse samples (fig 4). Front Oncol (2015) ncbi
domestic rabbit monoclonal (C74B9)
  • western blot; mouse; fig 4
In order to investigate changes to AURKA signaling after treatment with erlotinib/alisertib combination therapy, Cell Signaling Technology EGFR antibody (Cell Signaling, 2646) was used in western blot on mouse samples (fig 4). Front Oncol (2015) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; fig 6
Cell Signaling Technology EGFR antibody (Cell Signaling, 2238) was used in western blot on mouse samples at 1:1000 (fig 6). Cell Death Differ (2016) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; mouse; 1:1000; fig 6
Cell Signaling Technology EGFR antibody (Cell Signaling, 3777) was used in western blot on mouse samples at 1:1000 (fig 6). Cell Death Differ (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; fig 6
Cell Signaling Technology EGFR antibody (Cell Signaling, 2231) was used in western blot on mouse samples at 1:1000 (fig 6). Cell Death Differ (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; fig 6
In order to learn the requirement for embryonic poly(A)-binding protein (EPAB) in female mice to provide granulosa cell EGF signaling and cumulus expansion, Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 2234s) was used in western blot on mouse samples (fig 6). Endocrinology (2016) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; 1:2000; fig s2b
In order to elucidate how EGFR mutations contribute to glioblastoma development, Cell Signaling Technology EGFR antibody (Cell Signaling, 3777S) was used in western blot on human samples at 1:2000 (fig s2b). Mol Cell (2015) ncbi
domestic rabbit monoclonal (D38B1)
  • immunoprecipitation; human; fig 1
  • western blot; human; fig 1
Cell Signaling Technology EGFR antibody (Cell signaling, D38B1) was used in immunoprecipitation on human samples (fig 1) and in western blot on human samples (fig 1). Glycobiology (2016) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; fig 1
Cell Signaling Technology EGFR antibody (Cell signaling, D7A5) was used in western blot on human samples (fig 1). Glycobiology (2016) ncbi
domestic rabbit monoclonal (C74B9)
  • immunohistochemistry - paraffin section; human; 1:50; fig 4
  • western blot; human; fig 4
Cell Signaling Technology EGFR antibody (Cell Signaling Tech, C74B9) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 4) and in western blot on human samples (fig 4). Oncotarget (2015) ncbi
domestic rabbit monoclonal (53A5)
  • western blot; human; fig 3
Cell Signaling Technology EGFR antibody (Cell Signaling, 4407S) was used in western blot on human samples (fig 3). Oncotarget (2015) ncbi
mouse monoclonal (1H12)
  • western blot; human; 1:2000; loading ...; fig 3
Cell Signaling Technology EGFR antibody (Cell Signaling, 2236) was used in western blot on human samples at 1:2000 (fig 3). PLoS ONE (2015) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; 1:2000; loading ...; fig 3
Cell Signaling Technology EGFR antibody (Cell Signaling, 4267) was used in western blot on human samples at 1:2000 (fig 3). PLoS ONE (2015) ncbi
domestic rabbit monoclonal (D38B1)
  • immunocytochemistry; human; fig 5
In order to elucidate the mechanism of intracellular activation of EGFR by fatty acid synthase dependent palmitoylation, Cell Signaling Technology EGFR antibody (Cell Signaling, 4267) was used in immunocytochemistry on human samples (fig 5). Oncotarget (2015) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 4
Cell Signaling Technology EGFR antibody (Cell signaling, 2232) was used in western blot on human samples (fig 4). Oncogene (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 4
Cell Signaling Technology EGFR antibody (Cell signaling, 2231) was used in western blot on human samples (fig 4). Oncogene (2016) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; 1:1000
In order to study allorecognition using Botryllus schlosseri, Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 4267) was used in western blot on human samples at 1:1000. Immunogenetics (2015) ncbi
domestic rabbit monoclonal (15F8)
  • immunocytochemistry; human; fig s1
Cell Signaling Technology EGFR antibody (Cell signaling, 4405S) was used in immunocytochemistry on human samples (fig s1). Mol Biol Cell (2015) ncbi
mouse monoclonal (1H12)
  • immunocytochemistry; human; fig 1
  • western blot; human; fig 5
Cell Signaling Technology EGFR antibody (Cell signaling, 2236S) was used in immunocytochemistry on human samples (fig 1) and in western blot on human samples (fig 5). Mol Biol Cell (2015) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human
In order to study the role of ADAM17 in cellular senescence and senescence secretome, Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 4267) was used in western blot on human samples . Breast Cancer Res (2015) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human
In order to study the role of ADAM17 in cellular senescence and senescence secretome, Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 3777) was used in western blot on human samples . Breast Cancer Res (2015) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; mouse; 1:500
Cell Signaling Technology EGFR antibody (Cell Signaling, 3777) was used in western blot on mouse samples at 1:500. Neuroscience (2015) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; fig 1
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 8543) was used in western blot on human samples (fig 1). PLoS ONE (2015) ncbi
mouse monoclonal (1H12)
  • western blot; human
Cell Signaling Technology EGFR antibody (Cell Signaling, 2236) was used in western blot on human samples . J Biomed Sci (2015) ncbi
mouse monoclonal (1H12)
  • western blot; human; 1:1000
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 2236) was used in western blot on human samples at 1:1000. Oncol Lett (2015) ncbi
domestic rabbit monoclonal (53A5)
  • western blot; human; fig 5
Cell Signaling Technology EGFR antibody (Cell Signaling, 4407) was used in western blot on human samples (fig 5). EBioMedicine (2015) ncbi
domestic rabbit monoclonal (53A5)
  • western blot; human; fig s3
Cell Signaling Technology EGFR antibody (Cell Signaling, 4407L) was used in western blot on human samples (fig s3). Oncotarget (2015) ncbi
domestic rabbit monoclonal (D38B1)
  • immunohistochemistry - paraffin section; human; 1:25
In order to develop and characterize patient-derived primary xenografts to a model of muscle invasive bladder cancer, Cell Signaling Technology EGFR antibody (Cell Signaling, 4267) was used in immunohistochemistry - paraffin section on human samples at 1:25. Oncotarget (2015) ncbi
domestic rabbit monoclonal (D63B4)
  • western blot; human; loading ...; fig 1c,2a,2b,2c,
In order to study mechanisms that confer resistance to therapeutic interventions in the insulin-like growth factor receptor pathway, Cell Signaling Technology EGFR antibody (CST, 6963) was used in western blot on human samples (fig 1c,2a,2b,2c,). Mol Cancer (2015) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; 1:500
In order to determine if miRNA that target Muc1 are protective against pancreatic cancer, Cell Signaling Technology EGFR antibody (Cell Signaling, 4267s) was used in western blot on human samples at 1:500. Biochim Biophys Acta (2015) ncbi
domestic rabbit monoclonal (D38B1)
  • immunohistochemistry; human; fig 1
  • western blot; human; fig 3
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 4267) was used in immunohistochemistry on human samples (fig 1) and in western blot on human samples (fig 3). Oncotarget (2015) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; fig 4
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 3777) was used in western blot on human samples (fig 4). Oncotarget (2015) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human
In order to discuss novel EGFR-targeting therapeutics to treat cancer, Cell Signaling Technology EGFR antibody (Cell Signaling, #4267) was used in western blot on human samples . BMC Cancer (2015) ncbi
domestic rabbit monoclonal (D38B1)
  • immunocytochemistry; human; fig 3
  • western blot; human; fig 3
Cell Signaling Technology EGFR antibody (Cell Signaling Tech, 4267s) was used in immunocytochemistry on human samples (fig 3) and in western blot on human samples (fig 3). Int J Mol Med (2015) ncbi
mouse monoclonal (1H12)
  • western blot; human
In order to study signaling events downstream to the G-protein-coupled estrogen receptor activated by dehydroepiandrosterone, Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 2236) was used in western blot on human samples . J Biol Chem (2015) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; 1:1000; fig 2
Cell Signaling Technology EGFR antibody (Cell Signaling, D38B1) was used in western blot on human samples at 1:1000 (fig 2). Nat Commun (2015) ncbi
domestic rabbit monoclonal (D63B4)
  • western blot; human
In order to study the effect of using an ADAM17 inhibitory antibody, MEDI3622, in several EGFR-dependent tumor models, Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 6963) was used in western blot on human samples . Mol Cancer Ther (2015) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human
In order to study the effect of using an ADAM17 inhibitory antibody, MEDI3622, in several EGFR-dependent tumor models, Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 3777) was used in western blot on human samples . Mol Cancer Ther (2015) ncbi
mouse monoclonal (1H12)
  • western blot; human
Cell Signaling Technology EGFR antibody (Cell Signaling, 2236) was used in western blot on human samples . Mol Cell Endocrinol (2015) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; loading ...; fig 2a, 3b, 4g, 4h
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 4267) was used in western blot on human samples (fig 2a, 3b, 4g, 4h). Oncotarget (2015) ncbi
domestic rabbit monoclonal (D63B4)
  • western blot; human; loading ...; fig 2a
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 6963) was used in western blot on human samples (fig 2a). Oncotarget (2015) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; 1:1000; fig s7
Cell Signaling Technology EGFR antibody (Cell Signaling, 4267S) was used in western blot on human samples at 1:1000 (fig s7). Nat Commun (2015) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; 1:1000; fig 4
In order to determine the contribution of low molecular weight protein tyrosine phosphatase to colorectal cancer, Cell Signaling Technology EGFR antibody (Cell Signaling Tech, 3777) was used in western blot on human samples at 1:1000 (fig 4). Oncotarget (2015) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 3777) was used in western blot on human samples . Int J Oncol (2015) ncbi
domestic rabbit monoclonal (D38B1)
  • immunocytochemistry; human
  • western blot; human
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 4267) was used in immunocytochemistry on human samples and in western blot on human samples . Int J Oncol (2015) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; fig 6
Cell Signaling Technology EGFR antibody (Cell Signaling, 3777) was used in western blot on human samples (fig 6). Cancer Cell (2015) ncbi
mouse monoclonal (1F4)
  • western blot; human; fig 6
Cell Signaling Technology EGFR antibody (Cell Signaling, 2239) was used in western blot on human samples (fig 6). Cancer Cell (2015) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; mouse; 1:1000; fig 5a
Cell Signaling Technology EGFR antibody (Cell Signaling, 3777) was used in western blot on mouse samples at 1:1000 (fig 5a). Mol Med Rep (2015) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; mouse; 1:1000; fig 5a
Cell Signaling Technology EGFR antibody (Cell Signaling, 4267) was used in western blot on mouse samples at 1:1000 (fig 5a). Mol Med Rep (2015) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human
In order to elucidate a role for heat shock proteins in ischemia, Cell Signaling Technology EGFR antibody (Cell Signaling Technologies, 4267) was used in western blot on human samples . J Cell Sci (2015) ncbi
mouse monoclonal (1H12)
  • immunohistochemistry - paraffin section; human; 1:400
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 2236) was used in immunohistochemistry - paraffin section on human samples at 1:400. World J Gastroenterol (2015) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human
In order to study the role of lysosomal degradation of CD44 in anoikis and extravasation in metastatic carcinoma cells, Cell Signaling Technology EGFR antibody (Cell Signaling, 4267) was used in western blot on human samples . J Biol Chem (2015) ncbi
domestic rabbit monoclonal (53A5)
  • western blot; human
In order to study the mechanism for the metastasis of ErbB2-positive breast cancer cells, Cell Signaling Technology EGFR antibody (Cell Signaling, 4407) was used in western blot on human samples . J Biol Chem (2015) ncbi
domestic rabbit monoclonal (D38B1)
  • immunocytochemistry; human
  • western blot; human
In order to study the mechanism for the metastasis of ErbB2-positive breast cancer cells, Cell Signaling Technology EGFR antibody (Cell Signaling, 4267) was used in immunocytochemistry on human samples and in western blot on human samples . J Biol Chem (2015) ncbi
domestic rabbit monoclonal (53A5)
  • western blot; human; loading ...; fig 1a
Cell Signaling Technology EGFR antibody (Cell Signaling, 53A5) was used in western blot on human samples (fig 1a). Oncogene (2015) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; 1:1000; fig 2
Cell Signaling Technology EGFR antibody (Cell Signaling, D38B1) was used in western blot on human samples at 1:1000 (fig 2). Placenta (2015) ncbi
mouse monoclonal (1H12)
  • western blot; human
In order to study the effects of uPA and EGF in breast adenocarcinoma cell lines, Cell Signaling Technology EGFR antibody (Cell Signalling, 2236) was used in western blot on human samples . Mol Carcinog (2016) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; fig 1
Cell Signaling Technology EGFR antibody (Signaling Technology, 4267) was used in western blot on human samples (fig 1). Oncogene (2015) ncbi
domestic rabbit monoclonal (D7A5)
  • immunoprecipitation; human
  • immunocytochemistry; human; 1:50
  • western blot; human
Cell Signaling Technology EGFR antibody (Cell Signaling, D7A5) was used in immunoprecipitation on human samples , in immunocytochemistry on human samples at 1:50 and in western blot on human samples . Nature (2015) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; mouse; 1:1000
In order to study heart valve development and cardiac function in Galnt1 KO mice, Cell Signaling Technology EGFR antibody (Cell Signaling, 4267) was used in western blot on mouse samples at 1:1000. PLoS ONE (2015) ncbi
domestic rabbit monoclonal (C74B9)
  • western blot; human
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 2646) was used in western blot on human samples . J Diabetes (2016) ncbi
domestic rabbit polyclonal
  • western blot; human
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 2234) was used in western blot on human samples . J Diabetes (2016) ncbi
domestic rabbit monoclonal (C74B9)
  • western blot; hamsters; loading ...; fig 7a
Cell Signaling Technology EGFR antibody (Cell Signaling, 2646) was used in western blot on hamsters samples (fig 7a). J Biol Chem (2015) ncbi
domestic rabbit polyclonal
  • western blot; rat; 1:1000
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 2232S) was used in western blot on rat samples at 1:1000. Mol Neurobiol (2016) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; rat; 1:1000
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 3777S) was used in western blot on rat samples at 1:1000. Mol Neurobiol (2016) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; rat; 1:500; fig 10
Cell Signaling Technology EGFR antibody (Cell Signaling, 3777) was used in western blot on rat samples at 1:500 (fig 10). J Appl Toxicol (2015) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; fig s1
Cell Signaling Technology EGFR antibody (Cell Signaling, 3777) was used in western blot on human samples (fig s1). Oncogene (2015) ncbi
domestic rabbit monoclonal (D38B1)
  • immunocytochemistry; African green monkey; fig 6k
In order to identify and characterize a new endocytic route that is called fast endophilin-mediated endocytosis, Cell Signaling Technology EGFR antibody (Cell Signaling Technologies, 4267) was used in immunocytochemistry on African green monkey samples (fig 6k). Nature (2015) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; fig 5
In order to study the suppression of nuclear EGFR-mediated transcriptional activation of MMP2 by PML that represses lung cancer metastasis, Cell Signaling Technology EGFR antibody (Cell Signaling Technology, D38B1) was used in western blot on human samples (fig 5). Cell Cycle (2014) ncbi
domestic rabbit monoclonal (D38B1)
  • immunohistochemistry - paraffin section; human; fig 1
  • immunocytochemistry; human; fig 1
In order to analyze EGF induced mitochondrial fusion of cancer cells created by de novo synthesized palmitate and mitochondrial EGFR, Cell Signaling Technology EGFR antibody (Cell Signaling, 4267) was used in immunohistochemistry - paraffin section on human samples (fig 1) and in immunocytochemistry on human samples (fig 1). Cell Cycle (2014) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; mouse
In order to determine the effect of STA-2842 on liver size and cystic burden in Pkd-/- mice with established polycystic liver disease, Cell Signaling Technology EGFR antibody (Cell Signaling, 3777S) was used in western blot on mouse samples . PLoS ONE (2014) ncbi
domestic rabbit monoclonal (C74B9)
  • western blot; mouse
In order to determine the effect of STA-2842 on liver size and cystic burden in Pkd-/- mice with established polycystic liver disease, Cell Signaling Technology EGFR antibody (Cell Signaling, 2646) was used in western blot on mouse samples . PLoS ONE (2014) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human; fig 5
Cell Signaling Technology EGFR antibody (Cell signaling, 4267) was used in western blot on human samples (fig 5). J Cell Sci (2015) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human
In order to identify mechanisms by which metastatic gastroesophageal adenocarcinomas develop resistance to ERBB2 inhibition, Cell Signaling Technology EGFR antibody (Cell Signaling Technologies, 3777) was used in western blot on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (1H12)
  • western blot; human; fig 4
Cell Signaling Technology EGFR antibody (Cell Signaling, 2236S) was used in western blot on human samples (fig 4). Proc Natl Acad Sci U S A (2014) ncbi
domestic rabbit monoclonal (43B2)
  • immunocytochemistry; mouse
  • western blot; mouse
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 3197S) was used in immunocytochemistry on mouse samples and in western blot on mouse samples . Am J Respir Cell Mol Biol (2015) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; 1:1000; fig 4B
Cell Signaling Technology EGFR antibody (Cell Signaling, 3777) was used in western blot on human samples at 1:1000 (fig 4B). Environ Health Perspect (2015) ncbi
domestic rabbit monoclonal (C74B9)
  • western blot; human
In order to determine if inhibition of AKT signaling augments erlotinib activity and abrogates HGF-mediated resistance, Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 2646) was used in western blot on human samples . J Cancer Res Clin Oncol (2015) ncbi
mouse monoclonal (1H12)
  • western blot; human
Cell Signaling Technology EGFR antibody (Cell Signaling, 2236) was used in western blot on human samples . Oncotarget (2014) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human
Cell Signaling Technology EGFR antibody (Cell Signaling, 4267) was used in western blot on human samples . Oncotarget (2014) ncbi
mouse monoclonal (1H12)
  • western blot; human
In order to study the effect of Hinokitiol on DNA damage and autophagy in gefitinib-resistant lung adenocarcinoma cells, Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 2236S) was used in western blot on human samples . PLoS ONE (2014) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 3777) was used in western blot on human samples . Biochim Biophys Acta (2014) ncbi
mouse monoclonal (1H12)
  • western blot; human
In order to study mechanism of resistance to the FGFR inhibitor BGJ398 and the FGFR inhibitor ponatinib, Cell Signaling Technology EGFR antibody (cell signaling, 2236S) was used in western blot on human samples . Oncogene (2015) ncbi
mouse monoclonal (1F4)
  • western blot; human; 1:1000
Cell Signaling Technology EGFR antibody (Cell Signaling, 2239S) was used in western blot on human samples at 1:1000. Mol Cancer Ther (2014) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; 1:1000
Cell Signaling Technology EGFR antibody (Cell Signaling, 3777S) was used in western blot on human samples at 1:1000. Mol Cancer Ther (2014) ncbi
domestic rabbit monoclonal (43B2)
  • immunoprecipitation; human; 1:1000
Cell Signaling Technology EGFR antibody (Cell Signaling, 3197S) was used in immunoprecipitation on human samples at 1:1000. Mol Cancer Ther (2014) ncbi
domestic rabbit monoclonal (C74B9)
  • western blot; human; fig 1c
In order to suggest that Akt activation by ERBB3/HER2 limits the effectiveness of EGFR inhibition, Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 2646) was used in western blot on human samples (fig 1c). Mol Cancer Ther (2014) ncbi
domestic rabbit monoclonal (43B2)
  • western blot; human; 1:1000
Cell Signaling Technology EGFR antibody (Cell Signaling, 3197) was used in western blot on human samples at 1:1000. PLoS ONE (2014) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human
Cell Signaling Technology EGFR antibody (Cell Signaling, 4267S) was used in western blot on human samples . J Biol Chem (2014) ncbi
domestic rabbit monoclonal (D38B1)
  • immunohistochemistry - paraffin section; human; 1:50
  • western blot; human; 1:1000
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, 4267) was used in immunohistochemistry - paraffin section on human samples at 1:50 and in western blot on human samples at 1:1000. Mol Oncol (2014) ncbi
domestic rabbit monoclonal (D7A5)
  • immunohistochemistry - paraffin section; human; 1:400
  • western blot; human; 1:1000
Cell Signaling Technology EGFR antibody (Cell Signaling, 3777) was used in immunohistochemistry - paraffin section on human samples at 1:400 and in western blot on human samples at 1:1000. Mol Oncol (2014) ncbi
domestic rabbit monoclonal (D7A5)
  • immunohistochemistry - free floating section; chicken
Cell Signaling Technology EGFR antibody (Cell Signaling Technology, CST-3777) was used in immunohistochemistry - free floating section on chicken samples . Oncogene (2014) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human
In order to study targeting sEcad for treatment of breast cancer, Cell Signaling Technology EGFR antibody (Cell Signaling, 3777) was used in western blot on human samples . Mol Carcinog (2014) ncbi
domestic rabbit monoclonal (D38B1)
  • western blot; human
In order to study targeting sEcad for treatment of breast cancer, Cell Signaling Technology EGFR antibody (Cell Signaling, 4267) was used in western blot on human samples . Mol Carcinog (2014) ncbi
domestic rabbit monoclonal (D38B1)
  • immunohistochemistry - frozen section; mouse
  • immunohistochemistry - paraffin section; human
Cell Signaling Technology EGFR antibody (Cell Signaling, 4267) was used in immunohistochemistry - frozen section on mouse samples and in immunohistochemistry - paraffin section on human samples . PLoS ONE (2013) ncbi
domestic rabbit monoclonal (D7A5)
  • immunohistochemistry - frozen section; mouse
  • immunohistochemistry - paraffin section; human
Cell Signaling Technology EGFR antibody (Cell Signaling, 3777) was used in immunohistochemistry - frozen section on mouse samples and in immunohistochemistry - paraffin section on human samples . PLoS ONE (2013) ncbi
domestic rabbit monoclonal (D7A5)
  • western blot; human; 1:1000
Cell Signaling Technology EGFR antibody (Cell signal, 3777) was used in western blot on human samples at 1:1000. Cell Tissue Res (2013) ncbi
domestic rabbit monoclonal (15F8)
  • western blot; human
Cell Signaling Technology EGFR antibody (Cell Signaling, 4405s) was used in western blot on human samples . J Biol Chem (2013) ncbi
domestic rabbit monoclonal (C74B9)
  • immunocytochemistry; human; fig 3a
Cell Signaling Technology EGFR antibody (Cell Signaling, C74B9) was used in immunocytochemistry on human samples (fig 3a). Sci Signal (2012) ncbi
Dako
mouse monoclonal (H11)
  • immunohistochemistry - paraffin section; human; 1:500; fig 3b
Dako EGFR antibody (DAKO, M3563) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 3b). Sci Rep (2021) ncbi
mouse monoclonal (DAK-H1-1197)
  • immunohistochemistry; human; 1:50; loading ...; fig 1d
Dako EGFR antibody (Dako-Agilent, M7239) was used in immunohistochemistry on human samples at 1:50 (fig 1d). Cancers (Basel) (2020) ncbi
mouse monoclonal (DAK-H1-1197)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1
Dako EGFR antibody (Dako, M7299) was used in immunohistochemistry - paraffin section on human samples (fig 1). Oncotarget (2017) ncbi
mouse monoclonal (H11)
  • immunohistochemistry - paraffin section; human
Dako EGFR antibody (Dako, H11) was used in immunohistochemistry - paraffin section on human samples . Hum Pathol (2016) ncbi
mouse monoclonal (H11)
  • flow cytometry; human; 1:2000; loading ...; fig s2d
Dako EGFR antibody (DAKO, H11) was used in flow cytometry on human samples at 1:2000 (fig s2d). Oncotarget (2016) ncbi
mouse monoclonal (H11)
  • immunohistochemistry - paraffin section; human; loading ...; fig 2b
Dako EGFR antibody (Dako, H11) was used in immunohistochemistry - paraffin section on human samples (fig 2b). J Pediatr Urol (2016) ncbi
mouse monoclonal (H11)
  • western blot; human; fig 1a
Dako EGFR antibody (DAKO, H11) was used in western blot on human samples (fig 1a). Tumour Biol (2016) ncbi
mouse monoclonal (H11)
  • immunohistochemistry - paraffin section; human; tbl 2
In order to analyze breast cancer subtypes and retrospective analysis of metastatic behaviour, Dako EGFR antibody (Dako, H11) was used in immunohistochemistry - paraffin section on human samples (tbl 2). Breast Cancer Res Treat (2015) ncbi
mouse monoclonal (H11)
  • immunohistochemistry; human; 1:200
Dako EGFR antibody (DakoCytomation, H11) was used in immunohistochemistry on human samples at 1:200. BMC Cancer (2014) ncbi
mouse monoclonal (H11)
  • immunohistochemistry; human; 1:500; fig 2
In order to characterize unresectable, locally advanced head and neck squamous cell carcinoma in an Easter cooperative oncology group trial E3303 phase II study of cetuximab in combination with radiation and cisplatin, Dako EGFR antibody (Dako, H11) was used in immunohistochemistry on human samples at 1:500 (fig 2). Clin Cancer Res (2014) ncbi
BD Biosciences
mouse monoclonal (13/EGFR)
  • western blot; human; loading ...; fig 4a
BD Biosciences EGFR antibody (BD Biosciences, 610017) was used in western blot on human samples (fig 4a). Mol Oncol (2021) ncbi
mouse monoclonal (13/EGFR)
  • western blot; human; loading ...; fig e11-7b
BD Biosciences EGFR antibody (BD Biosciences, 610017) was used in western blot on human samples (fig e11-7b). Nature (2019) ncbi
mouse monoclonal (EGFR.1)
  • other; human; loading ...; fig s1
In order to investigate the mechanisms of toxicity by the negative allosteric modulators of metabotropic glutamate receptor 5, BD Biosciences EGFR antibody (BD/Pharm, 555996) was used in other on human samples (fig s1). Cell Chem Biol (2017) ncbi
mouse monoclonal (13/EGFR)
  • western blot; human; loading ...; fig 1b
BD Biosciences EGFR antibody (BD Biosciences, 610017) was used in western blot on human samples (fig 1b). Cancer Res (2017) ncbi
mouse monoclonal (EGFR.1)
  • immunohistochemistry - frozen section; human; 5 ug/ml; loading ...; fig st7
In order to outline the protocols for antibodies used for immunohistochemical studies, BD Biosciences EGFR antibody (BD Biosciences, 555996) was used in immunohistochemistry - frozen section on human samples at 5 ug/ml (fig st7). J Toxicol Pathol (2017) ncbi
mouse monoclonal (21/Mena)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1a
BD Biosciences EGFR antibody (BD Bioscience, 610693) was used in immunohistochemistry - paraffin section on human samples (fig 1a). Oncoimmunology (2016) ncbi
mouse monoclonal (EGFR.1)
  • flow cytometry; human; 1:100; loading ...; fig 1a
In order to improve the therapeutic efficacy of cetuximab for non-small cell lung cancer by co-administrating the tumor-penetrating internalizing RGD peptide, BD Biosciences EGFR antibody (BD Biosciences, 555997) was used in flow cytometry on human samples at 1:100 (fig 1a). Oncol Lett (2016) ncbi
mouse monoclonal (EGFR.1)
  • flow cytometry; hamsters; loading ...; fig 1d
BD Biosciences EGFR antibody (BD Biosciences, 555997) was used in flow cytometry on hamsters samples (fig 1d). Cell Commun Signal (2016) ncbi
mouse monoclonal (EGFR.1)
  • western blot; human; loading ...; fig S1C
In order to investigate the crosstalk among MenaINV, RTKs, and integrins, BD Biosciences EGFR antibody (BD, 555996) was used in western blot on human samples (fig S1C). Mol Biol Cell (2016) ncbi
mouse monoclonal (EGFR.1)
  • other; human; 500 ug/ml; fig 1
BD Biosciences EGFR antibody (Becton Dickinson, 555996) was used in other on human samples at 500 ug/ml (fig 1). J Extracell Vesicles (2016) ncbi
mouse monoclonal (13/EGFR)
  • western blot; human; fig 1
BD Biosciences EGFR antibody (BD Biosciences, 610017) was used in western blot on human samples (fig 1). Oncotarget (2016) ncbi
mouse monoclonal (EGFR.1)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BD Biosciences EGFR antibody (BD, 555997) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
mouse monoclonal (13/EGFR)
  • immunoprecipitation; human; fig 3
  • western blot; human; fig 2
BD Biosciences EGFR antibody (BD Biosciences, 610017) was used in immunoprecipitation on human samples (fig 3) and in western blot on human samples (fig 2). Breast Cancer Res (2016) ncbi
mouse monoclonal (13/EGFR)
  • western blot; human; 1:500; loading ...; fig 2b
In order to demonstrate that receptor tyrosine kinase-like orphan receptor 1 is a scaffold for cavin-1 and caveolin-1, BD Biosciences EGFR antibody (BD Bioscience, 610017) was used in western blot on human samples at 1:500 (fig 2b). Nat Commun (2016) ncbi
mouse monoclonal (EGFR.1)
  • flow cytometry; human; fig 5d
BD Biosciences EGFR antibody (Becton Dickinson, 555997) was used in flow cytometry on human samples (fig 5d). Oncotarget (2016) ncbi
mouse monoclonal (12A3)
  • immunocytochemistry; human; loading ...; fig 1-s1c
BD Biosciences EGFR antibody (BD Biosciences, 558381) was used in immunocytochemistry on human samples (fig 1-s1c). elife (2015) ncbi
mouse monoclonal (21/Mena)
  • immunohistochemistry - paraffin section; human; 1:1000; tbl 1
In order to characterize a quantitative method of metastasis assessment called Menacalc that is a prognostic marker for axillary node-negative breast cancer, BD Biosciences EGFR antibody (BD Biosciences, 610693) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (tbl 1). BMC Cancer (2015) ncbi
mouse monoclonal (13/EGFR)
  • western blot; human; fig s3
BD Biosciences EGFR antibody (BD Biosciences, 610017) was used in western blot on human samples (fig s3). Oncotarget (2015) ncbi
mouse monoclonal (13/EGFR)
  • western blot; human; fig 1
In order to analyze the contribution of genetic alterations and cell type of origin in breast cancer phenotypes, BD Biosciences EGFR antibody (BD Bioscience, 610016) was used in western blot on human samples (fig 1). Oncotarget (2015) ncbi
mouse monoclonal (13/EGFR)
  • western blot; human
In order to study the role of Src homology phosphotyrosyl phosphatase 2 (SHP2) in triple negative breast cancers, BD Biosciences EGFR antibody (BD Biosciences, 610017) was used in western blot on human samples . BMC Cancer (2015) ncbi
mouse monoclonal (EGFR.1)
  • immunocytochemistry; human; fig 2
BD Biosciences EGFR antibody (BD biosciences, 555996) was used in immunocytochemistry on human samples (fig 2). PLoS ONE (2015) ncbi
mouse monoclonal (13/EGFR)
  • western blot; human; loading ...; fig 4a,b
BD Biosciences EGFR antibody (BD Biosciences, 610017) was used in western blot on human samples (fig 4a,b). Onco Targets Ther (2015) ncbi
mouse monoclonal (EGFR.1)
  • flow cytometry; human
In order to describe a novel, non-invasive, and adaptable method for the capture and genetic analysis of single tumor cells from cancer patients, BD Biosciences EGFR antibody (BD Biosciences, BD555997) was used in flow cytometry on human samples . Front Oncol (2014) ncbi
mouse monoclonal (13/EGFR)
  • western blot; human; fig 4
BD Biosciences EGFR antibody (BD Biosciences, 610016) was used in western blot on human samples (fig 4). Carcinogenesis (2014) ncbi
mouse monoclonal (13/EGFR)
  • western blot; human; 1:1000; fig 7
In order to investigate the interaction between alpha-taxilin and nexin 4 and its role in the recycling pathway of transferrin receptor, BD Biosciences EGFR antibody (BD Biosciences, 610016) was used in western blot on human samples at 1:1000 (fig 7). PLoS ONE (2014) ncbi
mouse monoclonal (13/EGFR)
  • western blot; human; fig 8a
BD Biosciences EGFR antibody (BD, 610017) was used in western blot on human samples (fig 8a). Mol Biol Cell (2014) ncbi
MilliporeSigma
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 7f
MilliporeSigma EGFR antibody (Atlas Antibodies, HPA018530) was used in western blot on human samples (fig 7f). elife (2020) ncbi
mouse monoclonal (225)
  • immunocytochemistry; human; 1:100; loading ...; tbl 1
MilliporeSigma EGFR antibody (Sigma, E2156) was used in immunocytochemistry on human samples at 1:100 (tbl 1). PLoS ONE (2017) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; 1:100; loading ...; fig 3e
  • western blot; human; 1:1000; loading ...; fig 1d
In order to examine the role of Breast Cancer Associated gene 2 in EGFR endocytosis and down-regulation and to determine its links with breast cancer outcome, MilliporeSigma EGFR antibody (Sigma, HPA018530) was used in immunocytochemistry on human samples at 1:100 (fig 3e) and in western blot on human samples at 1:1000 (fig 1d). J Cancer (2016) ncbi
mouse monoclonal (225)
  • flow cytometry; human; loading ...; fig s2a
In order to evaluate platelet-derived growth factor-alpha receptor as the receptor for human cytomegalovirus gHgLgO trimer, MilliporeSigma EGFR antibody (Sigma, 225) was used in flow cytometry on human samples (fig s2a). Nat Microbiol (2016) ncbi
ATCC
mouse monoclonal
  • western blot; dogs; loading ...; fig 3a
ATCC EGFR antibody (American Type Culture Collection, HB8506) was used in western blot on dogs samples (fig 3a). Nature (2018) ncbi
mouse monoclonal
  • immunoprecipitation; human; fig 1
  • immunocytochemistry; human; 1:200; fig 2
ATCC EGFR antibody (ATCC, HB-8509) was used in immunoprecipitation on human samples (fig 1) and in immunocytochemistry on human samples at 1:200 (fig 2). J Biol Chem (2015) ncbi
Articles Reviewed
  1. Pan R, Yu Y, Zhu H, Zhang W, Qin Y, Ye L, et al. RSPO2 promotes progression of ovarian cancer through dual receptor-mediated FAK/Src signaling activation. iScience. 2022;25:105184 pubmed publisher
  2. Cai S, Hu T, Venkatesan M, Allam M, Schneider F, Ramalingam S, et al. Multiplexed protein profiling reveals spatial subcellular signaling networks. iScience. 2022;25:104980 pubmed publisher
  3. Coy S, Wang S, Stopka S, Lin J, Yapp C, Ritch C, et al. Single cell spatial analysis reveals the topology of immunomodulatory purinergic signaling in glioblastoma. Nat Commun. 2022;13:4814 pubmed publisher
  4. Du X, Yuan L, Yao Y, Yang Y, Zhou K, Wu X, et al. ITGB4 Deficiency in Airway Epithelium Aggravates RSV Infection and Increases HDM Sensitivity. Front Immunol. 2022;13:912095 pubmed publisher
  5. Zhou S, Hassan A, Kungyal T, Tabari xe8 s S, Luna J, Siegel P, et al. CD109 Is a Critical Determinant of EGFR Expression and Signaling, and Tumorigenicity in Squamous Cell Carcinoma Cells. Cancers (Basel). 2022;14: pubmed publisher
  6. Vignone D, Gonzalez Paz O, Fini I, Cellucci A, Auciello G, Battista M, et al. Modelling the Human Blood-Brain Barrier in Huntington Disease. Int J Mol Sci. 2022;23: pubmed publisher
  7. Shu W, Zhu X, Wang K, Cherepanoff S, Conway R, Madigan M, et al. The multi-kinase inhibitor afatinib serves as a novel candidate for the treatment of human uveal melanoma. Cell Oncol (Dordr). 2022;45:601-619 pubmed publisher
  8. Huang J, Wang X, Li B, Shen S, Wang R, Tao H, et al. L-5-hydroxytryptophan promotes antitumor immunity by inhibiting PD-L1 inducible expression. J Immunother Cancer. 2022;10: pubmed publisher
  9. Eikmans M, van der Keur C, Anholts J, Drabbels J, van Beelen E, de Sousa Lopes S, et al. Primary Trophoblast Cultures: Characterization of HLA Profiles and Immune Cell Interactions. Front Immunol. 2022;13:814019 pubmed publisher
  10. Chen Y, Xu J, Pan W, Xu X, Ma X, Chu Y, et al. Galectin-3 enhances trastuzumab resistance by regulating cancer malignancy and stemness in HER2-positive breast cancer cells. Thorac Cancer. 2022;13:1961-1973 pubmed publisher
  11. Melese E, Franks E, Cederberg R, Harbourne B, Shi R, Wadsworth B, et al. CCL5 production in lung cancer cells leads to an altered immune microenvironment and promotes tumor development. Oncoimmunology. 2022;11:2010905 pubmed publisher
  12. Due S, Watson D, Bastian I, Eichelmann A, Hussey D. Oestrogen Receptor Isoforms May Represent a Therapeutic Target in Oesophageal Adenocarcinoma. Cancers (Basel). 2022;14: pubmed publisher
  13. Lin T, Yang C, Chou H, Cheng C, Liu Y, Wang J, et al. EGFR Mutation-Harboring Lung Cancer Cells Produce CLEC11A with Endothelial Trophic and Tumor-Promoting Activities. Cancers (Basel). 2022;14: pubmed publisher
  14. Wu X, Ren L, Yang Q, Song H, Tang Q, Zhang M, et al. Glucocorticoids Inhibit EGFR Signaling Activation in Podocytes in Anti-GBM Crescentic Glomerulonephritis. Front Med (Lausanne). 2022;9:697443 pubmed publisher
  15. Tapia Galisteo A, S xe1 nchez Rodr xed guez x, Aguilar Sope xf1 a O, Harwood S, Narbona J, Ferreras Gutierrez M, et al. Trispecific T-cell engagers for dual tumor-targeting of colorectal cancer. Oncoimmunology. 2022;11:2034355 pubmed publisher
  16. Castillo P, Aisagbonhi O, Saenz C, ElShamy W. Novel insights linking BRCA1-IRIS role in mammary gland development to formation of aggressive PABCs: the case for longer breastfeeding. Am J Cancer Res. 2022;12:396-426 pubmed
  17. Kinkhabwala A, Herbel C, Pankratz J, Yushchenko D, R xfc berg S, Praveen P, et al. MACSima imaging cyclic staining (MICS) technology reveals combinatorial target pairs for CAR T cell treatment of solid tumors. Sci Rep. 2022;12:1911 pubmed publisher
  18. Tan J, Li H, Ji C, Zhang L, Zhao C, Tang L, et al. Electron transfer-triggered imaging of EGFR signaling activity. Nat Commun. 2022;13:594 pubmed publisher
  19. Shen M, Zhang R, Jia W, Zhu Z, Zhao L, Huang G, et al. RNA-binding protein p54nrb/NONO potentiates nuclear EGFR-mediated tumorigenesis of triple-negative breast cancer. Cell Death Dis. 2022;13:42 pubmed publisher
  20. Li P, Li L, Li Z, Wang S, Li R, Zhao W, et al. Annexin A1 promotes the progression of bladder cancer via regulating EGFR signaling pathway. Cancer Cell Int. 2022;22:7 pubmed publisher
  21. Humeres C, Shinde A, Hanna A, Alex L, Hern xe1 ndez S, Li R, et al. Smad7 effects on TGF-β and ErbB2 restrain myofibroblast activation and protect from postinfarction heart failure. J Clin Invest. 2022;132: pubmed publisher
  22. Shi Y, Hu Y, Wang Y, Ma X, Tang L, Tao M, et al. Blockade of Autophagy Prevents the Development and Progression of Peritoneal Fibrosis. Front Pharmacol. 2021;12:724141 pubmed publisher
  23. Lo Cascio C, McNamara J, Melendez E, Lewis E, Dufault M, Sanai N, et al. Nonredundant, isoform-specific roles of HDAC1 in glioma stem cells. JCI Insight. 2021;6: pubmed publisher
  24. Wang Y, Liu I, Chen K, Wu H. NOTCH1 signaling promotes protein stability of HER3 through the AKT pathway in squamous cell carcinoma of head and neck. Oncogenesis. 2021;10:59 pubmed publisher
  25. Moon S, Lee H, Kim S, Hong J, Chun S, Lee H, et al. Inhibition of STAT3 enhances sensitivity to tamoxifen in tamoxifen-resistant breast cancer cells. BMC Cancer. 2021;21:931 pubmed publisher
  26. Wang Y, Liu X, Hu G, Hu C, Gao Y, Huo M, et al. EGFR-IL-6 Signaling Axis Mediated the Inhibitory Effect of Methylseleninic Acid on Esophageal Squamous Cell Carcinoma. Front Pharmacol. 2021;12:719785 pubmed publisher
  27. Vichas A, Riley A, Nkinsi N, Kamlapurkar S, Parrish P, Lo A, et al. Integrative oncogene-dependency mapping identifies RIT1 vulnerabilities and synergies in lung cancer. Nat Commun. 2021;12:4789 pubmed publisher
  28. Laliotis G, Chavdoula E, Paraskevopoulou M, Kaba A, La Ferlita A, Singh S, et al. AKT3-mediated IWS1 phosphorylation promotes the proliferation of EGFR-mutant lung adenocarcinomas through cell cycle-regulated U2AF2 RNA splicing. Nat Commun. 2021;12:4624 pubmed publisher
  29. Coudert L, Osseni A, Gangloff Y, Schaeffer L, Leblanc P. The ESCRT-0 subcomplex component Hrs/Hgs is a master regulator of myogenesis via modulation of signaling and degradation pathways. BMC Biol. 2021;19:153 pubmed publisher
  30. Shang P, Stepicheva N, Teel K, McCauley A, Fitting C, Hose S, et al. βA3/A1-crystallin regulates apical polarity and EGFR endocytosis in retinal pigmented epithelial cells. Commun Biol. 2021;4:850 pubmed publisher
  31. Lee S, Jung J, Lee Y, Kim S, Kim J, Kim B, et al. Targeting HSF1 as a Therapeutic Strategy for Multiple Mechanisms of EGFR Inhibitor Resistance in EGFR Mutant Non-Small-Cell Lung Cancer. Cancers (Basel). 2021;13: pubmed publisher
  32. Wang Q, Tao C, Hannan A, Yoon S, Min X, Peregrin J, et al. Lacrimal gland budding requires PI3K-dependent suppression of EGF signaling. Sci Adv. 2021;7: pubmed publisher
  33. Pham Q, Taniyama D, Sekino Y, Akabane S, Babasaki T, Kobayashi G, et al. Clinicopathologic features of TDO2 overexpression in renal cell carcinoma. BMC Cancer. 2021;21:737 pubmed publisher
  34. Sun L, Meckes D. Multiplex protein profiling method for extracellular vesicle protein detection. Sci Rep. 2021;11:12477 pubmed publisher
  35. Torres A, Rodríguez Escribà M, Marcet Houben M, Santos Vieira H, Camacho N, Catena H, et al. Human tRNAs with inosine 34 are essential to efficiently translate eukarya-specific low-complexity proteins. Nucleic Acids Res. 2021;49:7011-7034 pubmed publisher
  36. Zhu J, Cai T, Zhou J, Du W, Zeng Y, Liu T, et al. CD151 drives cancer progression depending on integrin α3β1 through EGFR signaling in non-small cell lung cancer. J Exp Clin Cancer Res. 2021;40:192 pubmed publisher
  37. Xu H, Yang X, Xuan X, Wu D, Zhang J, Xu X, et al. STAMBP promotes lung adenocarcinoma metastasis by regulating the EGFR/MAPK signaling pathway. Neoplasia. 2021;23:607-623 pubmed publisher
  38. Citron F, Segatto I, Musco L, Pellarin I, Rampioni Vinciguerra G, Franchin G, et al. miR-9 modulates and predicts the response to radiotherapy and EGFR inhibition in HNSCC. EMBO Mol Med. 2021;13:e12872 pubmed publisher
  39. Tripathi P, Guo H, Dreser A, Yamoah A, Sechi A, Jesse C, et al. Pathomechanisms of ALS8: altered autophagy and defective RNA binding protein (RBP) homeostasis due to the VAPB P56S mutation. Cell Death Dis. 2021;12:466 pubmed publisher
  40. Catalano A, Adlesic M, Kaltenbacher T, Klar R, Albers J, Seidel P, et al. Sensitivity and Resistance of Oncogenic RAS-Driven Tumors to Dual MEK and ERK Inhibition. Cancers (Basel). 2021;13: pubmed publisher
  41. Wang Z, Goto Y, Allevato M, Wu V, Saddawi Konefka R, Gilardi M, et al. Disruption of the HER3-PI3K-mTOR oncogenic signaling axis and PD-1 blockade as a multimodal precision immunotherapy in head and neck cancer. Nat Commun. 2021;12:2383 pubmed publisher
  42. Wang X, Zhang H, Sapio R, Yang J, Wong J, Zhang X, et al. SOD1 regulates ribosome biogenesis in KRAS mutant non-small cell lung cancer. Nat Commun. 2021;12:2259 pubmed publisher
  43. Gangoso E, Southgate B, Bradley L, Rus S, Gálvez Cancino F, McGivern N, et al. Glioblastomas acquire myeloid-affiliated transcriptional programs via epigenetic immunoediting to elicit immune evasion. Cell. 2021;184:2454-2470.e26 pubmed publisher
  44. Gao S, Gao L, Wang S, Shi X, Yue C, Wei S, et al. ATF3 Suppresses Growth and Metastasis of Clear Cell Renal Cell Carcinoma by Deactivating EGFR/AKT/GSK3β/β-Catenin Signaling Pathway. Front Cell Dev Biol. 2021;9:618987 pubmed publisher
  45. Levi M, Muscatello L, Brunetti B, Benazzi C, Parenti F, Gobbo F, et al. High Intrinsic Expression of P-glycoprotein and Breast Cancer Resistance Protein in Canine Mammary Carcinomas Regardless of Immunophenotype and Outcome. Animals (Basel). 2021;11: pubmed publisher
  46. Hoesl C, Frohlich T, Posch C, Kneitz H, Goebeler M, Schneider M, et al. The transmembrane protein LRIG1 triggers melanocytic tumor development following chemically induced skin carcinogenesis. Mol Oncol. 2021;15:2140-2155 pubmed publisher
  47. Wang P, Zhao L, Gong S, Xiong S, Wang J, Zou D, et al. HIF1α/HIF2α-Sox2/Klf4 promotes the malignant progression of glioblastoma via the EGFR-PI3K/AKT signalling pathway with positive feedback under hypoxia. Cell Death Dis. 2021;12:312 pubmed publisher
  48. Kitamura Y, Kanaya N, Moleirinho S, Du W, Reinshagen C, Attia N, et al. Anti-EGFR VHH-armed death receptor ligand-engineered allogeneic stem cells have therapeutic efficacy in diverse brain metastatic breast cancers. Sci Adv. 2021;7: pubmed publisher
  49. He Y, Kan W, Li Y, Hao Y, Huang A, Gu H, et al. A potent and selective small molecule inhibitor of myoferlin attenuates colorectal cancer progression. Clin Transl Med. 2021;11:e289 pubmed publisher
  50. Fu C, Zhang Q, Wang A, Yang S, Jiang Y, Bai L, et al. EWI-2 controls nucleocytoplasmic shuttling of EGFR signaling molecules and miRNA sorting in exosomes to inhibit prostate cancer cell metastasis. Mol Oncol. 2021;15:1543-1565 pubmed publisher
  51. Kashyap R, Balzano M, Lechat B, Lambaerts K, Egea Jimenez A, Lembo F, et al. Syntenin-knock out reduces exosome turnover and viral transduction. Sci Rep. 2021;11:4083 pubmed publisher
  52. Fleming Martinez A, D xf6 ppler H, Bastea L, Edenfield B, Patel T, Leitges M, et al. Dysfunctional EGFR and oxidative stress-induced PKD1 signaling drive formation of DCLK1+ pancreatic stem cells. iScience. 2021;24:102019 pubmed publisher
  53. Foth R, Shomroni O, Sigler M, Hörer J, Cleuziou J, Paul T, et al. Screening for potential targets to reduce stenosis in bioprosthetic heart valves. Sci Rep. 2021;11:2464 pubmed publisher
  54. Isomura H, Taguchi A, Kajino T, Asai N, Nakatochi M, Kato S, et al. Conditional Ror1 knockout reveals crucial involvement in lung adenocarcinoma development and identifies novel HIF-1α regulator. Cancer Sci. 2021;: pubmed publisher
  55. Kitazawa K, Nadanaka S, Kadomatsu K, Kitagawa H. Chondroitin 6-sulfate represses keratinocyte proliferation in mouse skin, which is associated with psoriasis. Commun Biol. 2021;4:114 pubmed publisher
  56. Ni W, Chen Z, Zhou X, Yang R, Yu M, Lu J, et al. Targeting Notch and EGFR signaling in human mucoepidermoid carcinoma. Signal Transduct Target Ther. 2021;6:27 pubmed publisher
  57. Andrews M, Mukhtar T, Eze U, Simoneau C, Perez Y, Mostajo Radji M, et al. Tropism of SARS-CoV-2 for Developing Human Cortical Astrocytes. bioRxiv. 2021;: pubmed publisher
  58. Hu X, Villodre E, Larson R, Rahal O, Wang X, Gong Y, et al. Decorin-mediated suppression of tumorigenesis, invasion, and metastasis in inflammatory breast cancer. Commun Biol. 2021;4:72 pubmed publisher
  59. Zheng Q, Dong H, Mo J, Zhang Y, Huang J, Ouyang S, et al. A novel STAT3 inhibitor W2014-S regresses human non-small cell lung cancer xenografts and sensitizes EGFR-TKI acquired resistance. Theranostics. 2021;11:824-840 pubmed publisher
  60. Dong X, Yang Y, Zou Z, Zhao Y, Ci B, Zhong L, et al. Sorting nexin 5 mediates virus-induced autophagy and immunity. Nature. 2021;589:456-461 pubmed publisher
  61. Wang Q, Gavin W, Masiello N, Tran K, Laible G, Shepherd P. Cetuximab produced from a goat mammary gland expression system is equally efficacious as innovator cetuximab in animal cancer models. Biotechnol Rep (Amst). 2020;28:e00533 pubmed publisher
  62. Zhou S, Zhang W, Cai G, Ding Y, Wei C, Li S, et al. Myofiber necroptosis promotes muscle stem cell proliferation via releasing Tenascin-C during regeneration. Cell Res. 2020;30:1063-1077 pubmed publisher
  63. Banik S, Pedram K, Wisnovsky S, Ahn G, Riley N, Bertozzi C. Lysosome-targeting chimaeras for degradation of extracellular proteins. Nature. 2020;584:291-297 pubmed publisher
  64. Dabelsteen S, Pallesen E, Marinova I, Nielsen M, Adamopoulou M, Rømer T, et al. Essential Functions of Glycans in Human Epithelia Dissected by a CRISPR-Cas9-Engineered Human Organotypic Skin Model. Dev Cell. 2020;54:669-684.e7 pubmed publisher
  65. Leelatian N, Sinnaeve J, Mistry A, Barone S, Brockman A, Diggins K, et al. Unsupervised machine learning reveals risk stratifying glioblastoma tumor cells. elife. 2020;9: pubmed publisher
  66. Du Z, Dong J, Li M, Zhang J, Bi J, Ren Y, et al. Overexpression of Platelet-Derived Growth Factor Receptor Α D842V Mutants Prevents Liver Regeneration and Chemically Induced Hepatocarcinogenesis via Inhibition of MET and EGFR. J Cancer. 2020;11:4614-4624 pubmed publisher
  67. Izumi H, Wang Z, Goto Y, Ando T, Wu X, Zhang X, et al. Pathway-Specific Genome Editing of PI3K/mTOR Tumor Suppressor Genes Reveals that PTEN Loss Contributes to Cetuximab Resistance in Head and Neck Cancer. Mol Cancer Ther. 2020;19:1562-1571 pubmed publisher
  68. Fan Z, Tian Y, Chen Z, Liu L, Zhou Q, He J, et al. Blocking interaction between SHP2 and PD-1 denotes a novel opportunity for developing PD-1 inhibitors. EMBO Mol Med. 2020;12:e11571 pubmed publisher
  69. Mahameed M, Boukeileh S, Obiedat A, Darawshi O, Dipta P, Rimon A, et al. Pharmacological induction of selective endoplasmic reticulum retention as a strategy for cancer therapy. Nat Commun. 2020;11:1304 pubmed publisher
  70. Chew H, De Lima P, Gonzalez Cruz J, Banushi B, Echejoh G, Hu L, et al. Endocytosis Inhibition in Humans to Improve Responses to ADCC-Mediating Antibodies. Cell. 2020;180:895-914.e27 pubmed publisher
  71. Howell M, Green R, Khalil R, Foran E, Quarni W, Nair R, et al. Lung cancer cells survive epidermal growth factor receptor tyrosine kinase inhibitor exposure through upregulation of cholesterol synthesis. FASEB Bioadv. 2020;2:90-105 pubmed publisher
  72. Padthaisong S, Thanee M, Namwat N, Phetcharaburanin J, Klanrit P, Khuntikeo N, et al. A panel of protein kinase high expression is associated with postoperative recurrence in cholangiocarcinoma. BMC Cancer. 2020;20:154 pubmed publisher
  73. Hu D, Chen H, Lou L, Zhang H, Yang G. SKA3 promotes lung adenocarcinoma metastasis through the EGFR-PI3K-Akt axis. Biosci Rep. 2020;40: pubmed publisher
  74. Haag A, Walser M, Henggeler A, Hajnal A. The CHORD protein CHP-1 regulates EGF receptor trafficking and signaling in C. elegans and in human cells. elife. 2020;9: pubmed publisher
  75. Ayanlaja A, Ji G, Wang J, Gao Y, Cheng B, Kanwore K, et al. Doublecortin undergo nucleocytoplasmic transport via the RanGTPase signaling to promote glioma progression. Cell Commun Signal. 2020;18:24 pubmed publisher
  76. Lai S, Lin H, Liu Y, Yang L, Lu D. Monocarboxylate Transporter 4 Regulates Glioblastoma Motility and Monocyte Binding Ability. Cancers (Basel). 2020;12: pubmed publisher
  77. Chen X, Wang K, Guo W, Li L, Yu P, Sun X, et al. UCH-L1-mediated Down-regulation of Estrogen Receptor α Contributes to Insensitivity to Endocrine Therapy for Breast Cancer. Theranostics. 2020;10:1833-1848 pubmed publisher
  78. Seitz C, Schroeder S, Knopf P, Krahl A, Hau J, Schleicher S, et al. GD2-targeted chimeric antigen receptor T cells prevent metastasis formation by elimination of breast cancer stem-like cells. Oncoimmunology. 2020;9:1683345 pubmed publisher
  79. Meng X, Zhao Y, Han B, Zha C, Zhang Y, Li Z, et al. Dual functionalized brain-targeting nanoinhibitors restrain temozolomide-resistant glioma via attenuating EGFR and MET signaling pathways. Nat Commun. 2020;11:594 pubmed publisher
  80. Zhao J, Li X, Liu L, Cao J, Goscinski M, Fan H, et al. Oncogenic Role of Guanylate Binding Protein 1 in Human Prostate Cancer. Front Oncol. 2019;9:1494 pubmed publisher
  81. Lyashenko E, Niepel M, Dixit P, Lim S, Sorger P, Vitkup D. Receptor-based mechanism of relative sensing and cell memory in mammalian signaling networks. elife. 2020;9: pubmed publisher
  82. Rao L, Giannico D, Leone P, Solimando A, Maiorano E, Caporusso C, et al. HB-EGF-EGFR Signaling in Bone Marrow Endothelial Cells Mediates Angiogenesis Associated with Multiple Myeloma. Cancers (Basel). 2020;12: pubmed publisher
  83. Xue J, Zhao Y, Aronowitz J, Mai T, Vides A, Qeriqi B, et al. Rapid non-uniform adaptation to conformation-specific KRAS(G12C) inhibition. Nature. 2020;577:421-425 pubmed publisher
  84. Zhang C, Lin X, Zhao Q, Wang Y, Jiang F, Ji C, et al. YARS as an oncogenic protein that promotes gastric cancer progression through activating PI3K-Akt signaling. J Cancer Res Clin Oncol. 2020;146:329-342 pubmed publisher
  85. Zhang Z, Le K, La Placa D, Armstrong B, Miller M, Shively J. CXCR2 specific endocytosis of immunomodulatory peptide LL-37 in human monocytes and formation of LL-37 positive large vesicles in differentiated monoosteophils. Bone Rep. 2020;12:100237 pubmed publisher
  86. Lee Y, Ho S, Graves J, Xiao Y, Huang S, Lin W. CGRRF1, a growth suppressor, regulates EGFR ubiquitination in breast cancer. Breast Cancer Res. 2019;21:134 pubmed publisher
  87. Zoi I, Karamouzis M, Xingi E, Sarantis P, Thomaidou D, Lembessis P, et al. Combining RANK/RANKL and ERBB-2 targeting as a novel strategy in ERBB-2-positive breast carcinomas. Breast Cancer Res. 2019;21:132 pubmed publisher
  88. Lenting K, van den Heuvel C, van Ewijk A, Elmelik D, de Boer R, Tindall E, et al. Mapping actionable pathways and mutations in brain tumours using targeted RNA next generation sequencing. Acta Neuropathol Commun. 2019;7:185 pubmed publisher
  89. Zeng H, Castillo Cabrera J, Manser M, Lu B, Yang Z, Strande V, et al. Genome-wide CRISPR screening reveals genetic modifiers of mutant EGFR dependence in human NSCLC. elife. 2019;8: pubmed publisher
  90. Canon J, Rex K, Saiki A, Mohr C, Cooke K, Bagal D, et al. The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity. Nature. 2019;575:217-223 pubmed publisher
  91. Lundby A, Franciosa G, Emdal K, Refsgaard J, Gnosa S, Bekker Jensen D, et al. Oncogenic Mutations Rewire Signaling Pathways by Switching Protein Recruitment to Phosphotyrosine Sites. Cell. 2019;179:543-560.e26 pubmed publisher
  92. Wang C, Vegna S, Jin H, Benedict B, Lieftink C, Ramirez C, et al. Inducing and exploiting vulnerabilities for the treatment of liver cancer. Nature. 2019;: pubmed publisher
  93. Sang Y, Li Y, Zhang Y, Alvarez A, Yu B, Zhang W, et al. CDK5-dependent phosphorylation and nuclear translocation of TRIM59 promotes macroH2A1 ubiquitination and tumorigenicity. Nat Commun. 2019;10:4013 pubmed publisher
  94. Wang K, Zhu T, Zhao R. Filamin A regulates EGFR/ERK/Akt signaling and affects colorectal cancer cell growth and migration. Mol Med Rep. 2019;20:3671-3678 pubmed publisher
  95. Jiang S, Zhang M, Zhang Y, Zhou W, Zhu T, Ruan Q, et al. WNT5B governs the phenotype of basal-like breast cancer by activating WNT signaling. Cell Commun Signal. 2019;17:109 pubmed publisher
  96. Nagpal A, Redvers R, Ling X, Ayton S, Fuentes M, Tavancheh E, et al. Neoadjuvant neratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2+ve breast cancer metastasis. Breast Cancer Res. 2019;21:94 pubmed publisher
  97. Sanghvi V, Leibold J, Mina M, Mohan P, Berishaj M, Li Z, et al. The Oncogenic Action of NRF2 Depends on De-glycation by Fructosamine-3-Kinase. Cell. 2019;178:807-819.e21 pubmed publisher
  98. Hori A, Shimoda M, Naoi Y, Kagara N, Tanei T, Miyake T, et al. Vasculogenic mimicry is associated with trastuzumab resistance of HER2-positive breast cancer. Breast Cancer Res. 2019;21:88 pubmed publisher
  99. Bi J, Ichu T, Zanca C, Yang H, Zhang W, Gu Y, et al. Oncogene Amplification in Growth Factor Signaling Pathways Renders Cancers Dependent on Membrane Lipid Remodeling. Cell Metab. 2019;30:525-538.e8 pubmed publisher
  100. Du F, Qiao C, Li X, Chen Z, Liu H, Wu S, et al. Forkhead box K2 promotes human colorectal cancer metastasis by upregulating ZEB1 and EGFR. Theranostics. 2019;9:3879-3902 pubmed publisher
  101. Wen H, Gao S, Wang Y, Ray M, Magnuson M, Wright C, et al. Myeloid cell-derived HB-EGF Drives Tissue Recovery After Pancreatitis. Cell Mol Gastroenterol Hepatol. 2019;: pubmed publisher
  102. Lee Y, Chen M, Lee J, Zhang J, Lin S, Fu T, et al. Reactivation of PTEN tumor suppressor for cancer treatment through inhibition of a MYC-WWP1 inhibitory pathway. Science. 2019;364: pubmed publisher
  103. Larsen M, Pérez Verdaguer M, Schmidt B, Bruchez M, Watkins S, Sorkin A. Generation of endogenous pH-sensitive EGF receptor and its application in high-throughput screening for proteins involved in clathrin-mediated endocytosis. elife. 2019;8: pubmed publisher
  104. Chung H, Zou X, Bajar B, Brand V, Huo Y, Alcudia J, et al. A compact synthetic pathway rewires cancer signaling to therapeutic effector release. Science. 2019;364: pubmed publisher
  105. Kim E, Lisby A, Ma C, Lo N, Ehmer U, Hayer K, et al. Promotion of growth factor signaling as a critical function of β-catenin during HCC progression. Nat Commun. 2019;10:1909 pubmed publisher
  106. Wagner J, Rapsomaniki M, Chevrier S, Anzeneder T, Langwieder C, Dykgers A, et al. A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer. Cell. 2019;177:1330-1345.e18 pubmed publisher
  107. Liu X, Chen H, Hou Y, Ma X, Ye M, Huang R, et al. Adaptive EGF expression sensitizes pancreatic cancer cells to ionizing radiation through activation of the cyclin D1/P53/PARP pathway. Int J Oncol. 2019;54:1466-1480 pubmed publisher
  108. Fearnley G, Young K, Edgar J, Antrobus R, Hay I, Liang W, et al. The homophilic receptor PTPRK selectively dephosphorylates multiple junctional regulators to promote cell-cell adhesion. elife. 2019;8: pubmed publisher
  109. Drews K, Calgi M, Harrison W, Drews C, Costa Pinheiro P, Shaw J, et al. Glucosylceramidase Maintains Influenza Virus Infection by Regulating Endocytosis. J Virol. 2019;93: pubmed publisher
  110. Tsai C, Tsai C, Yi J, Kao H, Huang Y, Wang C, et al. Activin A regulates the epidermal growth factor receptor promoter by activating the PI3K/SP1 pathway in oral squamous cell carcinoma cells. Sci Rep. 2019;9:5197 pubmed publisher
  111. Quinney K, Frankel E, Shankar R, Kasberg W, Luong P, Audhya A. Growth factor stimulation promotes multivesicular endosome biogenesis by prolonging recruitment of the late-acting ESCRT machinery. Proc Natl Acad Sci U S A. 2019;116:6858-6867 pubmed publisher
  112. Pergu R, Dagar S, Kumar H, Kumar R, Bhattacharya J, Mylavarapu S. The chaperone ERp29 is required for tunneling nanotube formation by stabilizing MSec. J Biol Chem. 2019;294:7177-7193 pubmed publisher
  113. Greer Y, Gilbert S, Gril B, Narwal R, Peacock Brooks D, Tice D, et al. MEDI3039, a novel highly potent tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptor 2 agonist, causes regression of orthotopic tumors and inhibits outgrowth of metastatic triple-negative breast cancer. Breast Cancer Res. 2019;21:27 pubmed publisher
  114. Liu J, Zhu G, Jia N, Wang W, Wang Y, Yin M, et al. CD9 regulates keratinocyte migration by negatively modulating the sheddase activity of ADAM17. Int J Biol Sci. 2019;15:493-506 pubmed publisher
  115. Chen H, Poran A, Unni A, Huang S, Elemento O, Snoeck H, et al. Generation of pulmonary neuroendocrine cells and SCLC-like tumors from human embryonic stem cells. J Exp Med. 2019;216:674-687 pubmed publisher
  116. Nava M, Dutta P, Zemke N, Farias Eisner R, Vadgama J, Wu Y. Transcriptomic and ChIP-sequence interrogation of EGFR signaling in HER2+ breast cancer cells reveals a dynamic chromatin landscape and S100 genes as targets. BMC Med Genomics. 2019;12:32 pubmed publisher
  117. Kubli S, Bassi C, Roux C, Wakeham A, Göbl C, Zhou W, et al. AhR controls redox homeostasis and shapes the tumor microenvironment in BRCA1-associated breast cancer. Proc Natl Acad Sci U S A. 2019;116:3604-3613 pubmed publisher
  118. Cai Y, Zhu G, Liu S, Pan Z, Quintero M, Poole C, et al. Indispensable role of the Ubiquitin-fold modifier 1-specific E3 ligase in maintaining intestinal homeostasis and controlling gut inflammation. Cell Discov. 2019;5:7 pubmed publisher
  119. Xie C, Zhu J, Wang X, Chen J, Geng S, Wu J, et al. Tobacco smoke induced hepatic cancer stem cell-like properties through IL-33/p38 pathway. J Exp Clin Cancer Res. 2019;38:39 pubmed publisher
  120. Wintgens J, Wichert S, Popovic L, Rossner M, Wehr M. Monitoring activities of receptor tyrosine kinases using a universal adapter in genetically encoded split TEV assays. Cell Mol Life Sci. 2019;76:1185-1199 pubmed publisher
  121. Tang Z, Ding Y, Shen Q, Zhang C, Li J, Nazar M, et al. KIAA1199 promotes invasion and migration in non-small-cell lung cancer (NSCLC) via PI3K-Akt mediated EMT. J Mol Med (Berl). 2019;97:127-140 pubmed publisher
  122. Unni A, Harbourne B, Oh M, Wild S, Ferrarone J, Lockwood W, et al. Hyperactivation of ERK by multiple mechanisms is toxic to RTK-RAS mutation-driven lung adenocarcinoma cells. elife. 2018;7: pubmed publisher
  123. Jeong J, Choi J, Kim W, Dann P, Takyar F, Gefter J, et al. Inhibition of ezrin causes PKCα-mediated internalization of erbb2/HER2 tyrosine kinase in breast cancer cells. J Biol Chem. 2019;294:887-901 pubmed publisher
  124. Lee S, Cho Y, Cha P, Yoon J, Ro E, Jeong W, et al. A small molecule approach to degrade RAS with EGFR repression is a potential therapy for KRAS mutation-driven colorectal cancer resistance to cetuximab. Exp Mol Med. 2018;50:153 pubmed publisher
  125. Grohmann M, Wiede F, Dodd G, Gurzov E, Ooi G, Butt T, et al. Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC. Cell. 2018;175:1289-1306.e20 pubmed publisher
  126. Liang C, Ma Y, Yong L, Yang C, Wang P, Liu X, et al. Y-box binding protein-1 promotes tumorigenesis and progression via the epidermal growth factor receptor/AKT pathway in spinal chordoma. Cancer Sci. 2019;110:166-179 pubmed publisher
  127. Gut G, Herrmann M, Pelkmans L. Multiplexed protein maps link subcellular organization to cellular states. Science. 2018;361: pubmed publisher
  128. Fan P, Narzisi G, Jayaprakash A, Venturini E, Robine N, Smibert P, et al. YES1 amplification is a mechanism of acquired resistance to EGFR inhibitors identified by transposon mutagenesis and clinical genomics. Proc Natl Acad Sci U S A. 2018;115:E6030-E6038 pubmed publisher
  129. Xue Z, Vis D, Bruna A, Sustic T, van Wageningen S, Batra A, et al. MAP3K1 and MAP2K4 mutations are associated with sensitivity to MEK inhibitors in multiple cancer models. Cell Res. 2018;28:719-729 pubmed publisher
  130. Park J, Kim I, Choi J, Lim H, Shin J, Kim Y, et al. AHNAK Loss in Mice Promotes Type II Pneumocyte Hyperplasia and Lung Tumor Development. Mol Cancer Res. 2018;16:1287-1298 pubmed publisher
  131. Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed publisher
  132. Vlachogiannis G, Hedayat S, Vatsiou A, Jamin Y, Fernández Mateos J, Khan K, et al. Patient-derived organoids model treatment response of metastatic gastrointestinal cancers. Science. 2018;359:920-926 pubmed publisher
  133. Gstrein T, Edwards A, Přistoupilová A, Leca I, Breuss M, Pilat Carotta S, et al. Mutations in Vps15 perturb neuronal migration in mice and are associated with neurodevelopmental disease in humans. Nat Neurosci. 2018;21:207-217 pubmed publisher
  134. Palesch D, Bosinger S, Tharp G, Vanderford T, Paiardini M, Chahroudi A, et al. Sooty mangabey genome sequence provides insight into AIDS resistance in a natural SIV host. Nature. 2018;553:77-81 pubmed publisher
  135. Park G, Kim D. Cigarette smoke-induced EGFR activation promotes epithelial mesenchymal migration of human retinal pigment epithelial cells through regulation of the FAK-mediated Syk/Src pathway. Mol Med Rep. 2018;17:3563-3574 pubmed publisher
  136. Oldrini B, Hsieh W, Erdjument Bromage H, Codega P, Carro M, Curiel García A, et al. EGFR feedback-inhibition by Ran-binding protein 6 is disrupted in cancer. Nat Commun. 2017;8:2035 pubmed publisher
  137. Yu R, Longo J, van Leeuwen J, Mullen P, Ba Alawi W, Haibe Kains B, et al. Statin-Induced Cancer Cell Death Can Be Mechanistically Uncoupled from Prenylation of RAS Family Proteins. Cancer Res. 2018;78:1347-1357 pubmed publisher
  138. Zeng L, Kang R, Zhu S, Wang X, Cao L, Wang H, et al. ALK is a therapeutic target for lethal sepsis. Sci Transl Med. 2017;9: pubmed publisher
  139. Mai W, Gosa L, Daniëls V, Ta L, Tsang J, Higgins B, et al. Cytoplasmic p53 couples oncogene-driven glucose metabolism to apoptosis and is a therapeutic target in glioblastoma. Nat Med. 2017;23:1342-1351 pubmed publisher
  140. Liu S, Liu H, Johnston A, Hanna Addams S, Reynoso E, Xiang Y, et al. MLKL forms disulfide bond-dependent amyloid-like polymers to induce necroptosis. Proc Natl Acad Sci U S A. 2017;114:E7450-E7459 pubmed publisher
  141. Baumann C, Ullrich A, Torka R. GAS6-expressing and self-sustaining cancer cells in 3D spheroids activate the PDK-RSK-mTOR pathway for survival and drug resistance. Mol Oncol. 2017;11:1430-1447 pubmed publisher
  142. Guo J, Jayaprakash P, Dan J, Wise P, Jang G, Liang C, et al. PRAS40 Connects Microenvironmental Stress Signaling to Exosome-Mediated Secretion. Mol Cell Biol. 2017;37: pubmed publisher
  143. Shah F, Stepan A, O Mahony A, Velichko S, Folias A, Houle C, et al. Mechanisms of Skin Toxicity Associated with Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators. Cell Chem Biol. 2017;24:858-869.e5 pubmed publisher
  144. Laviolette L, Mermoud J, Calvo I, Olson N, Boukhali M, Steinlein O, et al. Negative regulation of EGFR signalling by the human folliculin tumour suppressor protein. Nat Commun. 2017;8:15866 pubmed publisher
  145. ElHady A, Abdel Halim M, Abadi A, Engel M. Development of Selective Clk1 and -4 Inhibitors for Cellular Depletion of Cancer-Relevant Proteins. J Med Chem. 2017;60:5377-5391 pubmed publisher
  146. Vaishnavi A, Schubert L, Rix U, Marek L, Le A, Keysar S, et al. EGFR Mediates Responses to Small-Molecule Drugs Targeting Oncogenic Fusion Kinases. Cancer Res. 2017;77:3551-3563 pubmed publisher
  147. Xiao Z, Gaertner S, Morresi Hauf A, Genzel R, Duell T, Ullrich A, et al. Metformin Triggers Autophagy to Attenuate Drug-Induced Apoptosis in NSCLC Cells, with Minor Effects on Tumors of Diabetic Patients. Neoplasia. 2017;19:385-395 pubmed publisher
  148. Bi P, Ramirez Martinez A, Li H, Cannavino J, McAnally J, Shelton J, et al. Control of muscle formation by the fusogenic micropeptide myomixer. Science. 2017;356:323-327 pubmed publisher
  149. Setty B, Pillay Smiley N, Pool C, Jin Y, Liu Y, Nelin L. Hypoxia-induced proliferation of HeLa cells depends on epidermal growth factor receptor-mediated arginase II induction. Physiol Rep. 2017;5: pubmed publisher
  150. Solis N, Swidergall M, Bruno V, Gaffen S, Filler S. The Aryl Hydrocarbon Receptor Governs Epithelial Cell Invasion during Oropharyngeal Candidiasis. MBio. 2017;8: pubmed publisher
  151. Lee H, Kim M, Baek M, Morales L, Jang I, Slaga T, et al. Targeted disruption of TC-PTP in the proliferative compartment augments STAT3 and AKT signaling and skin tumor development. Sci Rep. 2017;7:45077 pubmed publisher
  152. Manzanares M, Usui A, Campbell D, Dumur C, Maldonado G, Fausther M, et al. Transforming Growth Factors α and β Are Essential for Modeling Cholangiocarcinoma Desmoplasia and Progression in a Three-Dimensional Organotypic Culture Model. Am J Pathol. 2017;187:1068-1092 pubmed publisher
  153. Gupta A, Anjomani Virmouni S, Koundouros N, Dimitriadi M, Choo Wing R, Valle A, et al. PARK2 Depletion Connects Energy and Oxidative Stress to PI3K/Akt Activation via PTEN S-Nitrosylation. Mol Cell. 2017;65:999-1013.e7 pubmed publisher
  154. Cherniack A, Shen H, Walter V, Stewart C, Murray B, Bowlby R, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017;31:411-423 pubmed publisher
  155. Shizu R, Osabe M, Perera L, Moore R, Sueyoshi T, Negishi M. Phosphorylated Nuclear Receptor CAR Forms a Homodimer To Repress Its Constitutive Activity for Ligand Activation. Mol Cell Biol. 2017;37: pubmed publisher
  156. Li K, Mo C, Gong D, Chen Y, Huang Z, Li Y, et al. DDX17 nucleocytoplasmic shuttling promotes acquired gefitinib resistance in non-small cell lung cancer cells via activation of β-catenin. Cancer Lett. 2017;400:194-202 pubmed publisher
  157. Shi J, Bei Y, Kong X, Liu X, Lei Z, Xu T, et al. miR-17-3p Contributes to Exercise-Induced Cardiac Growth and Protects against Myocardial Ischemia-Reperfusion Injury. Theranostics. 2017;7:664-676 pubmed publisher
  158. Gomes de Castro M, Hobartner C, Opazo F. Aptamers provide superior stainings of cellular receptors studied under super-resolution microscopy. PLoS ONE. 2017;12:e0173050 pubmed publisher
  159. Schumacher M, Hedl M, Abraham C, Bernard J, Lozano P, Hsieh J, et al. ErbB4 signaling stimulates pro-inflammatory macrophage apoptosis and limits colonic inflammation. Cell Death Dis. 2017;8:e2622 pubmed publisher
  160. Senturk S, Shirole N, Nowak D, Corbo V, Pal D, Vaughan A, et al. Rapid and tunable method to temporally control gene editing based on conditional Cas9 stabilization. Nat Commun. 2017;8:14370 pubmed publisher
  161. Peiris D, Spector A, Lomax Browne H, Azimi T, Ramesh B, Loizidou M, et al. Cellular glycosylation affects Herceptin binding and sensitivity of breast cancer cells to doxorubicin and growth factors. Sci Rep. 2017;7:43006 pubmed publisher
  162. Radder J, Zhang Y, Gregory A, Yu S, Kelly N, Leader J, et al. Extreme Trait Whole-Genome Sequencing Identifies PTPRO as a Novel Candidate Gene in Emphysema with Severe Airflow Obstruction. Am J Respir Crit Care Med. 2017;196:159-171 pubmed publisher
  163. Wu Y, Wang Y, Lin Y, Liu Y, Wang Y, Jia J, et al. Dub3 inhibition suppresses breast cancer invasion and metastasis by promoting Snail1 degradation. Nat Commun. 2017;8:14228 pubmed publisher
  164. Furukawa S, Nagaike M, Ozaki K. Databases for technical aspects of immunohistochemistry. J Toxicol Pathol. 2017;30:79-107 pubmed publisher
  165. Dong Q, Fu L, Zhao Y, Tan S, Wang E. Derlin-1 overexpression confers poor prognosis in muscle invasive bladder cancer and contributes to chemoresistance and invasion through PI3K/AKT and ERK/MMP signaling. Oncotarget. 2017;8:17059-17069 pubmed publisher
  166. Way G, Allaway R, Bouley S, Fadul C, Sanchez Y, Greene C. A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma. BMC Genomics. 2017;18:127 pubmed publisher
  167. Duhachek Muggy S, Qi Y, Wise R, Alyahya L, Li H, Hodge J, et al. Metalloprotease-disintegrin ADAM12 actively promotes the stem cell-like phenotype in claudin-low breast cancer. Mol Cancer. 2017;16:32 pubmed publisher
  168. Melchionna R, Iapicca P, Di Modugno F, Trono P, Sperduti I, Fassan M, et al. The pattern of hMENA isoforms is regulated by TGF-?1 in pancreatic cancer and may predict patient outcome. Oncoimmunology. 2016;5:e1221556 pubmed publisher
  169. Lisse T, Rieger S. IKKα regulates human keratinocyte migration through surveillance of the redox environment. J Cell Sci. 2017;130:975-988 pubmed publisher
  170. Xu J, Zhang X, Wang H, Ge S, Gao T, Song L, et al. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition. Biomed Pharmacother. 2017;88:421-429 pubmed publisher
  171. Ma K, Fu W, Tang M, Zhang C, Hou T, Li R, et al. PTK2-mediated degradation of ATG3 impedes cancer cells susceptible to DNA damage treatment. Autophagy. 2017;13:579-591 pubmed publisher
  172. Cao H, Yu S, Chen D, Jing C, Wang Z, Ma R, et al. Liver X receptor agonist T0901317 reverses resistance of A549 human lung cancer cells to EGFR-TKI treatment. FEBS Open Bio. 2017;7:35-43 pubmed publisher
  173. Muranen T, Iwanicki M, Curry N, Hwang J, DuBois C, Coloff J, et al. Starved epithelial cells uptake extracellular matrix for survival. Nat Commun. 2017;8:13989 pubmed publisher
  174. Zhao B, Hu W, Kumar S, Gonyo P, Rana U, Liu Z, et al. The Nogo-B receptor promotes Ras plasma membrane localization and activation. Oncogene. 2017;36:3406-3416 pubmed publisher
  175. Li J, Liu B, Shi Y, Xie K, Yin H, Yan L, et al. CXCL4 Contributes to the Pathogenesis of Chronic Liver Allograft Dysfunction. J Immunol Res. 2016;2016:9276986 pubmed publisher
  176. Kozlova N, Wottawa M, Katschinski D, Kristiansen G, Kietzmann T. Hypoxia-inducible factor prolyl hydroxylase 2 (PHD2) is a direct regulator of epidermal growth factor receptor (EGFR) signaling in breast cancer. Oncotarget. 2017;8:9885-9898 pubmed publisher
  177. Khelwatty S, Essapen S, Bagwan I, Green M, Seddon A, Modjtahedi H. The impact of co-expression of wild-type EGFR and its ligands determined by immunohistochemistry for response to treatment with cetuximab in patients with metastatic colorectal cancer. Oncotarget. 2017;8:7666-7677 pubmed publisher
  178. Hill S, Nesser N, Johnson Camacho K, Jeffress M, Johnson A, Boniface C, et al. Context Specificity in Causal Signaling Networks Revealed by Phosphoprotein Profiling. Cell Syst. 2017;4:73-83.e10 pubmed publisher
  179. Tian X, Ye M, Cao Y, Wang C. Losartan Improves Palmitate-Induced Insulin Resistance in 3T3-L1 Adipocytes Through Upregulation of Src Phosphorylation. Exp Clin Endocrinol Diabetes. 2017;125:136-140 pubmed publisher
  180. Kadlecova Z, Spielman S, Loerke D, Mohanakrishnan A, Reed D, Schmid S. Regulation of clathrin-mediated endocytosis by hierarchical allosteric activation of AP2. J Cell Biol. 2017;216:167-179 pubmed publisher
  181. Li C, Luo X, Zhao S, Siu G, Liang Y, Chan H, et al. COPI-TRAPPII activates Rab18 and regulates its lipid droplet association. EMBO J. 2017;36:441-457 pubmed publisher
  182. Vakana E, Pratt S, Blosser W, Dowless M, Simpson N, Yuan X, et al. LY3009120, a panRAF inhibitor, has significant anti-tumor activity in BRAF and KRAS mutant preclinical models of colorectal cancer. Oncotarget. 2017;8:9251-9266 pubmed publisher
  183. Wymant J, Hiscox S, Westwell A, Urbé S, Clague M, Jones A. The Role of BCA2 in the Endocytic Trafficking of EGFR and Significance as a Prognostic Biomarker in Cancer. J Cancer. 2016;7:2388-2407 pubmed
  184. Kneissl J, Hartmann A, Pfarr N, Erlmeier F, Lorber T, Keller S, et al. Influence of the HER receptor ligand system on sensitivity to cetuximab and trastuzumab in gastric cancer cell lines. J Cancer Res Clin Oncol. 2017;143:573-600 pubmed publisher
  185. Mukhopadhyay C, Triplett A, Bargar T, HECKMAN C, Wagner K, Naramura M. Casitas B-cell lymphoma (Cbl) proteins protect mammary epithelial cells from proteotoxicity of active c-Src accumulation. Proc Natl Acad Sci U S A. 2016;113:E8228-E8237 pubmed publisher
  186. Lee H, Khan S, Khaliqdina S, Altintas M, Grahammer F, Zhao J, et al. Absence of miR-146a in Podocytes Increases Risk of Diabetic Glomerulopathy via Up-regulation of ErbB4 and Notch-1. J Biol Chem. 2017;292:732-747 pubmed publisher
  187. Zhang Y, Yang J, Ding M, Li L, Lu Z, Zhang Q, et al. Tumor-penetration and antitumor efficacy of cetuximab are enhanced by co-administered iRGD in a murine model of human NSCLC. Oncol Lett. 2016;12:3241-3249 pubmed
  188. Scharaw S, Iskar M, Ori A, Boncompain G, Laketa V, Poser I, et al. The endosomal transcriptional regulator RNF11 integrates degradation and transport of EGFR. J Cell Biol. 2016;215:543-558 pubmed
  189. Reuther C, Heinzle V, Nölting S, Herterich S, Hahner S, Halilovic E, et al. The HDM2 (MDM2) Inhibitor NVP-CGM097 Inhibits Tumor Cell Proliferation and Shows Additive Effects with 5-Fluorouracil on the p53-p21-Rb-E2F1 Cascade in the p53wild type Neuroendocrine Tumor Cell Line GOT1. Neuroendocrinology. 2018;106:1-19 pubmed publisher
  190. Du M, Zhang Y, Mao Y, Mou J, Zhao J, Xue Q, et al. MiR-33a suppresses proliferation of NSCLC cells via targeting METTL3 mRNA. Biochem Biophys Res Commun. 2017;482:582-589 pubmed publisher
  191. Sun L, Pan J, Yu L, Liu H, Shu X, Sun L, et al. Tumor endothelial cells promote metastasis and cancer stem cell-like phenotype through elevated Epiregulin in esophageal cancer. Am J Cancer Res. 2016;6:2277-2288 pubmed
  192. Amessou M, Ebrahim A, Dilly A, Joseph M, Tabolina M, Chukkapalli S, et al. Spatio-temporal regulation of EGFR signaling by the Eps15 homology domain-containing protein 3 (EHD3). Oncotarget. 2016;7:79203-79216 pubmed publisher
  193. Needham S, Roberts S, Arkhipov A, Mysore V, Tynan C, Zanetti Domingues L, et al. EGFR oligomerization organizes kinase-active dimers into competent signalling platforms. Nat Commun. 2016;7:13307 pubmed publisher
  194. Jaber N, Mohd Naim N, Wang Z, Deleon J, Kim S, Zhong H, et al. Vps34 regulates Rab7 and late endocytic trafficking through recruitment of the GTPase-activating protein Armus. J Cell Sci. 2016;129:4424-4435 pubmed
  195. Day K, Lorenzatti Hiles G, Kozminsky M, Dawsey S, Paul A, Broses L, et al. HER2 and EGFR Overexpression Support Metastatic Progression of Prostate Cancer to Bone. Cancer Res. 2017;77:74-85 pubmed publisher
  196. Grugan K, Dorn K, Jarantow S, Bushey B, Pardinas J, Laquerre S, et al. Fc-mediated activity of EGFR x c-Met bispecific antibody JNJ-61186372 enhanced killing of lung cancer cells. MAbs. 2017;9:114-126 pubmed publisher
  197. Parrales A, Ranjan A, Iyer S, Padhye S, Weir S, Roy A, et al. DNAJA1 controls the fate of misfolded mutant p53 through the mevalonate pathway. Nat Cell Biol. 2016;18:1233-1243 pubmed publisher
  198. Yong K, Li A, Ou W, Hong C, Zhao W, Wang F, et al. Targeting SALL4 by entinostat in lung cancer. Oncotarget. 2016;7:75425-75440 pubmed publisher
  199. Mitra S, Ghosh B, Gayen N, Roy J, Mandal A. Bipartite Role of Heat Shock Protein 90 (Hsp90) Keeps CRAF Kinase Poised for Activation. J Biol Chem. 2016;291:24579-24593 pubmed
  200. Cizmecioglu O, Ni J, Xie S, Zhao J, Roberts T. Rac1-mediated membrane raft localization of PI3K/p110? is required for its activation by GPCRs or PTEN loss. elife. 2016;5: pubmed publisher
  201. Kang S, Wang Y, Reder N, Liu J. Multiplexed Molecular Imaging of Biomarker-Targeted SERS Nanoparticles on Fresh Tissue Specimens with Channel-Compressed Spectrometry. PLoS ONE. 2016;11:e0163473 pubmed publisher
  202. Truong D, Puleo J, Llave A, Mouneimne G, Kamm R, Nikkhah M. Breast Cancer Cell Invasion into a Three Dimensional Tumor-Stroma Microenvironment. Sci Rep. 2016;6:34094 pubmed publisher
  203. Wang A, Cui M, Qu H, Di J, Wang Z, Xing J, et al. Induction of anti-EGFR immune response with mimotopes identified from a phage display peptide library by panitumumab. Oncotarget. 2016;7:75293-75306 pubmed publisher
  204. Treindl F, Ruprecht B, Beiter Y, Schultz S, Döttinger A, Staebler A, et al. A bead-based western for high-throughput cellular signal transduction analyses. Nat Commun. 2016;7:12852 pubmed publisher
  205. Horn T, Ferretti S, Ebel N, Tam A, Ho S, Harbinski F, et al. High-Order Drug Combinations Are Required to Effectively Kill Colorectal Cancer Cells. Cancer Res. 2016;76:6950-6963 pubmed
  206. Hang Q, Isaji T, Hou S, Zhou Y, Fukuda T, Gu J. N-Glycosylation of integrin ?5 acts as a switch for EGFR-mediated complex formation of integrin ?5?1 to ?6?4. Sci Rep. 2016;6:33507 pubmed publisher
  207. Chen P, Qin L, Li G, Tellides G, Simons M. Fibroblast growth factor (FGF) signaling regulates transforming growth factor beta (TGF?)-dependent smooth muscle cell phenotype modulation. Sci Rep. 2016;6:33407 pubmed publisher
  208. Edinger N, Lebendiker M, Klein S, Zigler M, Langut Y, Levitzki A. Targeting polyIC to EGFR over-expressing cells using a dsRNA binding protein domain tethered to EGF. PLoS ONE. 2016;11:e0162321 pubmed publisher
  209. Xu J, Xiong G, Cao Z, Huang H, Wang T, You L, et al. PIM-1 contributes to the malignancy of pancreatic cancer and displays diagnostic and prognostic value. J Exp Clin Cancer Res. 2016;35:133 pubmed publisher
  210. Kimani S, Kumar S, Davra V, Chang Y, Kasikara C, Geng K, et al. Normalization of TAM post-receptor signaling reveals a cell invasive signature for Axl tyrosine kinase. Cell Commun Signal. 2016;14:19 pubmed publisher
  211. Mair B, Konopka T, Kerzendorfer C, Sleiman K, Salic S, Serra V, et al. Gain- and Loss-of-Function Mutations in the Breast Cancer Gene GATA3 Result in Differential Drug Sensitivity. PLoS Genet. 2016;12:e1006279 pubmed publisher
  212. Jiang M, Qiu J, Zhang L, Lu D, Long M, Chen L, et al. Changes in tension regulates proliferation and migration of fibroblasts by remodeling expression of ECM proteins. Exp Ther Med. 2016;12:1542-1550 pubmed
  213. Kabanova A, Marcandalli J, Zhou T, Bianchi S, Baxa U, Tsybovsky Y, et al. Platelet-derived growth factor-α receptor is the cellular receptor for human cytomegalovirus gHgLgO trimer. Nat Microbiol. 2016;1:16082 pubmed publisher
  214. Li C, Lim S, Xia W, Lee H, Chan L, Kuo C, et al. Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity. Nat Commun. 2016;7:12632 pubmed publisher
  215. Jaako K, Waniek A, Parik K, Klimaviciusa L, Aonurm Helm A, Noortoots A, et al. Prolyl endopeptidase is involved in the degradation of neural cell adhesion molecules in vitro. J Cell Sci. 2016;129:3792-3802 pubmed
  216. Oudin M, Miller M, Klazen J, Kosciuk T, Lussiez A, Hughes S, et al. MenaINV mediates synergistic cross-talk between signaling pathways driving chemotaxis and haptotaxis. Mol Biol Cell. 2016;27:3085-3094 pubmed
  217. Sun M, Cai J, Anderson R, Sun Y. Type I ? Phosphatidylinositol Phosphate 5-Kinase i5 Controls the Ubiquitination and Degradation of the Tumor Suppressor Mitogen-inducible Gene 6. J Biol Chem. 2016;291:21461-21473 pubmed
  218. Jordan N, Bardia A, Wittner B, Benes C, Ligorio M, Zheng Y, et al. HER2 expression identifies dynamic functional states within circulating breast cancer cells. Nature. 2016;537:102-106 pubmed publisher
  219. LAW M, Ferreira R, Davis B, Higgins P, Kim J, Castellano R, et al. CUB domain-containing protein 1 and the epidermal growth factor receptor cooperate to induce cell detachment. Breast Cancer Res. 2016;18:80 pubmed publisher
  220. Im J, Yoon S, Kim B, Ban H, Won K, Chung K, et al. DNA damage induced apoptosis suppressor (DDIAS) is upregulated via ERK5/MEF2B signaling and promotes ?-catenin-mediated invasion. Biochim Biophys Acta. 2016;1859:1449-1458 pubmed publisher
  221. Carino A, Graziosi L, D Amore C, Cipriani S, Marchianò S, Marino E, et al. The bile acid receptor GPBAR1 (TGR5) is expressed in human gastric cancers and promotes epithelial-mesenchymal transition in gastric cancer cell lines. Oncotarget. 2016;7:61021-61035 pubmed publisher
  222. Zhang Y, Velez Delgado A, Mathew E, Li D, Mendez F, Flannagan K, et al. Myeloid cells are required for PD-1/PD-L1 checkpoint activation and the establishment of an immunosuppressive environment in pancreatic cancer. Gut. 2017;66:124-136 pubmed publisher
  223. Deblois G, Smith H, Tam I, Gravel S, Caron M, Savage P, et al. ERR? mediates metabolic adaptations driving lapatinib resistance in breast cancer. Nat Commun. 2016;7:12156 pubmed publisher
  224. Grassi M, Palma C, Thomé C, Lanfredi G, Poersch A, Faça V. Proteomic analysis of ovarian cancer cells during epithelial-mesenchymal transition (EMT) induced by epidermal growth factor (EGF) reveals mechanisms of cell cycle control. J Proteomics. 2017;151:2-11 pubmed publisher
  225. Elkin S, Oswald N, Reed D, Mettlen M, Macmillan J, Schmid S. Ikarugamycin: A Natural Product Inhibitor of Clathrin-Mediated Endocytosis. Traffic. 2016;17:1139-49 pubmed publisher
  226. Huang C, Lee C, Lin H, Chang J. Cathepsin S attenuates endosomal EGFR signalling: A mechanical rationale for the combination of cathepsin S and EGFR tyrosine kinase inhibitors. Sci Rep. 2016;6:29256 pubmed publisher
  227. Edmondson R, Adcock A, Yang L. Influence of Matrices on 3D-Cultured Prostate Cancer Cells' Drug Response and Expression of Drug-Action Associated Proteins. PLoS ONE. 2016;11:e0158116 pubmed publisher
  228. Tisza M, Zhao W, Fuentes J, Prijic S, Chen X, Levental I, et al. Motility and stem cell properties induced by the epithelial-mesenchymal transition require destabilization of lipid rafts. Oncotarget. 2016;7:51553-51568 pubmed publisher
  229. Toyama K, Mizuguchi T, Nomura W, Tamamura H. Functional evaluation of fluorescein-labeled derivatives of a peptide inhibitor of the EGF receptor dimerization. Bioorg Med Chem. 2016;24:3406-12 pubmed publisher
  230. Wang J, Farris A, Xu K, Wang P, Zhang X, Duong D, et al. GPRC5A suppresses protein synthesis at the endoplasmic reticulum to prevent radiation-induced lung tumorigenesis. Nat Commun. 2016;7:11795 pubmed publisher
  231. Schütz I, López Hernández T, Gao Q, Puchkov D, Jabs S, Nordmeyer D, et al. Lysosomal Dysfunction Caused by Cellular Accumulation of Silica Nanoparticles. J Biol Chem. 2016;291:14170-84 pubmed publisher
  232. Chamberland J, Antonow L, Dias Santos M, Ritter B. NECAP2 controls clathrin coat recruitment to early endosomes for fast endocytic recycling. J Cell Sci. 2016;129:2625-37 pubmed publisher
  233. He F, Wei L, Luo W, Liao Z, Li B, Zhou X, et al. Glutaredoxin 3 promotes nasopharyngeal carcinoma growth and metastasis via EGFR/Akt pathway and independent of ROS. Oncotarget. 2016;7:37000-37012 pubmed publisher
  234. Currier M, Lee S, Stobart C, Hotard A, Villenave R, Meng J, et al. EGFR Interacts with the Fusion Protein of Respiratory Syncytial Virus Strain 2-20 and Mediates Infection and Mucin Expression. PLoS Pathog. 2016;12:e1005622 pubmed publisher
  235. Rapiteanu R, Davis L, Williamson J, Timms R, Paul Luzio J, Lehner P. A Genetic Screen Identifies a Critical Role for the WDR81-WDR91 Complex in the Trafficking and Degradation of Tetherin. Traffic. 2016;17:940-58 pubmed publisher
  236. Lin S, Choe J, Du P, Triboulet R, Gregory R. The m(6)A Methyltransferase METTL3 Promotes Translation in Human Cancer Cells. Mol Cell. 2016;62:335-345 pubmed publisher
  237. Jahani Asl A, Yin H, Soleimani V, Haque T, Luchman H, Chang N, et al. Control of glioblastoma tumorigenesis by feed-forward cytokine signaling. Nat Neurosci. 2016;19:798-806 pubmed publisher
  238. Thomas J, Chhuy Hy L, Andrykovich K, Moos M. SMOC Binds to Pro-EGF, but Does Not Induce Erk Phosphorylation via the EGFR. PLoS ONE. 2016;11:e0154294 pubmed publisher
  239. Engel B, Bowser J, Broaddus R, Carson D. MUC1 stimulates EGFR expression and function in endometrial cancer. Oncotarget. 2016;7:32796-809 pubmed publisher
  240. Belov L, Matic K, Hallal S, Best O, Mulligan S, Christopherson R. Extensive surface protein profiles of extracellular vesicles from cancer cells may provide diagnostic signatures from blood samples. J Extracell Vesicles. 2016;5:25355 pubmed publisher
  241. Guo Z, Lloyd R. Use of monoclonal antibodies to detect specific mutations in formalin-fixed, paraffin-embedded tissue sections. Hum Pathol. 2016;53:168-77 pubmed publisher
  242. Simon N, Antignani A, Sarnovsky R, Hewitt S, Fitzgerald D. Targeting a Cancer-Specific Epitope of the Epidermal Growth Factor Receptor in Triple-Negative Breast Cancer. J Natl Cancer Inst. 2016;108: pubmed publisher
  243. Hatanaka M, Higashi Y, Kawai K, Su J, Zeng W, Chen X, et al. CD147-targeted siRNA in A375 malignant melanoma cells induces the phosphorylation of EGFR and downregulates cdc25C and MEK phosphorylation. Oncol Lett. 2016;11:2424-2428 pubmed
  244. Jadwin J, Oh D, Curran T, Ogiue Ikeda M, Jia L, White F, et al. Time-resolved multimodal analysis of Src Homology 2 (SH2) domain binding in signaling by receptor tyrosine kinases. elife. 2016;5:e11835 pubmed publisher
  245. Xing M, Wang X, Chi Y, Zhou D. Gene therapy for colorectal cancer using adenovirus-mediated full-length antibody, cetuximab. Oncotarget. 2016;7:28262-72 pubmed publisher
  246. Phelps Polirer K, Abt M, Smith D, Yeh E. Co-Targeting of JNK and HUNK in Resistant HER2-Positive Breast Cancer. PLoS ONE. 2016;11:e0153025 pubmed publisher
  247. Huang M, Liu T, Ma P, Mitteer R, Zhang Z, Kim H, et al. c-Met-mediated endothelial plasticity drives aberrant vascularization and chemoresistance in glioblastoma. J Clin Invest. 2016;126:1801-14 pubmed publisher
  248. Krampitz G, George B, Willingham S, Volkmer J, Weiskopf K, Jahchan N, et al. Identification of tumorigenic cells and therapeutic targets in pancreatic neuroendocrine tumors. Proc Natl Acad Sci U S A. 2016;113:4464-9 pubmed publisher
  249. Ren D, Xia Y, Wang B, You Z. Multiplexed Analysis for Anti-Epidermal Growth Factor Receptor Tumor Cell Growth Inhibition Based on Quantum Dot Probes. Anal Chem. 2016;88:4318-27 pubmed publisher
  250. Huang Y, Bharill S, Karandur D, Peterson S, Marita M, Shi X, et al. Molecular basis for multimerization in the activation of the epidermal growth factor receptor. elife. 2016;5: pubmed publisher
  251. Mancini M, Lien E, Toker A. Oncogenic AKT1(E17K) mutation induces mammary hyperplasia but prevents HER2-driven tumorigenesis. Oncotarget. 2016;7:17301-13 pubmed publisher
  252. Wen Y, Li H, Zeng Y, Wen W, Pendleton K, Lui V, et al. MAPK1E322K mutation increases head and neck squamous cell carcinoma sensitivity to erlotinib through enhanced secretion of amphiregulin. Oncotarget. 2016;7:23300-11 pubmed publisher
  253. Meng Y, Zheng L, Yang Y, Wang H, Dong J, Wang C, et al. A monoclonal antibody targeting ErbB2 domain III inhibits ErbB2 signaling and suppresses the growth of ErbB2-overexpressing breast tumors. Oncogenesis. 2016;5:e211 pubmed publisher
  254. Ezawa I, Sawai Y, Kawase T, Okabe A, Tsutsumi S, Ichikawa H, et al. Novel p53 target gene FUCA1 encodes a fucosidase and regulates growth and survival of cancer cells. Cancer Sci. 2016;107:734-45 pubmed publisher
  255. Ananthula S, Sinha A, El Gassim M, Batth S, Marshall G, Gardner L, et al. Geminin overexpression-dependent recruitment and crosstalk with mesenchymal stem cells enhance aggressiveness in triple negative breast cancers. Oncotarget. 2016;7:20869-89 pubmed publisher
  256. Kabe Y, Nakane T, Koike I, Yamamoto T, Sugiura Y, Harada E, et al. Haem-dependent dimerization of PGRMC1/Sigma-2 receptor facilitates cancer proliferation and chemoresistance. Nat Commun. 2016;7:11030 pubmed publisher
  257. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
  258. Atiq R, Hertz R, Eldad S, Smeir E, Bar Tana J. Suppression of B-Raf(V600E) cancers by MAPK hyper-activation. Oncotarget. 2016;7:18694-704 pubmed publisher
  259. Saygideğer Kont Y, Minas T, Jones H, Hour S, Çelik H, Temel I, et al. Ezrin Enhances EGFR Signaling and Modulates Erlotinib Sensitivity in Non-Small Cell Lung Cancer Cells. Neoplasia. 2016;18:111-20 pubmed publisher
  260. Haven B, Heilig E, Donham C, Settles M, Vasilevsky N, Owen K. Registered report: A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. elife. 2016;5: pubmed publisher
  261. He Y, Ryu T, Shrestha N, Yuan T, Kim H, Shrestha H, et al. Interaction of EGFR to δ-catenin leads to δ-catenin phosphorylation and enhances EGFR signaling. Sci Rep. 2016;6:21207 pubmed publisher
  262. Wang Y, Kang S, Khan A, Ruttner G, Leigh S, Murray M, et al. Quantitative molecular phenotyping with topically applied SERS nanoparticles for intraoperative guidance of breast cancer lumpectomy. Sci Rep. 2016;6:21242 pubmed publisher
  263. Kim D, Helfman D. Loss of MLCK leads to disruption of cell-cell adhesion and invasive behavior of breast epithelial cells via increased expression of EGFR and ERK/JNK signaling. Oncogene. 2016;35:4495-508 pubmed publisher
  264. Ebbing E, Medema J, Damhofer H, Meijer S, Krishnadath K, van Berge Henegouwen M, et al. ADAM10-mediated release of heregulin confers resistance to trastuzumab by activating HER3. Oncotarget. 2016;7:10243-54 pubmed publisher
  265. Hennig A, Markwart R, Wolff K, Schubert K, Cui Y, Prior I, et al. Feedback activation of neurofibromin terminates growth factor-induced Ras activation. Cell Commun Signal. 2016;14:5 pubmed publisher
  266. Nakazawa M, Eisinger Mathason T, Sadri N, Ochocki J, Gade T, Amin R, et al. Epigenetic re-expression of HIF-2α suppresses soft tissue sarcoma growth. Nat Commun. 2016;7:10539 pubmed publisher
  267. Hayashi H, Al Mamun A, Sakima M, Sato M. Activator of G-protein signaling 8 is involved in VEGF-mediated signal processing during angiogenesis. J Cell Sci. 2016;129:1210-22 pubmed publisher
  268. Derangère V, Fumet J, Boidot R, Bengrine L, Limagne E, Chevriaux A, et al. Does bevacizumab impact anti-EGFR therapy efficacy in metastatic colorectal cancer?. Oncotarget. 2016;7:9309-21 pubmed publisher
  269. Theodosiou M, Widmaier M, Böttcher R, Rognoni E, Veelders M, Bharadwaj M, et al. Kindlin-2 cooperates with talin to activate integrins and induces cell spreading by directly binding paxillin. elife. 2016;5:e10130 pubmed publisher
  270. Evans M, Sauer S, Nath S, Robinson T, Morse M, Devi G. X-linked inhibitor of apoptosis protein mediates tumor cell resistance to antibody-dependent cellular cytotoxicity. Cell Death Dis. 2016;7:e2073 pubmed publisher
  271. Yoshida T, Song L, Bai Y, Kinose F, Li J, Ohaegbulam K, et al. ZEB1 Mediates Acquired Resistance to the Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer. PLoS ONE. 2016;11:e0147344 pubmed publisher
  272. Roßner F, Gieseler C, Morkel M, Royer H, Rivera M, Bläker H, et al. Uncoupling of EGFR-RAS signaling and nuclear localization of YBX1 in colorectal cancer. Oncogenesis. 2016;5:e187 pubmed publisher
  273. Kooijmans S, Fliervoet L, van der Meel R, Fens M, Heijnen H, van Bergen En Henegouwen P, et al. PEGylated and targeted extracellular vesicles display enhanced cell specificity and circulation time. J Control Release. 2016;224:77-85 pubmed publisher
  274. Ketel K, Krauss M, Nicot A, Puchkov D, Wieffer M, Müller R, et al. A phosphoinositide conversion mechanism for exit from endosomes. Nature. 2016;529:408-12 pubmed publisher
  275. Lin A, Li C, Xing Z, Hu Q, Liang K, Han L, et al. The LINK-A lncRNA activates normoxic HIF1? signalling in triple-negative breast cancer. Nat Cell Biol. 2016;18:213-24 pubmed publisher
  276. Amato K, Wang S, Tan L, Hastings A, Song W, Lovly C, et al. EPHA2 Blockade Overcomes Acquired Resistance to EGFR Kinase Inhibitors in Lung Cancer. Cancer Res. 2016;76:305-18 pubmed publisher
  277. Jeong J, VanHouten J, Dann P, Kim W, Sullivan C, Yu H, et al. PMCA2 regulates HER2 protein kinase localization and signaling and promotes HER2-mediated breast cancer. Proc Natl Acad Sci U S A. 2016;113:E282-90 pubmed publisher
  278. Matalkah F, Martin E, Zhao H, Agazie Y. SHP2 acts both upstream and downstream of multiple receptor tyrosine kinases to promote basal-like and triple-negative breast cancer. Breast Cancer Res. 2016;18:2 pubmed publisher
  279. Yamaguchi T, Lu C, Ida L, Yanagisawa K, Usukura J, Cheng J, et al. ROR1 sustains caveolae and survival signalling as a scaffold of cavin-1 and caveolin-1. Nat Commun. 2016;7:10060 pubmed publisher
  280. Salova A, Belyaeva T, Leontieva E, Zlobina M, Kharchenko M, Kornilova E. Quantum dots implementation as a label for analysis of early stages of EGF receptor endocytosis: a comparative study on cultured cells. Oncotarget. 2016;7:6029-47 pubmed publisher
  281. Hessmann E, Zhang J, Chen N, Hasselluhn M, Liou G, Storz P, et al. NFATc4 Regulates Sox9 Gene Expression in Acinar Cell Plasticity and Pancreatic Cancer Initiation. Stem Cells Int. 2016;2016:5272498 pubmed publisher
  282. Vergani E, Di Guardo L, Dugo M, Rigoletto S, Tragni G, Ruggeri R, et al. Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b. Oncotarget. 2016;7:4428-41 pubmed publisher
  283. Roshan A, Murai K, Fowler J, Simons B, Nikolaidou Neokosmidou V, Jones P. Human keratinocytes have two interconvertible modes of proliferation. Nat Cell Biol. 2016;18:145-56 pubmed publisher
  284. Baumdick M, Brüggemann Y, Schmick M, Xouri G, Sabet O, Davis L, et al. EGF-dependent re-routing of vesicular recycling switches spontaneous phosphorylation suppression to EGFR signaling. elife. 2015;4: pubmed publisher
  285. Chen J, Chen Y, Yen C, Chen W, Huang W. HBx sensitizes hepatocellular carcinoma cells to lapatinib by up-regulating ErbB3. Oncotarget. 2016;7:473-89 pubmed publisher
  286. Safavi S, Järnum S, Vannas C, Udhane S, Jonasson E, Tomić T, et al. HSP90 inhibition blocks ERBB3 and RET phosphorylation in myxoid/round cell liposarcoma and causes massive cell death in vitro and in vivo. Oncotarget. 2016;7:433-45 pubmed publisher
  287. Rico Varela J, Singh T, McCutcheon S, Vazquez M. EGF as a New Therapeutic Target for Medulloblastoma Metastasis. Cell Mol Bioeng. 2015;8:553-565 pubmed
  288. Diersch S, Wirth M, Schneeweis C, Jörs S, Geisler F, Siveke J, et al. Kras(G12D) induces EGFR-MYC cross signaling in murine primary pancreatic ductal epithelial cells. Oncogene. 2016;35:3880-6 pubmed publisher
  289. Ponti D, Bastianelli D, Rosa P, Pacini L, Ibrahim M, Rendina E, et al. The expression of B23 and EGR1 proteins is functionally linked in tumor cells under stress conditions. BMC Cell Biol. 2015;16:27 pubmed publisher
  290. Gao L, Jiang Y, Mu L, Liu Y, Wang F, Wang P, et al. Efficient Generation of Mice with Consistent Transgene Expression by FEEST. Sci Rep. 2015;5:16284 pubmed publisher
  291. Oprea T, Sklar L, Agola J, Guo Y, Silberberg M, Roxby J, et al. Novel Activities of Select NSAID R-Enantiomers against Rac1 and Cdc42 GTPases. PLoS ONE. 2015;10:e0142182 pubmed publisher
  292. Chen S, Chen Y, Chen B, Cai Y, Zou Z, Wang J, et al. Plumbagin Ameliorates CCl 4 -Induced Hepatic Fibrosis in Rats via the Epidermal Growth Factor Receptor Signaling Pathway. Evid Based Complement Alternat Med. 2015;2015:645727 pubmed publisher
  293. Majumder P, Chakrabarti O. Mahogunin regulates fusion between amphisomes/MVBs and lysosomes via ubiquitination of TSG101. Cell Death Dis. 2015;6:e1970 pubmed publisher
  294. Nikonova A, Deneka A, Eckman L, Kopp M, Hensley H, Egleston B, et al. Opposing Effects of Inhibitors of Aurora-A and EGFR in Autosomal-Dominant Polycystic Kidney Disease. Front Oncol. 2015;5:228 pubmed publisher
  295. Castillo Martin M, Collazo Lorduy A, Gladoun N, Hyun G, Cordon Cardo C. H-RAS mutation is a key molecular feature of pediatric urothelial bladder cancer. A detailed report of three cases. J Pediatr Urol. 2016;12:91.e1-7 pubmed publisher
  296. Hirano T, Yasuda H, Tani T, Hamamoto J, Oashi A, Ishioka K, et al. In vitro modeling to determine mutation specificity of EGFR tyrosine kinase inhibitors against clinically relevant EGFR mutants in non-small-cell lung cancer. Oncotarget. 2015;6:38789-803 pubmed publisher
  297. Zomerman W, Plasschaert S, Diks S, Lourens H, Meeuwsen de Boer T, Hoving E, et al. Exogenous HGF Bypasses the Effects of ErbB Inhibition on Tumor Cell Viability in Medulloblastoma Cell Lines. PLoS ONE. 2015;10:e0141381 pubmed publisher
  298. Dong Y, Hou W, Li Y, Liu D, Hao G, Zhang H, et al. Unexpected requirement for a binding partner of the syntaxin family in phagocytosis by murine testicular Sertoli cells. Cell Death Differ. 2016;23:787-800 pubmed publisher
  299. Yang C, Lowther K, Lalioti M, Seli E. Embryonic Poly(A)-Binding Protein (EPAB) Is Required for Granulosa Cell EGF Signaling and Cumulus Expansion in Female Mice. Endocrinology. 2016;157:405-16 pubmed publisher
  300. Bertrand T, Lesept F, Chevilley A, Lenoir S, Aimable M, Briens A, et al. Conformations of tissue plasminogen activator (tPA) orchestrate neuronal survival by a crosstalk between EGFR and NMDAR. Cell Death Dis. 2015;6:e1924 pubmed publisher
  301. Liu F, Hon G, Villa G, Turner K, Ikegami S, Yang H, et al. EGFR Mutation Promotes Glioblastoma through Epigenome and Transcription Factor Network Remodeling. Mol Cell. 2015;60:307-18 pubmed publisher
  302. Kuo H, Hsu H, Chen Y, Chang Y, Liu F, Wu C. Galectin-3 modulates the EGFR signalling-mediated regulation of Sox2 expression via c-Myc in lung cancer. Glycobiology. 2016;26:155-65 pubmed publisher
  303. Donzelli S, Mori F, Bellissimo T, Sacconi A, Casini B, Frixa T, et al. Epigenetic silencing of miR-145-5p contributes to brain metastasis. Oncotarget. 2015;6:35183-201 pubmed publisher
  304. Mehner C, Oberg A, Kalli K, Nassar A, Hockla A, Pendlebury D, et al. Serine protease inhibitor Kazal type 1 (SPINK1) drives proliferation and anoikis resistance in a subset of ovarian cancers. Oncotarget. 2015;6:35737-54 pubmed publisher
  305. Panvichian R, Tantiwetrueangdet A, Sornmayura P, Leelaudomlipi S. Missense Mutations in Exons 18-24 of EGFR in Hepatocellular Carcinoma Tissues. Biomed Res Int. 2015;2015:171845 pubmed publisher
  306. Cecchetti S, Bortolomai I, Ferri R, Mercurio L, Canevari S, Podo F, et al. Inhibition of Phosphatidylcholine-Specific Phospholipase C Interferes with Proliferation and Survival of Tumor Initiating Cells in Squamous Cell Carcinoma. PLoS ONE. 2015;10:e0136120 pubmed publisher
  307. Zhang X, Jung I, Hwang Y. EGF enhances low-invasive cancer cell invasion by promoting IMP-3 expression. Tumour Biol. 2016;37:2555-63 pubmed publisher
  308. Bollu L, Katreddy R, Blessing A, Pham N, Zheng B, Wu X, et al. Intracellular activation of EGFR by fatty acid synthase dependent palmitoylation. Oncotarget. 2015;6:34992-5003 pubmed publisher
  309. Darr J, Klochendler A, Isaac S, Geiger T, Geiger T, Eden A. Phosphoproteomic analysis reveals Smarcb1 dependent EGFR signaling in Malignant Rhabdoid tumor cells. Mol Cancer. 2015;14:167 pubmed publisher
  310. Kitatani K, Usui T, Sriraman S, Toyoshima M, Ishibashi M, Shigeta S, et al. Ceramide limits phosphatidylinositol-3-kinase C2β-controlled cell motility in ovarian cancer: potential of ceramide as a metastasis-suppressor lipid. Oncogene. 2016;35:2801-12 pubmed publisher
  311. Taketa D, Nydam M, Langenbacher A, Rodriguez D, Sanders E, De Tomaso A. Molecular evolution and in vitro characterization of Botryllus histocompatibility factor. Immunogenetics. 2015;67:605-23 pubmed publisher
  312. Vennin C, Spruyt N, Dahmani F, Julien S, Bertucci F, Finetti P, et al. H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b. Oncotarget. 2015;6:29209-23 pubmed publisher
  313. Valley C, Arndt Jovin D, Karedla N, Steinkamp M, Chizhik A, Hlavacek W, et al. Enhanced dimerization drives ligand-independent activity of mutant epidermal growth factor receptor in lung cancer. Mol Biol Cell. 2015;26:4087-99 pubmed publisher
  314. Wu Y, Deng W, Klinke D. Exosomes: improved methods to characterize their morphology, RNA content, and surface protein biomarkers. Analyst. 2015;140:6631-42 pubmed publisher
  315. Fu Y, Cruz Monserrate Z, Helen Lin H, Chung Y, Ji B, Lin S, et al. Ductal activation of oncogenic KRAS alone induces sarcomatoid phenotype. Sci Rep. 2015;5:13347 pubmed publisher
  316. Morancho B, Martínez Barriocanal Ã, Villanueva J, Arribas J. Role of ADAM17 in the non-cell autonomous effects of oncogene-induced senescence. Breast Cancer Res. 2015;17:106 pubmed publisher
  317. Perillo E, Liu Y, Huynh K, Liu C, Chou C, Hung M, et al. Deep and high-resolution three-dimensional tracking of single particles using nonlinear and multiplexed illumination. Nat Commun. 2015;6:7874 pubmed publisher
  318. Tang Y, Ye M, Du Y, Qiu X, Lv X, Yang W, et al. EGFR signaling upregulates surface expression of the GluN2B-containing NMDA receptor and contributes to long-term potentiation in the hippocampus. Neuroscience. 2015;304:109-21 pubmed publisher
  319. Li W, Qiu Y, Zhang H, Tian X, Fang W. P2Y2 Receptor and EGFR Cooperate to Promote Prostate Cancer Cell Invasion via ERK1/2 Pathway. PLoS ONE. 2015;10:e0133165 pubmed publisher
  320. Zhou J, Joshi B, Duan X, Pant A, Qiu Z, Kuick R, et al. EGFR Overexpressed in Colonic Neoplasia Can be Detected on Wide-Field Endoscopic Imaging. Clin Transl Gastroenterol. 2015;6:e101 pubmed publisher
  321. Lin C, Pan C, Wang C, Liu S, Hsiao L, Yang C. Tumor necrosis factor-alpha induces VCAM-1-mediated inflammation via c-Src-dependent transactivation of EGF receptors in human cardiac fibroblasts. J Biomed Sci. 2015;22:53 pubmed publisher
  322. Yao X, Wu Y, Zhu M, Qian H, Chen Y. Nitric oxide/cyclic guanosine monophosphate inducers sodium nitroprusside and L-arginine inhibit the proliferation of gastric cancer cells via the activation of type II cyclic guanosine monophosphate-dependent protein kinase. Oncol Lett. 2015;10:479-484 pubmed
  323. Forse C, Agarwal S, Pinnaduwage D, Gertler F, Condeelis J, Lin J, et al. Menacalc, a quantitative method of metastasis assessment, as a prognostic marker for axillary node-negative breast cancer. BMC Cancer. 2015;15:483 pubmed publisher
  324. Dombernowsky S, Samsøe Petersen J, Petersen C, Instrell R, Hedegaard A, Thomas L, et al. The sorting protein PACS-2 promotes ErbB signalling by regulating recycling of the metalloproteinase ADAM17. Nat Commun. 2015;6:7518 pubmed publisher
  325. Yang L, Li Y, Bhattacharya A, Zhang Y. Inhibition of ERBB2-overexpressing Tumors by Recombinant Human Prolidase and Its Enzymatically Inactive Mutant. EBioMedicine. 2015;2:396-405 pubmed
  326. Hutchinson K, Johnson D, Johnson A, Sanchez V, Kuba M, Lu P, et al. ERBB activation modulates sensitivity to MEK1/2 inhibition in a subset of driver-negative melanoma. Oncotarget. 2015;6:22348-60 pubmed
  327. Ma S, Yin N, Qi X, Pfister S, Zhang M, Ma R, et al. Tyrosine dephosphorylation enhances the therapeutic target activity of epidermal growth factor receptor (EGFR) by disrupting its interaction with estrogen receptor (ER). Oncotarget. 2015;6:13320-33 pubmed
  328. Engel B, Constantinou P, Sablatura L, Doty N, Carson D, Farach Carson M, et al. Multilayered, Hyaluronic Acid-Based Hydrogel Formulations Suitable for Automated 3D High Throughput Drug Screening of Cancer-Stromal Cell Cocultures. Adv Healthc Mater. 2015;4:1664-74 pubmed publisher
  329. Jäger W, Xue H, Hayashi T, Janssen C, Awrey S, Wyatt A, et al. Patient-derived bladder cancer xenografts in the preclinical development of novel targeted therapies. Oncotarget. 2015;6:21522-32 pubmed
  330. Min H, Yun H, Lee J, Lee H, Cho J, Jang H, et al. Targeting the insulin-like growth factor receptor and Src signaling network for the treatment of non-small cell lung cancer. Mol Cancer. 2015;14:113 pubmed publisher
  331. Tréhoux S, Lahdaoui F, Delpu Y, Renaud F, Leteurtre E, Torrisani J, et al. Micro-RNAs miR-29a and miR-330-5p function as tumor suppressors by targeting the MUC1 mucin in pancreatic cancer cells. Biochim Biophys Acta. 2015;1853:2392-403 pubmed publisher
  332. Chen C, Kim K, Lau L. The matricellular protein CCN1 suppresses hepatocarcinogenesis by inhibiting compensatory proliferation. Oncogene. 2016;35:1314-23 pubmed publisher
  333. Li T, Lu H, Mukherjee D, Lahiri S, Shen C, Yu L, et al. Identification of epidermal growth factor receptor and its inhibitory microRNA141 as novel targets of Krüppel-like factor 8 in breast cancer. Oncotarget. 2015;6:21428-42 pubmed
  334. Ramirez U, Nikonova A, Liu H, Pecherskaya A, Lawrence S, Serebriiskii I, et al. Compounds identified by virtual docking to a tetrameric EGFR extracellular domain can modulate Grb2 internalization. BMC Cancer. 2015;15:436 pubmed publisher
  335. Li L, Qi L, Liang Z, Song W, Liu Y, Wang Y, et al. Transforming growth factor-β1 induces EMT by the transactivation of epidermal growth factor signaling through HA/CD44 in lung and breast cancer cells. Int J Mol Med. 2015;36:113-22 pubmed publisher
  336. Teng Y, Radde B, Litchfield L, Ivanova M, Prough R, Clark B, et al. Dehydroepiandrosterone Activation of G-protein-coupled Estrogen Receptor Rapidly Stimulates MicroRNA-21 Transcription in Human Hepatocellular Carcinoma Cells. J Biol Chem. 2015;290:15799-811 pubmed publisher
  337. Shao H, Chung J, Lee K, Balaj L, Min C, Carter B, et al. Chip-based analysis of exosomal mRNA mediating drug resistance in glioblastoma. Nat Commun. 2015;6:6999 pubmed publisher
  338. Rios Doria J, Sabol D, Chesebrough J, Stewart D, Xu L, Tammali R, et al. A Monoclonal Antibody to ADAM17 Inhibits Tumor Growth by Inhibiting EGFR and Non-EGFR-Mediated Pathways. Mol Cancer Ther. 2015;14:1637-49 pubmed publisher
  339. Bhagirath D, Zhao X, West W, Qiu F, Band H, Band V. Cell type of origin as well as genetic alterations contribute to breast cancer phenotypes. Oncotarget. 2015;6:9018-30 pubmed
  340. Zhang W, Zhu Y, Yang J, Yang G, Zhou D, Wang J. A Selected Lactobacillus rhamnosus Strain Promotes EGFR-Independent Akt Activation in an Enterotoxigenic Escherichia coli K88-Infected IPEC-J2 Cell Model. PLoS ONE. 2015;10:e0125717 pubmed publisher
  341. Zhao H, Agazie Y. Inhibition of SHP2 in basal-like and triple-negative breast cells induces basal-to-luminal transition, hormone dependency, and sensitivity to anti-hormone treatment. BMC Cancer. 2015;15:109 pubmed publisher
  342. Chien P, Lin C, Hsiao L, Yang C. c-Src/Pyk2/EGFR/PI3K/Akt/CREB-activated pathway contributes to human cardiomyocyte hypertrophy: Role of COX-2 induction. Mol Cell Endocrinol. 2015;409:59-72 pubmed publisher
  343. Ferreira R, Law M, Jahn S, Davis B, Heldermon C, Reinhard M, et al. Novel agents that downregulate EGFR, HER2, and HER3 in parallel. Oncotarget. 2015;6:10445-59 pubmed
  344. Verfaillie A, Imrichová H, Atak Z, Dewaele M, Rambow F, Hulselmans G, et al. Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. Nat Commun. 2015;6:6683 pubmed publisher
  345. Fausther M, Goree J, Lavoie Ã, Graham A, Sévigny J, Dranoff J. Establishment and characterization of rat portal myofibroblast cell lines. PLoS ONE. 2015;10:e0121161 pubmed publisher
  346. Savci Heijink C, Halfwerk H, Hooijer G, Horlings H, Wesseling J, van de Vijver M. Retrospective analysis of metastatic behaviour of breast cancer subtypes. Breast Cancer Res Treat. 2015;150:547-57 pubmed publisher
  347. Richter E, Harms M, Ventz K, Gierok P, Chilukoti R, Hildebrandt J, et al. A multi-omics approach identifies key hubs associated with cell type-specific responses of airway epithelial cells to staphylococcal alpha-toxin. PLoS ONE. 2015;10:e0122089 pubmed publisher
  348. Hoekstra E, Kodach L, Das A, Ruela de Sousa R, Ferreira C, Hardwick J, et al. Low molecular weight protein tyrosine phosphatase (LMWPTP) upregulation mediates malignant potential in colorectal cancer. Oncotarget. 2015;6:8300-12 pubmed
  349. Wang Y, Han A, Chen E, Singh R, Chichester C, Moore R, et al. The cranberry flavonoids PAC DP-9 and quercetin aglycone induce cytotoxicity and cell cycle arrest and increase cisplatin sensitivity in ovarian cancer cells. Int J Oncol. 2015;46:1924-34 pubmed publisher
  350. Wilson F, Johannessen C, Piccioni F, Tamayo P, Kim J, Van Allen E, et al. A functional landscape of resistance to ALK inhibition in lung cancer. Cancer Cell. 2015;27:397-408 pubmed publisher
  351. Wei Z, Yu D, Bi Y, Cao Y. A disintegrin and metalloprotease 17 promotes microglial cell survival via epidermal growth factor receptor signalling following spinal cord injury. Mol Med Rep. 2015;12:63-70 pubmed publisher
  352. Jayaprakash P, Dong H, Zou M, Bhatia A, O Brien K, Chen M, et al. Hsp90α and Hsp90β together operate a hypoxia and nutrient paucity stress-response mechanism during wound healing. J Cell Sci. 2015;128:1475-80 pubmed publisher
  353. Sinha L, Wang Y, Yang C, Khan A, Brankov J, Liu J, et al. Quantification of the binding potential of cell-surface receptors in fresh excised specimens via dual-probe modeling of SERS nanoparticles. Sci Rep. 2015;5:8582 pubmed publisher
  354. Sharivkin R, Walker M, Soen Y. Functional proteomics screen enables enrichment of distinct cell types from human pancreatic islets. PLoS ONE. 2015;10:e0115100 pubmed publisher
  355. Isidro R, Cruz M, Isidro A, Baez A, Arroyo A, González Marqués W, et al. Immunohistochemical expression of SP-NK-1R-EGFR pathway and VDR in colonic inflammation and neoplasia. World J Gastroenterol. 2015;21:1749-58 pubmed publisher
  356. Haakenson J, Khokhlatchev A, Choi Y, Linton S, Zhang P, Zaki P, et al. Lysosomal degradation of CD44 mediates ceramide nanoliposome-induced anoikis and diminished extravasation in metastatic carcinoma cells. J Biol Chem. 2015;290:8632-43 pubmed publisher
  357. Rayavarapu R, Heiden B, Pagani N, Shaw M, Shuff S, Zhang S, et al. The role of multicellular aggregation in the survival of ErbB2-positive breast cancer cells during extracellular matrix detachment. J Biol Chem. 2015;290:8722-33 pubmed publisher
  358. Fumagalli I, Dugue D, Bibault J, Clémenson C, Vozenin M, Mondini M, et al. Cytotoxic effect of lapatinib is restricted to human papillomavirus-positive head and neck squamous cell carcinoma cell lines. Onco Targets Ther. 2015;8:335-45 pubmed publisher
  359. Dong A, Wodziak D, Lowe A. Epidermal growth factor receptor (EGFR) signaling requires a specific endoplasmic reticulum thioredoxin for the post-translational control of receptor presentation to the cell surface. J Biol Chem. 2015;290:8016-27 pubmed publisher
  360. Greenall S, Donoghue J, van Sinderen M, Dubljevic V, Budiman S, Devlin M, et al. EGFRvIII-mediated transactivation of receptor tyrosine kinases in glioma: mechanism and therapeutic implications. Oncogene. 2015;34:5277-87 pubmed publisher
  361. Plessl K, Haider S, Fiala C, Pollheimer J, Knöfler M. Expression pattern and function of Notch2 in different subtypes of first trimester cytotrophoblast. Placenta. 2015;36:365-71 pubmed publisher
  362. Kozlova N, Samoylenko A, Drobot L, Kietzmann T. Urokinase is a negative modulator of Egf-dependent proliferation and motility in the two breast cancer cell lines MCF-7 and MDA-MB-231. Mol Carcinog. 2016;55:170-81 pubmed publisher
  363. Rohatgi R, Janusis J, Leonard D, Bellvé K, Fogarty K, Baehrecke E, et al. Beclin 1 regulates growth factor receptor signaling in breast cancer. Oncogene. 2015;34:5352-62 pubmed publisher
  364. Fillmore C, Xu C, Desai P, Berry J, Rowbotham S, Lin Y, et al. EZH2 inhibition sensitizes BRG1 and EGFR mutant lung tumours to TopoII inhibitors. Nature. 2015;520:239-42 pubmed publisher
  365. Huo L, Li C, Huang T, Lam Y, Xia W, Tu C, et al. Activation of Keap1/Nrf2 signaling pathway by nuclear epidermal growth factor receptor in cancer cells. Am J Transl Res. 2014;6:649-63 pubmed
  366. Tian E, Stevens S, Guan Y, Springer D, Anderson S, Starost M, et al. Galnt1 is required for normal heart valve development and cardiac function. PLoS ONE. 2015;10:e0115861 pubmed publisher
  367. Yun H, Kim H, Ga I, Oh H, Ho D, Kim J, et al. An early endosome regulator, Rab5b, is an LRRK2 kinase substrate. J Biochem. 2015;157:485-95 pubmed publisher
  368. Yoo J, Kim T, Kong S, Lee J, Choi W, Kim K, et al. Role of Mig-6 in hepatic glucose metabolism. J Diabetes. 2016;8:86-97 pubmed publisher
  369. Liu Z, Leng E, Gunasekaran K, Pentony M, Shen M, Howard M, et al. A novel antibody engineering strategy for making monovalent bispecific heterodimeric IgG antibodies by electrostatic steering mechanism. J Biol Chem. 2015;290:7535-62 pubmed publisher
  370. Maurya S, Mishra J, Abbas S, Bandyopadhyay S. Cypermethrin Stimulates GSK3β-Dependent Aβ and p-tau Proteins and Cognitive Loss in Young Rats: Reduced HB-EGF Signaling and Downstream Neuroinflammation as Critical Regulators. Mol Neurobiol. 2016;53:968-82 pubmed publisher
  371. Pino M, Verstraeten S. Tl(I) and Tl(III) alter the expression of EGF-dependent signals and cyclins required for pheochromocytoma (PC12) cell-cycle resumption and progression. J Appl Toxicol. 2015;35:952-69 pubmed publisher
  372. Kumar S, Das S, Rachagani S, Kaur S, Joshi S, Johansson S, et al. NCOA3-mediated upregulation of mucin expression via transcriptional and post-translational changes during the development of pancreatic cancer. Oncogene. 2015;34:4879-89 pubmed publisher
  373. Boucrot E, Ferreira A, Almeida Souza L, Debard S, Vallis Y, Howard G, et al. Endophilin marks and controls a clathrin-independent endocytic pathway. Nature. 2015;517:460-5 pubmed publisher
  374. Kim G, Lee J, Choi Y, Lee K, Lee J, Nam J, et al. Expression of matrix metalloproteinases and their inhibitors in different immunohistochemical-based molecular subtypes of breast cancer. BMC Cancer. 2014;14:959 pubmed publisher
  375. Leung S, Rice P, Barton J. In vivo molecular mapping of the tumor microenvironment in an azoxymethane-treated mouse model of colon carcinogenesis. Lasers Surg Med. 2015;47:40-9 pubmed publisher
  376. Kuo H, Huang Y, Tseng C, Chen Y, Chang Y, Shih H, et al. PML represses lung cancer metastasis by suppressing the nuclear EGFR-mediated transcriptional activation of MMP2. Cell Cycle. 2014;13:3132-42 pubmed publisher
  377. Bollu L, Ren J, Blessing A, Katreddy R, Gao G, Xu L, et al. Involvement of de novo synthesized palmitate and mitochondrial EGFR in EGF induced mitochondrial fusion of cancer cells. Cell Cycle. 2014;13:2415-30 pubmed publisher
  378. Smithline Z, Nikonova A, Hensley H, Cai K, Egleston B, Proia D, et al. Inhibiting heat shock protein 90 (HSP90) limits the formation of liver cysts induced by conditional deletion of Pkd1 in mice. PLoS ONE. 2014;9:e114403 pubmed publisher
  379. Diesenberg K, Beerbaum M, Fink U, Schmieder P, Krauss M. SEPT9 negatively regulates ubiquitin-dependent downregulation of EGFR. J Cell Sci. 2015;128:397-407 pubmed publisher
  380. Peng H, Kaplan N, Yang W, Getsios S, Lavker R. FIH-1 disrupts an LRRK1/EGFR complex to positively regulate keratinocyte migration. Am J Pathol. 2014;184:3262-71 pubmed publisher
  381. Hong Y, Kim J, Pectasides E, Fox C, Hong S, Ma Q, et al. Src mutation induces acquired lapatinib resistance in ERBB2-amplified human gastroesophageal adenocarcinoma models. PLoS ONE. 2014;9:e109440 pubmed publisher
  382. Tan L, Wang J, Tanizaki J, Huang Z, Aref A, Rusan M, et al. Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitors. Proc Natl Acad Sci U S A. 2014;111:E4869-77 pubmed publisher
  383. Bantikassegn A, Song X, Politi K. Isolation of epithelial, endothelial, and immune cells from lungs of transgenic mice with oncogene-induced lung adenocarcinomas. Am J Respir Cell Mol Biol. 2015;52:409-17 pubmed publisher
  384. Li N, Ramil C, Lim R, Lin Q. A genetically encoded alkyne directs palladium-mediated protein labeling on live mammalian cell surface. ACS Chem Biol. 2015;10:379-84 pubmed publisher
  385. Young O, Tang Z, Niven Fairchild T, Tadesse S, Krikun G, Norwitz E, et al. Toll-like receptor-mediated responses by placental Hofbauer cells (HBCs): a potential pro-inflammatory role for fetal M2 macrophages. Am J Reprod Immunol. 2015;73:22-35 pubmed publisher
  386. Gao X, Yu L, Moore A, Kissling G, Waalkes M, Dixon D. Cadmium and proliferation in human uterine leiomyoma cells: evidence of a role for EGFR/MAPK pathways but not classical estrogen receptor pathways. Environ Health Perspect. 2015;123:331-6 pubmed publisher
  387. Holland W, Chinn D, Lara P, Gandara D, Mack P. Effects of AKT inhibition on HGF-mediated erlotinib resistance in non-small cell lung cancer cell lines. J Cancer Res Clin Oncol. 2015;141:615-26 pubmed publisher
  388. De Santis R, Rosi A, Anastasi A, Chiapparino C, Albertoni C, Leoni B, et al. Efficacy of aerosol therapy of lung cancer correlates with EGFR paralysis induced by AvidinOX-anchored biotinylated Cetuximab. Oncotarget. 2014;5:9239-55 pubmed
  389. Hamdollah Zadeh M, Amin E, Hoareau Aveilla C, Domingo E, Symonds K, Ye X, et al. Alternative splicing of TIA-1 in human colon cancer regulates VEGF isoform expression, angiogenesis, tumour growth and bevacizumab resistance. Mol Oncol. 2015;9:167-78 pubmed publisher
  390. Carpenter E, Rader J, Ruden J, Rappaport E, Hunter K, Hallberg P, et al. Dielectrophoretic capture and genetic analysis of single neuroblastoma tumor cells. Front Oncol. 2014;4:201 pubmed publisher
  391. Arasada R, Amann J, Rahman M, Huppert S, Carbone D. EGFR blockade enriches for lung cancer stem-like cells through Notch3-dependent signaling. Cancer Res. 2014;74:5572-84 pubmed publisher
  392. Egloff A, Lee J, Langer C, Quon H, Vaezi A, Grandis J, et al. Phase II study of cetuximab in combination with cisplatin and radiation in unresectable, locally advanced head and neck squamous cell carcinoma: Eastern cooperative oncology group trial E3303. Clin Cancer Res. 2014;20:5041-51 pubmed publisher
  393. Li L, Wu P, Lee J, Li P, Hsieh W, Ho C, et al. Hinokitiol induces DNA damage and autophagy followed by cell cycle arrest and senescence in gefitinib-resistant lung adenocarcinoma cells. PLoS ONE. 2014;9:e104203 pubmed publisher
  394. Czaplinska D, Turczyk L, Grudowska A, Mieszkowska M, Lipinska A, Skladanowski A, et al. Phosphorylation of RSK2 at Tyr529 by FGFR2-p38 enhances human mammary epithelial cells migration. Biochim Biophys Acta. 2014;1843:2461-70 pubmed publisher
  395. Wang J, Mikse O, Liao R, Li Y, Tan L, Jänne P, et al. Ligand-associated ERBB2/3 activation confers acquired resistance to FGFR inhibition in FGFR3-dependent cancer cells. Oncogene. 2015;34:2167-77 pubmed publisher
  396. Zhu Z, Liu Y, Li K, Liu J, Wang H, Sun B, et al. Protein tyrosine phosphatase receptor U (PTPRU) is required for glioma growth and motility. Carcinogenesis. 2014;35:1901-10 pubmed publisher
  397. Tjin Tham Sjin R, Lee K, Walter A, Dubrovskiy A, Sheets M, Martin T, et al. In vitro and in vivo characterization of irreversible mutant-selective EGFR inhibitors that are wild-type sparing. Mol Cancer Ther. 2014;13:1468-79 pubmed publisher
  398. Sakane H, Horii Y, Nogami S, Kawano Y, Kaneko Kawano T, Shirataki H. ?-Taxilin interacts with sorting nexin 4 and participates in the recycling pathway of transferrin receptor. PLoS ONE. 2014;9:e93509 pubmed publisher
  399. Zhang L, Castanaro C, Luan B, Yang K, Fan L, Fairhurst J, et al. ERBB3/HER2 signaling promotes resistance to EGFR blockade in head and neck and colorectal cancer models. Mol Cancer Ther. 2014;13:1345-55 pubmed publisher
  400. Pan T, Sun J, Hu J, Hu Y, Zhou J, Chen Z, et al. Cytohesins/ARNO: the function in colorectal cancer cells. PLoS ONE. 2014;9:e90997 pubmed publisher
  401. Jiang P, Nishimura T, Sakamaki Y, Itakura E, Hatta T, Natsume T, et al. The HOPS complex mediates autophagosome-lysosome fusion through interaction with syntaxin 17. Mol Biol Cell. 2014;25:1327-37 pubmed publisher
  402. Stahlschmidt W, Robertson M, Robinson P, McCluskey A, Haucke V. Clathrin terminal domain-ligand interactions regulate sorting of mannose 6-phosphate receptors mediated by AP-1 and GGA adaptors. J Biol Chem. 2014;289:4906-18 pubmed publisher
  403. Stratmann A, Fecher D, Wangorsch G, Göttlich C, Walles T, Walles H, et al. Establishment of a human 3D lung cancer model based on a biological tissue matrix combined with a Boolean in silico model. Mol Oncol. 2014;8:351-65 pubmed publisher
  404. Gowing G, Shelley B, Staggenborg K, Hurley A, Avalos P, Victoroff J, et al. Glial cell line-derived neurotrophic factor-secreting human neural progenitors show long-term survival, maturation into astrocytes, and no tumor formation following transplantation into the spinal cord of immunocompromised rats. Neuroreport. 2014;25:367-72 pubmed publisher
  405. Grivas P, Day K, Karatsinides A, Paul A, Shakir N, Owainati I, et al. Evaluation of the antitumor activity of dacomitinib in models of human bladder cancer. Mol Med. 2013;19:367-76 pubmed publisher
  406. Yu L, Cheng H, Yang S. Clinicopathological and extensive immunohistochemical study of a type II pleuropulmonary blastoma. Fetal Pediatr Pathol. 2014;33:1-8 pubmed publisher
  407. Chen Z, Chen J, Gu Y, Hu C, Li J, Lin S, et al. Aberrantly activated AREG-EGFR signaling is required for the growth and survival of CRTC1-MAML2 fusion-positive mucoepidermoid carcinoma cells. Oncogene. 2014;33:3869-77 pubmed publisher
  408. Burel Vandenbos F, Turchi L, Benchetrit M, Fontas E, Pedeutour Z, Rigau V, et al. Cells with intense EGFR staining and a high nuclear to cytoplasmic ratio are specific for infiltrative glioma: a useful marker in neuropathological practice. Neuro Oncol. 2013;15:1278-88 pubmed publisher
  409. Minai L, Yeheskely Hayon D, Yelin D. High levels of reactive oxygen species in gold nanoparticle-targeted cancer cells following femtosecond pulse irradiation. Sci Rep. 2013;3:2146 pubmed publisher
  410. Brouxhon S, Kyrkanides S, Teng X, O Banion M, Clarke R, Byers S, et al. Soluble-E-cadherin activates HER and IAP family members in HER2+ and TNBC human breast cancers. Mol Carcinog. 2014;53:893-906 pubmed publisher
  411. Neeraja Dharmaraj -, Engel B, Carson D. Activated EGFR stimulates MUC1 expression in human uterine and pancreatic cancer cell lines. J Cell Biochem. 2013;114:2314-22 pubmed publisher
  412. Sigurdsson V, Ingthorsson S, Hilmarsdottir B, Gustafsdottir S, Franzdóttir S, Arason A, et al. Expression and functional role of sprouty-2 in breast morphogenesis. PLoS ONE. 2013;8:e60798 pubmed publisher
  413. Fong G, Backman L, Andersson G, Scott A, Danielson P. Human tenocytes are stimulated to proliferate by acetylcholine through an EGFR signalling pathway. Cell Tissue Res. 2013;351:465-75 pubmed publisher
  414. Vartanian S, BENTLEY C, Brauer M, Li L, Shirasawa S, Sasazuki T, et al. Identification of mutant K-Ras-dependent phenotypes using a panel of isogenic cell lines. J Biol Chem. 2013;288:2403-13 pubmed publisher
  415. Danysh B, Constantinou P, Lukianova Hleb E, Lapotko D, Carson D. The MUC1 Ectodomain: A Novel and Efficient Target for Gold Nanoparticle Clustering and Vapor Nanobubble Generation. Theranostics. 2012;2:777-87 pubmed publisher
  416. Yamashita M, Chattopadhyay S, Fensterl V, Saikia P, Wetzel J, Sen G. Epidermal growth factor receptor is essential for Toll-like receptor 3 signaling. Sci Signal. 2012;5:ra50 pubmed publisher
  417. Restivo G, Nguyen B, Dziunycz P, Ristorcelli E, Ryan R, Özuysal Ö, et al. IRF6 is a mediator of Notch pro-differentiation and tumour suppressive function in keratinocytes. EMBO J. 2011;30:4571-85 pubmed publisher
  418. Qi H, Zheng X, Yuan X, Pflugfelder S, Li D. Potential localization of putative stem/progenitor cells in human bulbar conjunctival epithelium. J Cell Physiol. 2010;225:180-5 pubmed publisher
  419. Roepstorff K, Grandal M, Henriksen L, Knudsen S, Lerdrup M, Grøvdal L, et al. Differential effects of EGFR ligands on endocytic sorting of the receptor. Traffic. 2009;10:1115-27 pubmed publisher
  420. Goldstein N, Decker D, Severson D, Schell S, Vicini F, Margolis J, et al. Molecular classification system identifies invasive breast carcinoma patients who are most likely and those who are least likely to achieve a complete pathologic response after neoadjuvant chemotherapy. Cancer. 2007;110:1687-96 pubmed
  421. Choi S, Mendrola J, Lemmon M. EGF-independent activation of cell-surface EGF receptors harboring mutations found in gefitinib-sensitive lung cancer. Oncogene. 2007;26:1567-76 pubmed
  422. Kraemer K, Schmidt U, Fuessel S, Herr A, Wirth M, Meye A. Microarray analyses in bladder cancer cells: inhibition of hTERT expression down-regulates EGFR. Int J Cancer. 2006;119:1276-84 pubmed
  423. Pangburn H, Kraus H, Ahnen D, Rice P. Sulindac metabolites inhibit epidermal growth factor receptor activation and expression. J Carcinog. 2005;4:16 pubmed
  424. Dawson J, Berger M, Lin C, Schlessinger J, Lemmon M, Ferguson K. Epidermal growth factor receptor dimerization and activation require ligand-induced conformational changes in the dimer interface. Mol Cell Biol. 2005;25:7734-42 pubmed
  425. Shen X, Kramer R. Adhesion-mediated squamous cell carcinoma survival through ligand-independent activation of epidermal growth factor receptor. Am J Pathol. 2004;165:1315-29 pubmed
  426. Traxler P, Allegrini P, Brandt R, Brueggen J, Cozens R, Fabbro D, et al. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity. Cancer Res. 2004;64:4931-41 pubmed
  427. Garcia Echeverria C, Pearson M, Marti A, Meyer T, Mestan J, Zimmermann J, et al. In vivo antitumor activity of NVP-AEW541-A novel, potent, and selective inhibitor of the IGF-IR kinase. Cancer Cell. 2004;5:231-9 pubmed
  428. Pedersen M, Tkach V, Pedersen N, Berezin V, Poulsen H. Expression of a naturally occurring constitutively active variant of the epidermal growth factor receptor in mouse fibroblasts increases motility. Int J Cancer. 2004;108:643-53 pubmed